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Abstract 
 
Human population-based studies of longitudinal design observe that higher 
intelligence in youth confers protection from premature mortality in adulthood. This 
field of study (“cognitive epidemiology”; Deary & Batty, 2007) has firmly 
established associations between intelligence and health outcomes, and has begun to 
address the likely mechanisms involved. The present thesis assessed some social, 
educational, and lifestyle factors that potentially confound and/or mediate the 
intelligence-mortality link. 
First, I carried out a systematic review of longitudinal cohort studies 
reporting intelligence differences in youth in relation to adult mortality risk, and in 
meta-analysis I aggregated the effect sizes from 16. A one SD advantage in 
intelligence scores was associated with 24% (95% CI 23% to 25%) lower risk of 
death, during 17- to 69-year follow-up; this magnitude showed no sex differential. 
Socioeconomic status in early life did not explain the effect. Rather, the person’s 
own occupational status in adulthood and educational attainment explained a third 
and a half of the association, respectively. 
One issue in controlling for education, in such models, is its strong 
correlation with intelligence test performance, which could lead to statistical 
overadjustment. A second aspect of this thesis, therefore, addressed the nature of the 
intelligence-education covariance in two behaviour-genetic studies of large general 
population-based samples of schoolchildren from England and The Netherlands. 
Previous studies that reported intelligence—education genetic covariances were 
potentially biased in their use of twin self-selection or pre-selection sampling. 
Moreover, the analysis in this thesis used a novel statistical approach, and included 
non-twin data to represent fully the variance in performance scores of a population. 
Analysis of the English cohort confirmed the top end of estimates from previous 
studies: 76% to 88% of the phenotypic correlation was due to heritability. The Dutch 
cohort showed greater variance for equivalent estimates (33% to 100%). The results 
indicate a limit to the extent to which education and intelligence might be causative 
of one another suggesting caution in interpreting some of the substantive attenuation 
effects by education reported in the literature. 
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Third, I investigated pathways from intelligence to cardiovascular disease 
risk factors, given the consistent and robust finding that an advantage in intelligence 
relates to lower cardiovascular disease-outcomes. I used data from the 1958 National 
Child Development Study to investigate age-11 intelligence in association with 
inflammatory and haemostatic biomarker status at age 46 years. The results 
replicated inverse associations previously reported in an older age sample, and a one 
SD advantage in intelligence related to a 1.1mg/L decrease in C-reactive protein. The 
effect was largely mediated by lifestyle factors, including smoking, occupational 
status and abdominal obesity. In two further studies I used the west of Scotland 
Twenty-07 cohort, to investigate processing speeds among 16, 36 and 56 year-olds in 
relation to: (1) Inflammation, and (2) metabolic-risk, after 20 years. The advantage of 
experimental rather than psychometric measures of cognitive ability is their reduced 
cultural and social bias. Faster reaction time predicted lower systemic inflammation 
in the youngest male cohort, which appeared to be partially confounded by baseline 
smoking and socioeconomic status. Furthermore, advantage in reaction time 
performance in the young and middle-aged cohorts significantly predicted reduced 
metabolic risk. This was partially explained by occupational status, but retained 
statistical significance in some fully-adjusted models. A one SD advantage in age 16 
simple reaction time variability, related to the 21% (95% CI 12% to 30%) reduced 
odds of metabolic syndrome by age 36 in the basic model, and this effect remained 
unchanged after controlling for all covariates. 
The growing evidence for specific social and behavioural factors that mediate 
intelligence-to-mortality pathways are discussed, in respect of indirect evidence that 
underlying system integrity or early life confounding may contribute incrementally 
to the effect.  
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Cognitive epidemiology defined 
 
Cognitive epidemiology is a new field for the study of individual differences, 
attempting to understand associations between premorbid cognitive ability (I shall 
also use the terms intelligence, mental ability, IQ) and health outcomes, particularly 
morbidity and mortality. The concept of intelligence in association with health may 
be a familiar one. Evidence in the field of cognitive ageing has related somatic 
diseases to a subsequent decline in intellectual function (Arvanitakis, Wilson, & 
Bennett, 2006; Comijs et al., 2009; Kivipelto et al., 2005; Okereke et al., 2008; 
Rafnsson, Deary, Smith, Whiteman, & Fowkes, 2007; Yaffe et al., 2004). Cross-
sectional studies pervade the health psychology literature demonstrating that mental 
performance and physical health variables significantly correlate. Examining the 
influences of individual differences in cognitive ability upon health is a more recent 
endeavour, with rapid progress in the last decade. Cognitive epidemiology began 
with the observation that scores on mental ability tests inversely correlated with the 
risk of all-cause mortality over a long-term follow-up. This finding has resonance for 
several disciplines. For differential psychologists it is further evidence for the 
predictive validity of general intelligence (g), the highly stable (Deary, Whalley, 
Lemmon, Crawford, & Starr, 2000) and heritable (Deary, Johnson, & Houlihan, 
2009) trait that significantly correlates with other lifetime outcomes including 
educational attainment and career success (Deary, Strand, Smith, & Fernandes, 2007; 
Gottfredson, 1997; Schmidt & Hunter, 2004). For epidemiologists, clinicians and 
policy makers the observation has importance in its contribution to understanding 
health inequalities in populations. The field has gained momentum and already a 
large body of empirical work exists which is helping to map out the underlying 
mechanisms relating cognitive ability to health outcomes.  
This chapter presents the latest empirical evidence from the field, and key 
issues that merit further investigation and understanding. Before doing so, two 
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important areas are covered. First, a brief historical context is presented on the events 
leading up to cognitive epidemiology becoming a defined area of research. Second, 
in recognition that the field brings together two main disciplines – differential 
psychology and epidemiology – I briefly introduce the psychology reader to some 
key concepts and methods in epidemiology. Evidence from the field’s empirical 
work comes in the following order of presentation: Premorbid intelligence in relation 
to all-cause mortality; cause-specific mortality and morbidities; and, disease risk 
factors. The final section of this chapter discusses the likely mechanisms that may 
explain these associations, with attention given to methods that should help to 
consolidate these in the future. 
 
A brief history 
 
A paper by Maller (1933) is cited as the first observational study to report an 
inverse association between childhood mental ability scores and risk of mortality 
(Deary & Batty, 2006; Gottfredson, 2004). This took the average mental ability test 
scores of schools distributed among 310 geographical areas of New York City, 
linking them to mortality rates in 1930 for each region. The correlation was r = -.43, 
such that higher IQ scores were associated with lower mortality risk. The study was 
important in observing a trend, but it was 55 years later that one of the first known 
peer-reviewed empirical studies to use individual data on premorbid intelligence and 
adult mortality was published. The Australian Veterans Health Studies linked mental 
ability test scores of over 2,300 servicemen born between 1947 and 1953, with 
mortality records spanning 17 years after IQ testing (O’Toole, Adena, & Jones, 
1988). The results showed that deceased ex-servicemen by follow-up had 
significantly lower mean scores on the Army Classification Test compared to those 
who were still alive at follow-up. The next published evidence followed 13 years 
later in the British Medical Journal, also reporting an inverse association between IQ 
and risk of mortality (Whalley & Deary, 2001). This study’s cohort represented 80% 
of children (n = 2,230) born in Aberdeen, Scotland in 1921, who were part of the 
Scottish Mental Survey 1932 (SMS32). It was a population-wide study, which 
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applied the same intelligence test to almost every child in Scotland born in 1921. The 
follow-up period for mortality was 65 years. The authors reported a significant 
hazard ratio of 0.79 (95% CI 0.75 to 0.84) for the risk of mortality by 76 years of 
age, given one SD advantage in IQ scores at age 11, and a hazard ratio of 0.63 (95% 
CI 0.56 to 0.71) for all-cause mortality given a two SD advantage in IQ. This study 
heralded several recent studies in the field, and had some strengths: A population-
representative cohort with long-term follow-up; publication in a general medical 
journal, which brought the IQ-mortality association to a wider readership; reporting 
hazard ratios for the risk of mortality – statistics more familiar to epidemiologists 
(see later section on Measuring risk for an explanation of hazard ratios, and related 
measures of risk) – which brought an individual differences measure into the arena of 
public health.   
The contribution that individual differences in general cognitive ability could 
make to understanding health inequalities had been suggested before, although it was 
recognized that epidemiologists might not readily embrace this idea:  
 
[IQ]’s potential for informing public policy is grossly underappreciated. In 
part, this neglect is because intellectual assessment is typically focused on 
individuals (a hallmark of the psychometric approach) as distinct from 
populations (more of an epidemiological approach)” (Lubinski & 
Humphreys, 1997, p.159-160). 
 
Opinion pieces followed, emphasizing the importance of cognitive ability to 
health outcomes (Gottfredson & Deary, 2004), and proposing possible mechanisms 
to explain the association (Batty & Deary, 2004).   A theoretical review posited that 
intelligence might be the underlying cause of the well-documented socioeconomic 
inequalities in health (Gottfredson, 2004). The empirical work has continued, with 
existing large cohorts replicating the inverse intelligence-mortality link, giving 
further credibility to the basic finding. These have included (in publication date 
order): A second cohort of the SMS32 involving 922 men and women followed up 
for 69 years (Hart et al., 2003); the Danish Metropolit Study of 7,308 members, in 
which members completed IQ tests at 12 years and were followed up 33 years later 
(Osler et al., 2003); the Swedish Conscripts Birth Cohort 1949-51, involving 49,262 
men who took mental ability tests at 18 to 20 years and who were followed up for 31 
  4 
years (Hemmingsson, Melin, Allebeck, & Lundberg, 2006); a cohort of the Vietnam 
Experience Study (VES) with IQ test scores from the time of military conscription, 
who were followed up to a mean age of 53 years (Batty, Shipley, Mortensen, Boyle, 
et al., 2008).  
  The term “cognitive epidemiology” was first defined by Deary and Der 
(2005) in the journal Psychological Science. A glossary of the field, including a 
description of common epidemiological and intelligence-related concepts, was 
published in the Journal of Epidemiology and Community Health (Deary & Batty, 
2007). In the same year, a systematic review in Annals of Epidemiology collected the 
inverse associations between premorbid IQ and total mortality (Batty, Deary, & 
Gottfredson, 2007). Overview articles published in the journals Intelligence (Deary, 
2009; Lubinski, 2009), Maturitas (Kilgour, Starr, & Whalley, 2009), and Nature 
(Deary, 2008) summarised research in the field and developed the discussion 
surrounding potential mechanisms of the intelligence-mortality link. Crucially, a 
special issue on cognitive epidemiology (Vol. 37, No. 6) was published in 
Intelligence in 2009, advancing understanding of issues that have emerged more 
recently, with articles covering: Mediators along the intelligence-disease pathway 
including behaviour (Anstey, Low, Christensen, & Sachdev, 2009), medical 
compliance (Deary, Gale et al., 2009), substance use and abuse (Johnson, Hicks, 
McGue, & Iacono, 2009); the relation of cognitive ability to specific morbidities 
such as cardiovascular disease (Singh-Manoux et al., 2009), metabolic syndrome 
(Richards et al., 2009), and psychiatric health (Gale, Hatch, Batty, & Deary, 2009); 
the contribution of a ‘fitness factor’ in understanding underlying causes (Arden, 
Gottfredson, & Miller, 2009). The main findings of this empirical work are presented 
following this next section, on epidemiological practices.   
 
Finding roots in epidemiology 
 
A definition of epidemiology is:  
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The study of the distribution and determinants of health-related states and 
events in populations, and the application of this study to control health 
problems (Last, 1988, p.159) 
 
For cognitive epidemiology to prosper in this context, the disciplines of 
differential psychology and epidemiology should each aim to establish roots in the 
other. The field asks that epidemiologists give greater consideration to genetic 
influences on health inequalities, in balance with established environmental factors 
(Deary, 2010), and that psychometric intelligence tests, as valid and stable measures 
of general cognitive ability, are given credence. Conversely, psychologists studying 
individual differences require understanding of fundamental principles of 
epidemiology, distinguishing association from causation for one (Rothman & 
Greenland, 2005), and need to apply them using their variables, if they are to make 
valid contributions to the field. Such key epidemiological concepts and methods are 
introduced here, with examples given from cognitive epidemiology. More in depth 
coverage of these can be found in introductory, (Rothman, 2002) or comprehensive, 




Evaluating the evidence that cognitive ability is a direct, or indirect, causal 
factor for health outcomes is a complex challenge, familiar to epidemiologists who 
must carefully interpret new associations between risk factors and disease. Sets of 
guidelines available to observational epidemiology are useful tools in deciding upon 
whether causation can be reliably deduced. Table 1.1 presents a recent list of six such 
criteria (Bhopal, 2008), which find their origin in Bradford Hill’s (1965) nine 
“viewpoints”, with some credit given to Evans’ (1978) “rules of evidence”. Here 
each of these in turn is discussed, with relevance to validating the likelihood of 




  6 
The first criterion, temporality, considers if the measure of exposure precedes 
signs or symptoms of disease and can therefore be conceptualized as a predictor 
variable. In cognitive epidemiology, the most robust means to evaluate this comes 
from longitudinal cohort studies that link cognitive ability scores of children or 
young adults with their medical or mortality records in later adult life. Although 
general cognitive ability scores show high stability across the life-course (Deary et 
al., 2000), studies referenced in this chapter’s introduction show that onset of certain 
somatic diseases or their treatments, can result in changes to cognitive function. 
Therefore, cohorts that are young at the time of IQ testing reduce the risk of reverse 




The strength of an association is a second guideline, asking whether variation 
in the exposure is associated with differences in the risk of disease, which would give 
credence in support of causality. Large population datasets that have full, 
representative distributions of intelligence are best suited to evaluate this criterion, as 
are cohorts with longer periods of follow-up that increase the number of disease or 
mortality cases, ensuring adequate statistical power. Cognitive epidemiology has 
been fortunate to have such datasets available from several Westernized countries, 
including Australia, Scandinavia, US and the UK (Batty, Deary, & Gottfredson, 
2007). In most cases these have been government initiatives via educational or 
military institutions. Such sizeable and representative cohorts are quite novel to 
psychological research, which often draws upon smaller convenience samples, 
including student populations. Detailed descriptions of many of these cohorts are 
available elsewhere (Deary & Batty, 2011), but two examples include: The Scottish 
Mental Surveys of 1932 and 1947 (SMS32 and SMS47) involving mental ability 
scores from the majority of 11-year-olds who were born in Scotland in 1921 and 
1936 respectively, and who were attending schools on specific dates of testing in 
1932 and 1947 (see Deary, Whalley & Starr, 2009 for cohort profile). Together these 
cohorts involve over 150,000 individual children’s data, and follow up for health 
information on subsamples of the cohorts has so far been 69 years. The second 
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example of a population-based cohort is the Swedish Conscripts Study, including 
over 1.3 million men with IQ test scores taken at 18 years of age, at entry to national 
service, representing nearly the entire Swedish male population born during 1950 to 
1976 (Batty, Wennerstad, et al., 2007). These data are linked to recent detailed Cause 
of Death registers from Sweden, and because the maximum age at follow-up is about 
50 years at the present time, this cohort will continue to gain in value with the greater 
number of mortality data.  Evidence for the varying strength of the association 
between intelligence and mortality is discussed later on.   
 
 3. Specificity 
 
In support of causation is also the evidence for the specificity of an 
association: Does intelligence relate more strongly to the risk of some diseases over 
others? Findings from single cohort studies can indicate differences in the risk of 
particular causes of death associated with mental ability scores. For example, in the 
Swedish Conscripts study, a one SD decrease in IQ was associated with a 31% 
increased risk of coronary heart disease (CHD)-mortality, a 22% increased risk of 
accident and suicide-related mortalities, and a 3% increased risk of total cancer 
deaths by middle-age (Batty, Wennerstad, et al., 2009). However, such findings 
require replication to support specificity. Evaluation of empirical data on cause-




A fourth guideline, consistency, demands that the association between 
exposure and outcome be replicated across cohorts of varying time, place and 
circumstance, if causation is to be inferred (Bradford Hill, 1965). So far, this has 
been supported by a systematic review of premorbid IQ and all-cause mortality, 
which reported a significant inverse association across nine cohorts from five 
different countries (although all Caucasian). Mental ability scores came from a range 
of intelligence test batteries. Cohort members were born in various decades of the 
twentieth century, and were either representative of military personnel or, more 
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broadly, schoolchildren, from their background populations (Batty, Deary, 
Gottfredson, 2007).  
 
5. Biological plausibility 
 
A biological plausibility of the association between premorbid intelligence 
and morbidity is the most challenging to test of Bradford Hill’s criteria. A biological 
explanation for the intelligence-mortality association is presented by system integrity 
theory, which implies an underlying complex physiology that determines both 
cognition and health outcomes; this hypothesis may ultimately be addressed by the 
field of genetics research. An alternative explanation is that intelligence may act 
indirectly upon health outcomes, by determining health behaviours and 
socioeconomic factors in adulthood. These central theories are discussed in the final 
section of this chapter.  
 
5. Experimental evidence 
 
Experimental evidence for causation is another problematic guideline for the 
field of cognitive epidemiology to address. However, if a genetic or environmental 
exposure was identified that naturally showed changes to individuals’ intelligence 
test scores, then exposed versus non-exposed participants of a cohort could 
theoretically be tested and followed up for the risk of disease.  
 
Real or artefact? 
 
Confounding is a perennial problem in observational epidemiology and must 
be continuously appraised and tested in order to avoid errors of interpretation. For 
example, childhood socioeconomic status (SES), commonly indicated by factors 
such as family income, parental occupation, or education, is often cited as a potential 
confounder in the association between premorbid intelligence and health. In social 
epidemiology, childhood SES is studied as an underlying factor of health inequalities 
within populations, where cognitive resources are largely ignored, or regarded as 
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mediators of a SES-health phenomenon (Gallo, Espinosa de los Monteros, & Shipuri, 
2009; Lleras-Muney, 2005; Bartley & Plewis, 2007). The converse view taken is that 
intelligence may be the underlying cause of social inequalities in health (Gottfredson, 
2004). Whether the contribution of intelligence to health outcomes is a real effect, or 
an artefact of confounding SES factors, is addressed by cohort studies that contain 
detailed childhood measures of both variables. Some of this evidence is discussed 




Epidemiologists routinely use logistic regression or Cox proportional hazards 
regression when quantifying the relationship between a variable and disease risk. 
These methods are appropriate given that the health outcome is nearly always 
binomial: For example, disease or no disease; dead or alive. The odds ratio (OR) is 
the measure of risk probability derived from logistic regression (Cox, 1958), and in 
epidemiology is the ratio between two likelihoods of a health outcome occurring 
given a particular exposure, and of the health outcome not occurring given the same 
exposure. The hazard ratio (HR) is a similar proportional measure, derived from Cox 
proportional hazards regression (Cox, 1972), but is the preferred statistic by 
epidemiologists (Symons & Moore, 2002) because it takes in to account the time to 
an event for each individual, rather than assuming that the magnitude of risk is 
constant in respect of time.  
In cognitive epidemiology, when the exposure variable is continuous (e.g., as 
in IQ-type scores) it can be represented as a unit (per-point) difference, or a one SD 
difference in intelligence scores. The hazard or odds ratio are reported with their 
95% confidence interval (CI) giving an indication of the statistical significance of 
risk. Both effect sizes have null effects at 1, and a confidence interval that includes 1 
indicates that there is no statistically significant association between the health 
outcome (i.e. disease) and the exposure (e.g. IQ) at p < 0.05. Conventionally, if the 
ratio and its CI exceed 1, it indicates a significantly increased risk of disease given a 
specified SD decrease or increase in mental ability scores. Conversely, if an effect 
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size and its CI fall below 1, this indicates that risk of disease is significantly 
decreased given the unit change in test scores.  
The degree of risk is often reported as a percentage, so that for example, if a 
HR for mortality given a one SD increase in IQ is 0.78 this can be expressed as a 
22% reduced risk. Alternatively, a HR of 1.22 translates as a 22% increase in risk of 
disease. This expression offers a useful way to interpret the degree of attenuation by 
covariates, for example when studies report the HR before and after adjustment for 
SES. In understanding the risks generated by such analyses, it is always important to 
attend to the units of the exposure variable.  
 
Premorbid intelligence and risk of total mortality 
 
A systematic review published in the Annals of Epidemiology identified nine 
unrelated longitudinal cohorts, each one reporting a significant association between 
lower premorbid intelligence test scores and increased risk of all-cause mortality in 
adulthood (Batty, Deary, & Gottfredson, 2007). The paper not only helped to 
validate the IQ-mortality association, but it raised a number of questions for the field 
to address; for example: What is the size and nature of confounding by early life 
factors? What extent do adult SES factors mediate the association? Is the magnitude 
of the association the same for women as for men (most military cohorts were male-
only)? And, what is the influence of premorbid cognitive ability on specific causes of 
death?  
There has been a considerable increase in the publication frequency of 
intelligence versus all-cause mortality studies since the review. This has provided an 
opportunity to quantify the association using meta-analysis, and to address some of 
these pertinent issues, which is the subject of the next chapter. The systematic review 
I present in Chapter 2 involves an electronic search using strict inclusion criteria, to 
extract longitudinal studies where psychometric intelligence in youth have been 
associated with all-cause mortality by follow-up in adulthood.  
 
Gender differentials in intelligence-mortality associations 
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Gender differences in the onset, patterns and prevalence of health behaviours, 
risk factors, and disease (Anand et al., 2008; Wingard, 1984), might contribute to sex 
differentials in intelligence-health gradients. The SMS32 cohort was the first study to 
estimate IQ-mortality effects by sex, reporting a stronger association between 
childhood IQ and risk of mortality in women (more than double) compared to men 
(Whalley & Deary, 2001). However, the increased rate of death among high IQ-
scoring males during the Second World War may have reduced the effect size for 
men in this particular cohort. The UK’s National Survey of Health and Development 
(NSHD) study provided a more recent birth cohort, born in 1946, with cognitive 
scores at age 8 and followed up age 54. This study reported that, among male 
members with low cognitive scores, there was twice the risk of mortality compared 
to high scorers, whereas no effect was observed for women (Kuh, Richards, Hardy, 
Butterworth, & Wadsworth, 2004). However, the increased life expectancy of 
women compared to men, which reduces the relative number of female to male 
deaths, may have lost statistical power to this study. Indeed, in a more recent follow-
up of the same British cohort, with an increased number of female deaths, the effect 
became significant; that is, women scoring in the highest quartile for cognitive ability 
had a 51% reduced risk of mortality by follow-up, compared to those in the lowest 
quartile (Kuh et al., 2009). The meta-analysis in Chapter 2 reports on the aggregate 
effect sizes for the IQ-mortality association for men and women separately, to 
address the potential sex differential.   
 
Dose-response effects on all-cause mortality 
 
Studies that report on the risk of mortality according to a one SD difference in 
IQ-type scores assume a linear association. However, exploration of incremental 
effects on the intelligence-mortality slope could reveal a threshold beyond which an 
association no longer exists. The afore-described study of the 1946 cohort provided 
evidence that premorbid cognitive ability is only predictive of risk of death at the low 
end of the range for cognitive ability. Men who scored in the bottom quartile of the 
cognitive score distribution were reported to be at nearly twice the risk of mortality 
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compared to those scoring in the top quartile, whereas there were no statistically 
significant differences in risk of mortality between the second, third and top quartile 
groups (Kuh et al., 2004). After adjusting for educational attainment or adult SES the 
effect was removed, suggesting that the influence of cognitive ability on mortality 
might be mediated by adverse socioeconomic factors more common among low 
scorers (or that intelligence is a causal factor in these outcomes, as well as in health). 
Two further studies have also supported a threshold effect of cognitive ability on risk 
of all-cause mortality above the lower end of the IQ distribution (Hart et al., 2003; 
Hemmingsson et al., 2006). However, a US study of gifted children, with Stanford-
Binet IQ scores in the high range (135 to 163), reported a 32% decreased risk of 
mortality given one SD increase in IQ (Martin & Kubzansky, 2005), evidence that, 
even at the highest end of the IQ distribution, an intelligence-mortality gradient is 
observed. Furthermore, three population-representative cohorts support this (Batty, 
Wennerstad, et al., 2009; Osler et al., 2003; Whalley & Deary, 2001), ruling out the 
possibility that the effect is driven by specific health problems associated with 
learning disabilities (Batty & Deary, 2004). In a single study, over a million Swedish 
conscripts were divided evenly in to nine groups of ascending intelligence scores and 
a monotonic (linear) relationship was observed between IQ and risk of mortality 
(Batty, Wennerstad, et al., 2009). This is shown in the time-to-survival curve in 
Figure 1.2. This evidence emphasises the importance of a whole-population approach 
to understanding mechanisms relating premorbid intelligence to premature mortality. 
 
g or specific cognitive function? 
 
Despite the use of different cognitive ability test batteries among cohort 
studies used in cognitive epidemiology, including the Moray House Test, Wechsler 
Adult Intelligence Scale, Stanford-Binet, and Raven’s Progressive Matrices tests 
(Deary and Batty, 2007), the magnitude of the associations between their global IQ-
type scores and risk of all-cause mortality show relative consistency. It is likely 
therefore that the general intelligence factor (g), which accounts for up to half of the 
total variance in batteries of diverse mental ability tests’ scores (Carroll, 1993), is a 
better cognitive predictor of health outcomes than measures of specific cognitive 
  13 
function. In the Swedish Cohort Study performance scores on four cognitive tests 
including verbal reasoning, visuospatial ability, logical reasoning and technical 
ability, were each inversely associated with all-cause mortality to the same 
magnitude as that of a global cognitive score (Batty, Wennerstad, et al., 2009). 
However, among follow-up studies that have estimated the risk of mortality 
according to specific cognitive function measured in adulthood, a steeper gradient 
has been reported for fluid compared to crystallized intelligence (Batterham, 
Christensen, & Mackinnon, 2009), and a significant inverse association was shown 
for executive function but not for verbal and visuospatial reasoning abilities (Hall, 
Dubin, Crossley, Holmqvist, & D’Arcy, 2009). Still, until further cohort data of 
specific cognitive abilities in childhood become available, the issue remains as to 
whether specific cognitive function could relate differentially to health outcomes.  
One alternative indicator of cognitive function that has been measured in 
childhood, and that could help to explain mechanisms underlying associations with 
health outcomes, is processing speed. Reaction time tasks, which measure 
information processing efficiency, have been significantly associated with all-cause 
mortality, in that faster reaction times are associated with reduced risk (Deary & Der, 
2005). In this UK adult cohort of 898 members, reaction time also very substantially 
attenuated the association between IQ and all-cause mortality after 14 years’ follow 
up. This finding lends support to the system integrity theory (Whalley & Deary, 
2001) of intelligence’s associations with health outcomes, if processing speed is an 
effective indicator of neurological integrity which reflects overall physiological 
integrity. In Chapters 6 and 7 the Twenty-07 cohort is used to investigate 
associations between reaction time performances and CVD biomarkers measured 
after 20-year follow-up.  
 
Other psychological traits in cognitive epidemiology 
 
Intelligence measures remain the strongest and most consistent predictors of 
death in differential psychology, and yet behaviour traits such as personality may 
also be important risk factors for adult mortality, either independently or in 
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interaction with intelligence. In the SMS47 6-Day Sample 1,181 children who had 
IQ scores at age 11, and teacher-rated personality ratings at age 14, were followed-up 
for a period of 55 years for all-cause mortality (Deary, Batty, Pattie, & Gale, 2008). 
A dependability factor extracted from item scores measuring perseverance, 
conscientiousness, and stability of mood, was significantly associated with the 
reduced risk of death by follow-up. Furthermore, mortality risk was twice as great for 
children who scored in the bottom half of the IQ and dependability distributions, 
compared to those in the top half of those distributions. High scores on a neuroticism 
factor among US military conscripts were also significantly related to an increased 
risk of mortality (Weiss, Gale, Batty, & Deary, 2009). Neuroticism showed 
independent effects from IQ score in predicting risk of death, but an interaction 
effect was also reported; that is, the effect of intelligence on mortality was more 
pronounced at high levels of neuroticism, and, the effect of neuroticism on mortality 
was more pronounced at low levels of intelligence.  
More recently, a delinquency factor measured by the Minnesota Multiphasic 
Personality Inventory was associated with the risk of mortality at age 75, after 
controlling for the influences of education and IQ (Trumbetta, Seltzer, Gottesman, & 
McIntyre, 2010). However in this analysis, mean imputation was applied to a quarter 
of participants with missing IQ data, which may have weakened the effect of IQ in 
the model, particularly if missing cases were at the lower end of the distribution.  
 
Specific causes of morbidity and mortality 
 
A single theoretical basis for the intelligence association with total mortality 
is unlikely, given that causes of death vary so widely. For example, IQ’s association 
with risk of accidental injury (a leading cause of mortality in early adulthood) may 
not be explained by the same mechanism relating it to the risk of coronary heart 
disease (the main cause of death in Westernised countries by middle age). Unless it 
was shown that intelligence reflects a general propensity to look after one’s self in 
the short and longer terms. Many cohorts relevant to cognitive epidemiology have 
linked to death records that include specific causes of death, or medical or hospital 
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admission records that contain information on specific morbidities. In this section, 
empirical studies of the association between intelligence and specific causes of 
mortality and morbidity are reviewed, and the behavioural and psychological risk 




The higher incidence of cardiovascular disease (CVD)-related deaths 
compared to other causes of death in midlife has enabled several longitudinal studies 
to explore its risk according to premorbid intelligence. The first empirical data were 
from Scotland: 938 participants from the 1972 Midspan prospective cohort studies, 
whose IQ scores at age 11 were available from 1932, were followed up for a period 
of 25 years, by which time 43% had a CVD-related outcome (Hart et al., 2004). In 
this group a 15-point decrease in IQ was related to 11% increased risk of hospital 
admission or death due to CVD, with the risk increasing further for those events 
occurring up to 65 years (22%). Similar inverse associations for premorbid 
intelligence and risk of CVD diagnosis or death have been replicated by other well-
characterised cohorts, including: The SMS47 6-Day Sample (Deary, Whiteman, 
Starr, Whalley, & Fox, 2004), and the Swedish Conscripts Study 1940-51 in which 
data on nearly 50,000 men were collected (Hemmingsson et al., 2006). Coronary 
Heart Disease (CHD) and stroke are the most common causes of CVD-related deaths 
but albeit sharing some modifiable risk factors, they differ in their pathogeneses. It is 
therefore important to consider how intelligence might relate to each of these 
morbidities separately. 
 
Coronary heart disease 
 
In respect to risk of CHD outcomes the magnitude of the association with 
premorbid intelligence has been fairly consistent. The Midspan study by Hart et al. 
(2004) has been the longest follow-up study for CHD outcomes, reporting a 16% 
increased risk of CHD-related hospital admission or death according to a one SD 
decrease in IQ. This increased to a 29% risk once CHD events occurring above age 
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65 were excluded. Further cohorts, with follow-up to midlife, report similar findings.  
The Danish Metropolit study of 6,910 men born in 1953 in Copenhagen, obtained IQ 
test scores from 12 years, and traced cause-of-death and hospital discharge records to 
age 47 (Batty, Mortensen, Andersen, et al., 2005). Relative to the highest IQ scoring 
quartile, the lowest, second and third quartile groups had an increased risk of 170%, 
143% and 69%, respectively, for CHD events.  These effects were little changed 
after adjusting for early life factors, including birth weight and childhood SES. In a 
similar cohort design, the Aberdeen Children of the 1950s study of 11,125 members 
reported a 30% reduced risk of fatal or non-fatal CHD according to a one SD 
advantage in intelligence (Lawlor, Batty, Clark, Macintyre, & Leon, 2008). The risk 
of CHD in association with intelligence test scores was greater in women (51%) than 
in men (21%), and was also shown to be incremental when hazard ratios were 
calculated separately for eight groups of increasing IQ test score. However, after 
adjusting for education, the effects reduced to non-significance. The Swedish 
Conscripts study also reported attenuating effects of education on a 31% increased 
risk of CHD-mortality according to a one SD decrease in IQ, although this was by 
45% only, and the effect remained statistically significant (Batty, Wennerstad, et al., 
2009). In this study adjustment for early-life and physical factors including birth 
year, parental social class, BMI, blood pressure, and illness, made little change to the 




Studies of the association between premorbid intelligence and stroke have not 
been so definitive. This may be because the trend for an inverse association has not 
reached statistical significance in some cohorts (Batty, Mortensen, Andersen, et al., 
2005; Hart et al., 2004), owing to the lack of power from low numbers of stroke 
events. However, in a sufficiently large study - the Aberdeen Children of the 1950s - 
a one SD advantage in intelligence was significantly associated with a 32% reduced 
risk of incident stroke (Lawlor et al., 2008), an effect which increased for women 
compared to men. Furthermore, the Swedish Conscripts cohort was large enough to 
estimate effects of premorbid intelligence on risk of stroke subtype. The authors 
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reported inverse associations for all fatal and non-fatal stroke events, for each 
subtype, which were statistically significant in most cases (Wennerstad, 
Silventoinen, Tynelius, Bergman, & Rasmussen, 2009). However, the strongest 
association was estimated for hemorrhagic strokes, and there was a weaker effect for 
ischaemic strokes. Adjusting for childhood SES, BMI and systolic blood pressure, or 
education, only modestly attenuated these effects.    
 
CVD risk factors 
 
Established risk factors for CVD include diabetes mellitus, obesity or 
overweight, metabolic syndrome, and hypertension. If pathways between intelligence 
and cardiovascular outcomes are to be understood, then it is important to evaluate 
cognitive ability in relation to each of these. Among 7,476 men and women from the 
US National Longitudinal Survey of Youth (1979), with intelligence test scores from 
adolescence, a one SD increase in mental ability scores was associated with the 
significantly reduced odds of self-reported hypertension (16%), heart problems 
(16%) and diabetes (12%) at age 40 (Der, Batty, & Deary, 2009). Hypertension was 
also associated with childhood cognitive ability in the SMS32-Midspan cohort. 
Among 938 men and women a one SD increase in IQ was associated with a 3.15 
mmHg reduction in systolic blood pressure and a 1.5 mmHg reduction in diastolic 




Metabolic syndrome is characterised by a cluster of cardiovascular-risk 
factors including abdominal obesity, high blood pressure, high blood triglycerides, 
low HDL cholesterol, and hyperglycaemia. Data from the VES reported that 
premorbid intelligence scores were inversely associated with four out of five risk 
factors measured at midlife, including blood triglycerides, blood pressure, blood 
glucose and BMI. By adjusting for these, the risk of mortality from CVD according 
to IQ scores was attenuated by about a third. In the NSHD 1946, study a one SD 
advantage in IQ at age eight years was associated with a 14% reduced odds of 
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metabolic syndrome at 53 years of age (Richards et al., 2009). Of all the metabolic 
syndrome risk factors, lower IQ was most strongly associated with high blood 
pressure, blood triglycerides and abdominal obesity. Education or adult income 
attenuated the size of risk to non-significance, one interpretation of which is an 
indirect effect of cognitive ability on this cluster of risk factors. The inverse 
relationship between childhood IQ and risk of obesity and weight gain in midlife was 
also significant, according to data on nearly 10,000 men and women from the 1958 
National Child Development Study (Chandola, Deary, Blane, & Batty, 2006). This 
study reported a stronger effect of risk of obesity in women (38%) than men (26%) 
according to a one SD difference in IQ, and all effects were attenuated to non-
significance after adjusting for educational attainment.   
 
Emerging CVD biomarkers 
 
More recent work has begun to investigate the association between 
intelligence and emerging biomarkers for CVD. For example, one study reported that 
lower childhood cognitive ability was significantly associated with increased levels 
of C-reactive protein (CRP) and fibrinogen in blood samples taken between 67 and 
71 years of age (Luciano, Marioni, Gow, Starr, & Deary, 2009). Both are 
inflammatory markers that are frequently raised in patients with vascular diseases. 
An understanding of the mechanisms underlying the relation between cognitive 
ability and biomarkers of disease is warranted, in particular whether premorbid 
intelligence leads to health behaviours that increase inflammatory components of 
cells, or, whether inflammatory processes are an aspect of system integrity that 
underlie individual differences in intelligence. These questions are addressed to some 
extent in Chapters 5 and 6 of this thesis. 
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Given that cancers share some common modifiable risk factors with CVD, 
including obesity and smoking, it might be expected that the association between 
premorbid intelligence and cancer morbidities are consistent with those for CVD. 
However, the evidence to date does not support this. The Swedish Conscripts Study 
of nearly one million men reported a non-significant 3% increased risk of total 
cancer mortality according to a one SD decrease in IQ (Batty, Wennerstad, et al., 
2009). Similar negligible findings were reported from the earlier Swedish Conscripts 
Study (1949-51 birth cohort) that reported an increased risk of 4% for a one SD 
decrease in IQ (Hemmingsson et al., 2006), and the SMS32-Midspan cohort that 
reported a 8% increased risk of all-cancer-morality given the same unit change in IQ 
(Hart et al., 2003). However, one large U.S. military cohort has estimated a 
significant inverse relationship between IQ and risk of all-cancer mortality. Data 
from the Vietnam Experience Study, in which IQ scores were available for 14,491 
male conscripts at an average age of 20 years, were linked to cancer-mortality 
records up to middle age. A 27% increase in risk of all-cancer mortality was reported 
according to a one SD decrease in IQ (Batty, Mortensen, et al., 2009). This may be 
due to IQ’s association with specific cancers, as the risk was found particularly high 
for smoking-related cancer deaths (an increased risk of 37%).  
Given the many different types of cancers, with multiple causes and risk 
factors, it has been appropriate to look at the effects of IQ in relation to specific types 
of cancers, rather than treating them as a homogenous disease group.  Hart et al. 
(2003) reported a 36% increased risk of lung cancer associated with a one SD 
decrease in IQ, and a 46% increased risk in stomach cancer, although this failed to 
reach a level of statistical significance because of the small number of cases. No 
effects were observed for colorectal or breast cancers, but again larger cohorts would 
be required to achieve adequate statistical power. By far the largest study found 
statistically significant weak associations between intelligence and carcinoma of 
stomach (where any protective effect of intelligence was seen only in the highest 
intelligence tertile), but not lung or other cancer death; it also found that high 
intelligence was a risk factor for skin cancer (Batty, Wennerstad, et al., 2007). This 
latter effect may be due to the relation between higher intelligence and job income, 
and the resulting increased frequency of holidays spent in hot climates, although it 
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was only slightly attenuated after controlling for SES, and remained significant. It is 
possible that negative health behaviours such as smoking and poor diets may help 
understand mechanisms underlying IQ’s relation to particular malignancies. Future 





Given the inverse association between IQ and smoking and the positive 
association between IQ and smoking cessation uptake (Batty, Deary, & Macintyre, 
2007; Batty, Deary, Schoon, & Gale, 2007c; Taylor et al., 2003), it is perhaps 
unsurprising that higher premorbid IQ is also associated with the reduced risk of 
illnesses relating to respiratory function in adult life. For example, the NLSY79 
cohort reported a 22% reduced odds of developing chronic lung disease at age 40, 
according to a one SD increase in intelligence test scores (Der et al., 2009). 
Furthermore, two studies have demonstrated a significant association between 
childhood mental ability and improved lung capacity, based on forced expiratory 
volume (Deary, Whalley, Batty, & Starr, 2006; Richards, Strachan, Hardy, Kuh, & 
Wadsworth, 2005). This observation may be explained by IQ being positively related 
to height, and, by dint of their bodily habitus, taller people having high lung function, 
which may indicate a general fitness factor underlying the link between cognitive 
ability and these physical markers; however, in one study the positive association 
remained statistically significant after controlling for adult height in addition to birth 
weight, adult SES and lifetime smoking (Richards et al., 2005).  
 
Intentional and unintentional injury 
 
Unintentional injury or death can be the result of road traffic or industrial 
accidents, or falls for example. In the Danish Metropolit study higher childhood 
cognitive scores of 11,339 males were associated with a 22% reduced risk of fatal or 
nonfatal injury by road traffic accidents, falls or unintentional poisoning, by 48 years 
of age (Osler, Andersen, Laursen, & Lawlor, 2007). The effects of IQ on risk of 
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falling and poisoning were still significant after adjusting for educational status. IQ 
exposure was also inversely related to injury mortality among over one million 
Swedish men (Batty, Gale, et al., 2009). Low IQ scorers compared to the highest IQ 
scorers had a 482% increased risk of death by poisoning, a 339% increased risk of 
fire mortality, 217% increased risk of fall mortality, 216% higher risk of drowning, 
and a 117% increased risk of road injury mortality. The inverse association between 
cognitive ability and injury mortality was incremental across the IQ range, and SES 
inequalities explained about half of the total effects.  
The association between premorbid intelligence and accidental injury is 
consistently higher than that seen for chronic disease. However, this may only be the 
case for serious injuries that lead to hospitalisations or death. Studies that assess 
cognitive ability in relation to minor accidents or injuries can be complicated by 
problems of self-reporting. This may have affected differences in self-recall by 
participants from the British birth cohort of 1970, in which higher childhood 
cognitive scores were related to the increased reporting of accidents in the home by 
age 30 (Batty, Deary, Schoon, & Gale, 2007a).  
Intentional injury or death can be self-inflicted, for example attempted 
suicide, or it can be the result of others’ actions, including physical attack and 
homicide. Due to the low numbers of suicide and homicide cases in cohorts, only 
very large studies ensure sufficient statistical power with which to evaluate their 
associations with premorbid intelligence. A cross-sectional ecological study of 
census data from 48 European and Asian countries had reported a positive 
association between mean literacy rates and incidence of suicide among older adults, 
in that, the higher the literacy rate, the greater the incidence of suicide (Voracek, 
2005). However, such study design fails to take account of individual differences and 
changes in populations over time. Published in the same year, longitudinal data from 
the Swedish Conscripts Study reported a significant inverse association between 
premorbid intelligence test scores and risk of death by suicide up to midlife (Gunnell, 
Magnusson, & Rasmussen, 2005). The authors suggested that lower cognitive ability 
might contribute to an increased risk of suicide either because it is a risk factor for 
psychiatric illness, or because of a disadvantage in being able to resolve problems or 
personal crises. Within the same cohort Batty, Deary, Tengstrom, and Rasmussen 
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(2008) related the Swedish conscripts’ IQ scores to homicide mortality after twenty 
years of follow-up. A one SD increase in premorbid IQ was associated with a 51% 
reduced risk of death by homicide, and the effect was incremental across the IQ 
range. This effect was marginally attenuated by early life social factors, height, and 
somatic and psychiatric illness. Explanations for this finding included: People with 
higher IQ scores being more able to negotiate and resolve conflicts, or having a 
higher perception of risk; lower IQ scorers being more frequently intoxicated with 
alcohol or drugs; an association between the intelligence of perpetrator and victim 
(perpetrators of homicide have lower than average IQ scores) (Batty, Deary, 
Tengstrom, et al., 2008). Another explanation is the confounding influence of height, 
which, as described, has been positively associated with cognition (Gale, 2005; 
Vågerö & Modin, 2006), and may be protective against the threat of external 
physical attack (Batty, Deary, Tengstrom, et al., 2008). These potential explanations 
deviate from the mechanistic pathways posited for other cause-specific mortalities 
highlighting the need to evaluate multiple mechanistic models for intelligence and 
morbidity pathways.     
 
Behavioural risk factors for disease 
 
Tobacco smoking, excessive alcohol consumption and sedentary living are 
risk factors common to a range of life-threatening diseases, including CVD, which as 
reported above, shows some of the strongest and most consistent associations with 
premorbid intelligence. Longitudinal cohorts have been used to evaluate associations 
between premorbid mental ability and these health behaviours, to explore how they 




Higher childhood intelligence is positively associated with a reduced risk of 
current or previous cigarette smoking in adults (Batty, Deary, Schoon, et al., 2007c; 
Taylor et al., 2003), an effect which is attenuated by educational attainment, and to a 
lesser degree adult SES (Batty, Deary, Schoon, et al., 2007c). In two UK studies 
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smoking cessation in adulthood was more likely among higher childhood intelligence 
test scorers, particularly women (Batty, Deary, Schoon, et al., 2007c), and 
controlling for deprivation index attenuated the effect (Taylor et al., 2003). However, 
in the Swedish Conscripts Study (1949 to 1951), IQ was not associated with quitting 
smoking (Hemmingsson, Kriebel, Melin, Allebeck, & Lundberg, 2008). Members of 
this study would have been exposed to public health promotions of the 1970s to 
reduce smoking, at a younger age than cohort members of the previous two studies. 
This could suggest that higher intelligence leads to more adaptive behaviours, in 




The association between childhood IQ scores and excess alcohol 
consumption in adulthood is less consistent than for smoking. In a Scottish cohort 
born in the 1950s, assessed for IQ at age 11, and followed up with alcohol-related 
questionnaires at age 44 to 53, there was a significant inverse relationship between 
childhood IQ and self-reported hangovers (Batty, Deary, & Macintyre, 2006). For 
one SD increase in IQ there was a 20% reduced odds of having regular alcohol-
related hangovers in midlife – an indicator of regular binge drinking – that was 
attenuated after controlling for adult SES. However, in a different study from 
Denmark, a null association was reported between IQ and excess drinking in men 
(Mortensen, Sørensen, & Grønbæk, 2005). Furthermore, two studies have indicated 
that intelligence can positively correlate with excess alcohol consumption. Data on 
men and women from the NSHD 1946, including childhood cognitive scores from 
age 8, and self-assessment of alcohol abuse at age 53, reported that those whose 
cognitive scores were in the top half of the distribution, were at 2.4 times the odds 
for alcohol abuse (Hatch et al., 2007). A second British cohort of men and women 
born in 1970, with cognitive scores at 10 years, and information on alcohol use at age 
30, reported that higher intelligence was positively related to increased regular intake 
of alcohol, as well as perceived alcohol problems (Batty, Deary, Schoon, et al. 2008). 
This association was stronger for women, and remained significant after controlling 
for education and social factors. Attrition or response bias could be causing these 
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positive findings, but further studies are warranted to better understanding alcohol 
drinking behaviours (including participants’ choice of alcohol type) that are 




Childhood cognitive ability has also been related to taking more physical 
exercise, consuming more healthy foods (including fruit, vegetables and wholemeal 
bread) and less unhealthy foods (chips, cakes and biscuits), and vegetarianism, which 
could also mediate intelligence-disease pathways (Batty, Deary, Schoon, & Gale, 
2007b; Gale, Deary, Schoon, & Batty, 2007). More well characterised cohorts with 
detailed information on exercise and nutritional lifetime habits are required in order 




Mental health problems are also important to consider in cognitive 
epidemiology, because they pose greater health risks to individuals, are enduring 
throughout the life course, and lead to increased risk of comorbidities and mortality. 
For example, psychiatric illness is linked to more negative health behaviours, 
including smoking (Lawrence, Mitrou, & Zubrick, 2009), and is a risk factor for 
suicidal behaviour (Moscicki, 1995) and cardiovascular disease (Phillips et al., 2009; 
Van der Kooy et al., 2007). Large well-characterised cohort studies consistently 
show an inverse association between premorbid intelligence and risk of mental health 
problems, as characterised in Table 1.2. In Scotland and Denmark lower cognitive 
scores were associated with the increased likelihood of presenting with a psychiatric 
disorder over long-term follow-up (Batty, Mortensen, & Osler, 2005; Walker, 
McConville, Hunter, Deary, & Whalley, 2002). Furthermore, in cohorts from New 
Zealand, Sweden and US the association was significant for a range of specific 
psychiatric diagnoses, including anxiety-related disorders, depression and 
schizophrenia, by middle age (Gale, Batty, Tynelius, Deary, & Rasmussen, 2010; 
Gale et al., 2008) or younger (Koenen et al., 2009). For example, among over one 
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million men from the Swedish Conscripts Study, lower IQ scores were associated 
with a greater risk of hospitalization for eight psychiatric disorders by midlife (Gale 
et al., 2010). These included a 60% increased risk of being admitted for 
schizophrenia, a 50% increased risk for mood disorders, and a 75% increased risk of 
alcohol-related disorders, associated with a one SD decrease in IQ scores. In the VES 
cohort, intelligence was inversely related to the risk of alcohol disorders, depression, 
generalized anxiety disorder, and post-traumatic stress disorder (Gale et al., 2008), 
and the magnitude of these risks increased if more than one disorder was present, so 
that the likelihood of psychiatric comorbidity increased as participants moved 
towards the lower end of the IQ distribution.  
At the less extreme end of psychiatric illness, higher cognitive ability at age 
10 and 11 is also related to a reduced risk of self-reported psychological distress in 
early adulthood, according to a combined cohort of over 12,000 members from the 
1958 National Child Development Survey and the 1970 British Birth Cohort (Gale, 
Hatch et al., 2009). Adjusting for early life factors and SES in childhood and 
adulthood made no difference to this effect, but the inclusion of education in the 
model showed moderate attenuation. 
 
Pathological cognitive decline and dementia 
 
Lower premorbid intelligence is also associated with the risk of later 
pathological cognitive decline. A sample from the SMS32 cohort reported the 
inverse association with risk of late-onset, but not early-onset, dementia (Whalley et 
al., 2000). A larger sample of the SMS32 enabled late-onset dementia cases to be 
separated into vascular dementia and Alzheimer’s type dementia, in evaluating 
associations with premorbid cognitive ability. The investigators reported that lower 
childhood intelligence was a significant risk factor for late-onset vascular dementia, 
but not Alzheimer’s, suggesting that vascular processes rather than cognitive reserve 
are likely mediators in the pathway between early life intelligence and later cognitive 
decline (McGurn, Deary, & Starr, 2008). Whether this suggests an underlying 
biological mechanism consistent with system integrity theory, or can be explained by 
risk behaviours that damage vascular health, is an issue for future investigation.  
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An important point about this observation, in the context of this thesis, is that 
it highlights the potential for reverse causation in cognitive ageing studies that may 
infer a directional pathway only from pathological disease to cognitive decline. The 
field of cognitive epidemiology can therefore highlight the likelihood of reverse 
causation in disease specific cases, by understanding pathways from premorbid 
cognition to later health outcomes. Reverse causation is a subject for empirical study 
in Chapters 5 to 7 of this thesis.  
  
Intelligence to disease mechanisms 
 
The growing body of empirical studies reflected in this chapter has advanced 
the understanding of the likely mechanistic pathways that relate individual 
differences in cognitive ability scores to disease outcomes and death. Deary (2008) 
reflected that there is as yet “no clear chain of causation from intelligence to health” 
(p.176). It is, however, likely that intelligence differences may play an important role 
as risk factor, mediator, and covariate in models that explain health outcomes. It 
could also prove to be a partial confounder for other early life or social factors. A 
mechanistic model for the associations between IQ and mortality (from Batty, Deary, 
& Gottfredson, 2007), based on earlier theoretical suggestions of Whalley and Deary 
(2001), is shown in Figure 1.3, indicating most of these possibilities. Additional to 
the model is the more explicit recognition of the potential contribution of genetic 
factors that underlie both individual differences in intelligence and health, which are 
yet to be adequately explored (Arden, Gottfredson, & Miller, 2009). The theory of 
system integrity, present in the model, posits that an underlying physiological make-
up may explain the association between premorbid intelligence and health outcomes. 
Molecular genetics studies are required to directly test this theory, which is out with 
the present thesis. However, the plausibility of system integrity may be tested 
indirectly using indicators for an underlying trait, such as reaction times as 
mentioned above. Progress in cognitive epidemiology has been made in some 
pathways of this illustrated model more than others. The empirical evidence for the 
role of social and behavioural influences is presented next.      
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Social and environmental factors: Causation or mediation? 
 
It is an ongoing debate whether intelligence or socioeconomic status (SES), 
makes the greater contribution in predicting health outcomes of populations (Bartley 
& Plewis, 2007; Gallo et al., 2009; Gottfredson, 2004). In social epidemiology, 
common indicators of SES are education, occupational income or social class 
(Hackman & Farah, 2008), and advantages in these have been associated with lower 
risk of total or cause-specific mortality, and health morbidities, in longitudinal cohort 
studies (DeWalt, Berkman, Sheridan, Lohr, & Pignone, 2004; Huisman et al., 2005; 
Lleras-Muney, 2005; Singh-Manoux, Ferrie, Chandola, & Marmot, 2004; Torssander 
& Erikson, 2010) - although evidence suggests that these are not interchangeable 
factors for a latent social trait (Geyer, Hemstrom, Peter, & Vågerö, 2006; Torssander 
& Erikson, 2010). The issue is made more complex by the covariation between 
cognitive ability and socioeconomic indicators (Lubinski, 2009). Causal associations 
between intelligence and SES are obscured and controlling for either IQ or SES 
when evaluating the other’s relation to mortality can “weed out some of the very 
influence… we are trying to detect” (Deary, 2008, p.176).  
 
 Confounding by social inequalities 
 
One theory is that early life influences, particularly SES, are total 
confounders of the association between premorbid mental ability and adult 
morbidities. The evidence so far suggests that controlling for parental occupational 
status in early life has little effect on the IQ-mortality effect size (Batty, Deary, & 
Gottfredson, 2007). One study that controlled for an alternative childhood SES factor 
- overcrowding in the home - also showed negligible attenuation of the IQ-mortality 
link (Whalley & Deary, 2001). This also seems to be the trend in studies reported in 
the previous section of this chapter assessing specific morbidities in relation to 
premorbid cognition. However, the role of confounding by socioeconomic inequality 
requires formal testing, which is another subject of the next chapter.  
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Other potential early life confounding 
 
It has been posited that adverse events in the prenatal period or early 
childhood such as exposure to smoking, and obesity, which are not captured by 
common indices of SES, may yet explain some of the association between premorbid 
cognitive function and adult health outcomes (Kilgour et al., 2009), but data for such 
an idea are as yet unavailable. A study of young infants who were adopted within the 
first year of life, reported an inverse association between their adult mortality rates 
and the social class of their biological father, whereas a null association was found 
with risk of mortality and the adoptive fathers’ social class (Osler, Peterson, Prescott, 
Teasdale, & Sørensen, 2006). This suggests that genetic factors more likely explain 
the intelligence-mortality link, unless environmental factors that carry their influence 
in the very early stages of development remain unaccounted for. So far, studies that 
have controlled for birth weight (an indicator of prenatal events) have reported 
negligible attenuation of the association between intelligence and mortality (Jokela, 
Elovainio, Singh-Manoux, & Kivimaki, 2009; Leon, Lawlor, Clark, Batty, & 
Macintyre, 2009; Osler et al., 2003), although this may not be surprising given that 
correlations between birth weight and childhood cognitive ability are modest 
(Shenkin, Starr, & Deary, 2004). Future cohort studies of more detailed early life 
measures, including maternal factors, would help clarify whether IQ-type scores may 
act in part as a surrogate for early life determinants of health. 
 
Mediation by adult socioeconomic attainment  
 
Adult SES indicators may explain more of the influence of cognitive ability 
scores on health outcomes. It is well established that higher childhood mental ability 
is predictive of better educational and socioeconomic successes (Deary, Strand et al., 
2007; Schmidt & Hunter, 2004; Strenze, 2007; Von Stumm, Macintyre, Batty, Clark, 
& Deary, 2010; Zagorsky, 2007). These can lead to a “protective chain of events” for 
long life (Batty & Deary, 2004, p.586): Better working conditions in higher-ranking 
jobs provide safer and healthier environments; more comfortable, less hazardous 
home environments afforded by increased incomes; educational and/or occupational 
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successes leading to improved heath literacy and the means to better understand 
medical advice and intervention, and greater exposure to accurate public health 
knowledge with which to engage. In the meta-analysis of Chapter 2, one question 
addressed is the effect of adjusting for adult socioeconomic status on the IQ-all-cause 
mortality effect. It is noted among studies that have simultaneously controlled for 
occupational status and education, the association between premorbid intelligence 
and all-cause mortality has entirely diminished (Kuh et al., 2009: Jokela, Batty, 
Deary, Gale, & Kivimaki, 2009; Jokela, Elovainio, et al., 2009). Home ownership 
has also been shown to have a significant attenuation effect on the risk of mortality 
according to intelligence test scores (Kuh et al., 2009). However, due to these 
variables often strongly positively correlating, with each other and with intelligence 
test scores, there is the risk of statistical overadjustment when simultaneously 
controlling for their effects in epidemiological models. 
 
Adjustment for cognition in SES-mortality models 
 
An alternative way of evaluating intelligence along with SES in respect of 
health outcomes has been to assess the potential attenuating effects of cognitive 
ability in relations between social inequalities and health outcomes. This helps test 
the theory that intelligence is the fundamental cause of social inequalities in health, 
as posited by Gottfredson (2004). In the west of Scotland Twenty-07 study, 
respective risks of CHD-related and total mortalities according to five child and adult 
SES indices were estimated, before and after adjusting for adult IQ scores (Batty, 
Der, Macintyre, & Deary, 2006). In support of ‘fundamental cause’ theory, 
controlling for intelligence scores entirely attenuated the inverse associations 
between years in education and the risk of CHD-related and total mortality (by 111% 
and 131% respectively), as well as the inverse association between adult SES and 
risk for these mortalities (94% and 106% respectively). However, for other SES 
indices intelligence had less of an attenuating effect, reducing by about a third-to-a-
half the effects of childhood SES, income and deprivation on CHD and total-
mortality outcomes. Other health measures including respiratory function, long-term 
illness and poor self-perceived health also saw varying attenuation effects by IQ 
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scores in this study, and it was reported that low SES was still significantly 
predictive of some poor health outcomes after adjusting for intelligence in adulthood. 
In the Swedish Malmo cohort, where intelligence test scores were measured in 
childhood, these were not found to fully explain social inequalities in health 
outcomes although marked attenuation was apparent. Adjusting for IQ reduced the 
education-mortality gradient by only one quarter in men, and the size of the effect 
actually increased in women following controlling for cognitive ability (Lager, 
Bremberg, & Vågerö, 2009). The association between IQ and risk of mortality was 
neither entirely explained by childhood SES or education, suggesting that 
intelligence has independent effects on health outcomes from those of SES. 
 
A note on statistical overadjustment 
 
It is possible that attenuation effects observed in these studies may be caused 
by overadjustment (Deary & Batty, 2007), rather than mediation or confounding. A 
challenge for cognitive epidemiology is to separate these influences. Structural 
equation modelling (SEM) provides one means by which to do this, as it at least 
controls for covariation. One paper to use SEM analyses, presented alongside 
standard regression, used the Vietnam Experience Study data, and reported that the 
effect of IQ was entirely mediated by education, income and poor physical health, 
and had no direct effects on risk of mortality (Weiss et al., 2009). However, this 
evidence cannot rule out the possibility that education acts as a proxy for 
intelligence. To consider the potential overadjustment by controlling for education in 
IQ-mortality models, Chapters 3 and 4 employ a novel behaviour-genetics method 
applied to two whole-population samples, to investigate the extent to which 
heritability accounts for the significant phenotypic association between these two 
variables.  
 
Disease management and health behaviour 
 
It is likely that individual differences in lifetime patterns of health behaviours 
and self-care management are on the pathway between premorbid cognitive ability 
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and health outcomes, yet the extent of their mediation effects are not yet established. 
Although these are considered here separately, they are certainly not exclusive of 
socioeconomic factors and education but have strong associations in their effects on 
the IQ-mortality link. Indeed they may more accurately reflect the social and 
behavioural influences that interplay with cognitive processes, thereby affecting 
health outcomes.  
 
Self-management in population health 
 
Self-management of disease and treatment intervention is a cognitive 
undertaking (Gottfredson, 2004). Better health outcomes are more likely if people are 
able to understand and remember medical advice and instruction during the course of 
disease, if they can plan and execute necessary changes in their lifestyle to facilitate 
disease management or recovery, and if they recognise earlier on symptoms that are 
likely to necessitate further medical intervention. Within clinical populations 
cognitive ability has been positively associated with correctly following medical 
regimens. In female patient groups with diabetes, breast cancer and hyperlipidemia, 
better cognitive performance on memory, attention and executive function tasks, 
were associated with greater compliance with medication dosages (Stilley, Bender, 
Dunbar-Jacob, Sereika, and Ryan, 2010). Furthermore, in a randomised placebo-
controlled trial of patients with atherosclerosis, verbal intelligence in adulthood was 
positively related to continuing with medication two years after treatment allocation 
(Deary, Gale et al., 2009). Those scoring in the lowest quartile for the verbal test 
were 2.5 times more likely to have stopped medication within two years, compared 
to those in the highest quartile group. Among ageing populations of many 
industrialised countries, it is recognised that patients may be increasingly burdened 
with a life-long involvement in their own complex disease management, the success 
of which may depend on effective cognitive processes (Gottfredson, 2004). So far in 
cognitive epidemiology however, the extent to which disease management mediates 
intelligence-morbidity associations has been unexplored, due to the lack of such 
descriptive variables in longitudinal cohorts with premorbid cognitive test scores. 
Therefore this remains a pertinent area for the field to address. 
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Mediation by health behaviours  
 
Health behaviours are also integral to disease management or prevention. In 
the previous section of this chapter, associations between premorbid cognitive ability 
and health behaviours were discussed. However there is little evidence so far that 
such behaviours account for the link between mental ability, and morbidity or 
mortality. For example, in the Vietnam Experience Study the 29% reduced risk of 
all-cause mortality according to a one SD increase in IQ, was attenuated by 7% to 
14% after separately adjusting for alcohol consumption and smoking (Batty, Shipley, 
Mortensen, Boyle, et al., 2008). Furthermore, cognitive performance is sometimes 
more strongly predictive of risk of mortality relative to behavioural risk factors, 
suggesting that these cannot account for the intelligence-mortality link. Cognitive 
function, as measured using choice reaction time, was observed to be a stronger risk 
factor for CVD mortality, than smoking, alcohol consumption and physical exercise, 
in the UK Health and Lifestyle Survey (Roberts, Der, Deary, & Batty, 2009). In the 
Twenty-07 study childhood cognitive ability was more strongly associated with all-
cause mortality than all established risk factors for CVD, with the exception of 
smoking (Batty, Deary, Benzeval, & Der, 2010). If health behaviours do account for 
some of the inverse association between intelligence and risk of disease or mortality, 
then their effects are likely to vary according to cultural and historical contexts. In 
industrialised countries for example, where health behaviours and lifestyle may be 
playing a role in epidemics of chronic diseases, their mediation effects may be 




The theory of general body integrity posits that the inverse association 
between premorbid cognitive ability and health outcomes may be explained by 
underlying physiological make-up (Whalley & Deary, 2001). In this context, 
childhood mental ability is an early indicator of system integrity and therefore a 
covariate with risk of disease rather than a causal factor acting upon it. This theory 
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finds resonance with the field of cognitive ageing in which some empirical data show 
physical and cognitive deterioration acting in parallel (Deary, 2008). However, it 
presents challenges in its testing particularly as indicators for system integrity remain 
imperfect.  
 
Cognitive processing speed 
 
One putative marker for system integrity adopted by the field is reaction time, 
a measure of cognitive processing efficiency that may reflect neurological as well as 
general bodily integrity (Batty & Deary, 2004). Not only is faster reaction time 
significantly correlated with higher cognitive test scores (Neisser et al., 1996), it is 
associated with the reduced risk of CHD, CVD, respiratory disease, lung-cancer, 
digestive-related and all-cause mortalities (Gallacher et al., 2009; Roberts et al., 
2009; Shipley, Der, Taylor, & Deary, 2006). As mentioned earlier, the Twenty-07 
study reported that reaction time largely attenuated the inverse association between 
cognitive ability and all-cause mortality (Deary & Der, 2005), providing support for 
the system integrity theory. Another marker of system integrity is physical 
coordination, as measured by childhood upper and lower limb-related tasks. 
However, despite significant associations with both IQ and health outcomes, this 
indicator does not appear to explain the intelligence-mortality association (Gale, 
Batty, Cooper, & Deary, 2009).  
 
Alternative indicators for underlying system integrity 
 
Other potential markers of system integrity that positively correlate with 
mental ability scores, include low morning cortisol peaks (Power, Li, & Hertzman, 
2008), semen quality (Arden, Gottfredson, Miller, & Pierce, 2009), and indices of 
physical health that might indicate a ‘fitness factor’, including cranial, motor and 
peripheral sensory nerves, reflexes, head and general physical health (Arden, 
Gottfredson, & Miller, 2009). It remains to be seen whether these contribute to an 
understanding of the intelligence-mortality relation. A major contribution to testing 
this particular theory is likely to come from future genetics research. One relevant 
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study has identified a molecular genetic linkage between lower cognitive ability and 
a marker for inflammation, vagal tone (Frye, 2009). Reduced vagal nerve signalling 
is associated with an increased risk of total mortality, CVD, type 2-diabetes, 
metabolic syndrome, and depression, and so may yet provide evidence for a system 
integrity theory of the IQ-mortality association, in which inflammatory processes 




The empirical work in this thesis addresses some key questions in cognitive 
epidemiology, highlighted in this chapter, including the nature of the association 
between intelligence and education (Chapters 3 and 4)—relating to the issue of 
overadjusted models in predicting health outcomes, and, the social and mediating 
pathways linking premorbid cognition to preclinical CVD risk (Chapters 5 to 7). First 
however, Chapter 2 formally tests the magnitude of effect linking premorbid 
intelligence to all-cause mortality, including a statistical review of confounding and 
mediation by socioeconomic factors that may help to explain this replicated finding. 
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Table 1.1 Six epidemiological questions for assessing likelihood of causation 
 
 
Causation guideline Question 
Temporality Does the proposed causal factor precede the effect? 
Strength  Does exposure variation influence incidence of outcome?  
Specificity Does the exposure relate more strongly to some outcomes over others? 
Consistency Is the association replicated between and within studies? 
Experiment Does altering exposure to the cause influence incidence? 
Biological  Is the association biologically plausible? 
 
 
Note. The list of guidelines originated from Bradford Hill, A. (1965). The environment and disease: Association or causation? Proceedings of the Royal Society 
of Medicine, 58, 295-300, with distillation by Bhopal, R. (2008). Concepts of Epidemiology: Integrating the Ideas, Theories, Principles and Methods of 
Epidemiology, Second Edition. Oxford University Press.
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Table 1.2 Summary of longitudinal studies on premorbid cognitive ability and 











Cohort N Psychiatric outcome 
SMS32  Walker et al., 
2002 








12 49 7,022  Any psychiatric disorder 
NCDS58  Gale, Hatch, 
et al., 2009 
10 33 6,369  Psychological distress 
BCS70  Gale, Hatch, 
et al., 2009 
11 30 6,074  Psychological distress 
VES  Gale et al., 
2008 






















Gale et al., 
2010 


















Note. Arrows indicate the magnitude of effect, which here represents a significantly increased 
risk of a psychiatric outcome, per one standard deviation decrease in cognitive ability:  
indicates 10% to 39% increased risk;  40% to 69% increased risk;  70% or more 
increased risk. SMS32 = Scottish Mental Surveys 1932; NCDS58 = National Child Development 
Study 1958; BCS70 = British Cohort Study 1970; VES = Vietnam Experience Study; GAD = 
Generalized Anxiety Disorder; PTSD = Post-traumatic stress disorder. 
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Note. Compiled with permission from F. Rasmussen using the Swedish Cohort data described in Batty, G. D., Wennerstad, K. M, Davey Smith, G., 
Gunnell, G., Deary, I. J., Tynelius, P., & Rasmussen, F. (2007). IQ in early adulthood and later cancer risk: Cohort study of 1 million Swedish men. 
Annals of Oncology, 18, 21-28. 
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Note. Reproduced and revised with permission from: Batty, G.D., Deary, I.J., & Gottfredson, L.S. (2007). Premorbid (early life) IQ and later mortality 
risk: Systematic review. Annals of Epidemiology, 17, 278-288.  
a 
Although psychiatric disease is shown as a possible mediating variable between IQ and mortality, it might also be an antecedent variable if, for 
example, suboptimal neurodevelopment were the prior cause of both psychiatric disease and early mortality.  
b 
System integrity is shown as antecedent to both IQ and mortality. In this pathway, lower IQ is not a cause of mortality, but both IQ and mortality are 
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Chapter 2 
Intelligence in youth and all-cause mortality: Systematic 




As described in Chapter 1, individual differences in intelligence test scores, 
as measured by standardized IQ-type tests in childhood, show an inverse association 
with risk of death from all causes throughout adulthood. That is, higher intelligence 
appears to confer protection. This finding is replicated in prospective cohorts from 
several Westernized countries (Batty, Deary, & Gottfredson, 2007) across different 
ranges of intelligence (Leon et al., 2009) and in follow-up periods from early through 
to late adulthood (Batty, Wennerstad, et al., 2009; Hart et al., 2003; Leon et al., 
2009). Intelligence and somatic health may be inextricably linked throughout the life 
course. However, longitudinal studies help to establish causal pathway models of the 
effects of one upon the other. For example, morbidities such as diabetes, cancer, 
stroke and peripheral atherosclerosis, and/or their treatments, are reported to cause a 
decline in cognitive function after longitudinal follow-up (Arvanitikas, Wilson, & 
Bennett, 2006; Comijs et al., 2009; Kivipelto et al., 2005; Okereke et al., 2008; 
Rafnsson, Deary, Smith, Whiteman, & Fowkes, 2007; Yaffe et al., 2004). This 
illness-to-cognitive ability direction of association is a commonplace finding. The 
reverse direction of association is studied less often, and has only recently come to be 
recognized under the term “cognitive epidemiology” (Deary & Batty, 2007; Deary & 
Der, 2005). That is, mental ability scores from early life associated with later 
adulthood morbidities, and before any somatic symptoms or risk factors of disease 
are manifest, provide evidence that cognitive abilities may be predictive of later 
health outcomes.  The association between premorbid intelligence and adult all-cause 
mortality was the subject of a systematic review (Batty, Deary, & Gottfredson, 
2007), in which all nine studies that met the inclusion criteria demonstrated an 
inverse relationship between intelligence and risk of dying by the time of follow-up. 
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The review did not quantify the association. Furthermore, there were insufficient 
studies to address comprehensively a number of pertinent questions from this 
research domain.  
 
Sex differential effects 
 
One issue is whether or not the association between intelligence and mortality 
is the same in women as in men. For example, it is possible that sex differences in 
the incidence, age at onset of health behaviours, and the extent to which these act as 
risk factors for disease (Anand et al., 2008; Schenck-Gustafsson, 2009), could 
produce sex-specific intelligence–mortality gradients. Data from many more men 
than women have been included in intelligence–mortality cohort studies to date, 
mainly due to some studies using military conscript databases. Moreover, when 
mixed-sex cohorts report mortality risk as predicted by intelligence for men and 
women separately, they rarely test for statistical difference but, rather, report the 
observed trend. With more studies now reporting hazard ratios for mortality by sex, 
there is an opportunity to quantify the predictive effects of intelligence on mortality 
separately for men and women. 
 
Confounding by early social influences 
 
A second issue yet to be evaluated systematically is the extent to which 
intelligence as a predictor of mortality is confounded by early-life environmental 
influences including socioeconomic factors. Socioeconomic status (SES) is 
established as an important determinant of public health inequalities (Davey Smith & 
Lynch, 2004; Gallo, Espinosa de los Monteros, & Shivpuri, 2009; Macintyre, 1998; 
Marmot, 2010), including risk of mortality, and it can carry influence in childhood, 
via factors such as family income and parental education, to predict individual 
differences in childhood intelligence (Lawlor et al., 2005; McLoyd, 1998). In this 
context, therefore, intelligence may be considered a mediating variable on the 
pathway between early-life influences and adult health outcomes. If early social 
factors substantially confound the link between intelligence and longevity, then 
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adjusting for childhood SES would sizeably attenuate the effect size of the 
association between intelligence and mortality. In their systematic review, Batty, 
Deary and Gottfredson (2007) identified three out of nine studies that adjusted for 
childhood SES: One of these showed no change from an unadjusted model, and two 
had modest attenuating effects, suggesting that intelligence has independent effects 
on risk of mortality from those of early socioeconomic influences. Due to this small 
number of studies, the role of childhood SES in the intelligence–mortality link 
requires further investigation.  
 
Mediation by attained socioeconomic status 
 
One explanation why intelligence may exert an influence on life expectancy 
is its ability to predict educational outcomes (Deary, Strand, et al., 2007) and 
occupational class (Schmidt & Hunter, 2004), which can both affect health outcomes 
via a number of mechanisms; for example, the knowledge and living conditions that 
contribute to risk exposure, health behaviours, and self-management (Evans & Kim, 
2010; Stringhini et al., 2010). In population studies these adult SES factors are 
themselves inversely associated with risk of mortality (DeWalt et al., 2004; Huisman 
et al., 2005; Lleras-Muney, 2005). Some prospective cohorts take account of the 
attenuating effects of education and adult SES in estimating the risk of mortality 
according to intelligence; yet, to date, their influence has not been properly 
evaluated.  
 
The present study 
 
Investigators are giving increasing attention to the issues raised here, with a 
higher rate of publications reporting risk estimates for all-cause mortality according 
to differences in intelligence since the first systematic review (Batty, Deary, & 
Gottfredson, 2007). There is now an opportunity to re-evaluate this augmented 
literature, this time with a quantitative, meta-analytic approach. The systematic 
review from 2007 reported the overall quality of the nine studies as “moderate”, 
which was in part related to the weak validity of some measures of premorbid 
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intelligence. Therefore, one important change to the systematic process reported here 
is the inclusion of studies in which only valid cognitive assessments were used. 
Kilgour et al. (2009) also raised a number of methodological considerations that 
should be addressed in intelligence–mortality studies, including taking account of 
ascertainment bias, age, sex and education. In this article I will address the influence 
of these factors using subgroup analyses. Accordingly, the aims of this chapter are to:  
 
 Quantify the association between premorbid intelligence and all-cause 
mortality. 
 Determine whether there are sex differences in the association.  
 Conduct subgroup analyses on studies that adjust for early-life SES, adult 
SES and education, to discover their magnitude of influence as potential 




Systematic review process 
 
An electronic search was conducted of premorbid intelligence and all-cause 
mortality in all published articles, letters, abstracts and reviews, using the electronic 
databases MEDLINE, EMBASE and PSYCHINFO (via Ovid). Searches were 
limited to articles on humans published in the English language. The databases were 
searched using a cognitive ability related term (‘Aptitude or Cognition’* or 
‘Cognitive function’* or ‘Cognitive ability’ or ‘Cognitive characteristics’ or 
‘Cognitive style’ or ‘intellectual ability’ or ‘Intelligence measures’ or ‘Intelligence 
quotient’ or ‘Intelligence test’* or ‘Intelligence’* or ‘IQ or Language test’* or 
‘Memory’ or ‘Mental ability’* or ‘Mental capacity’ or ‘problem-solving’ or 
‘Problem solving’ or ‘Psychological performance’ or ‘Psychometrics’) AND a 
mortality term (‘Cause of Death’* or ‘Cause of Death trends’ or ‘Death’* or ‘death 
rate’ or ‘Incidence’ or ‘Morbidity’ or ‘Morbidity trends’ or ‘Mortality Rate’ or 
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‘Mortality risk’ or ‘Mortality*’ or ‘Mortality trends’), an asterisk allowing the search 
term to precede a longer word or phrase. 
The electronic search conducted on 5
th
 February 2010 yielded 19,236 articles. 
Two reviewers (N. Leckenby and I) independently scanned each title and abstract, 
retrieving articles on the basis of their relevance to intelligence and mortality. We 
applied the inclusion criteria listed below to these respective shortlists of papers. I 
then examined the reference lists of the selected articles, along with review papers on 
intelligence and mortality, and my own personal files (my supervisors checked their 
own), for articles that the electronic search might have missed. Among the final list 
of articles, when more than one paper reported intelligence–mortality associations 
from the same cohort, thereby duplicating data, it was agreed between myself and my 
supervisors, which papers would be retained, according to criteria of the following 
order: 1) The article reported the hazard ratio for mortality per one SD difference in 
IQ-type score; 2) The cohort size was larger; 3) The article was the original 




I included published cohort data that fulfilled criteria similar to that of the 
previous systematic review on intelligence and all-cause mortality (Batty, Deary, & 
Gottfredson, 2007). First, to minimize risk of reverse causality, only cohorts where 
intelligence test score data were collected at a mean age of 24 years or younger were 
included (the period classified as childhood and youth according to the World Health 
Organisation Study Group (WHO Study Group, 1990)). Second, the intelligence and 
mortality data were collected at the level of the individual. Third, the relationship 
between intelligence and all-cause mortality was reported quantitatively. 
Furthermore it was also stipulated that the premorbid test should demonstrate an 
acceptable degree of validity as a measure of intelligence. Finally, the cohort was 
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The HR with 95% CI for all-cause mortality per SD advantage in intelligence 
test score was the principal outcome variable. For hazard ratios expressed per one SD 
disadvantage in intelligence, the reciprocal was used. Reported odds ratios were 
treated as hazard ratios, with the caveat that these effect estimates approximate one 
another (Greenland, 1987) when the incidence of an event (e.g. mortality) is low 
(Symons & Moore, 2002). In case–control studies reporting intelligence test means 
for living and deceased, the standardized mean difference was converted to an OR 
using formulae by Chinn (2000). Authors were contacted if it was not possible to 
derive an effect size from their published data. Fixed effects models were assumed 
for the aggregation of hazard ratios based on evidence of a low degree of 
heterogeneity, where p < 0.10 (Sutton et al., 2000). Subgroup analyses were 
conducted by sex group, for those studies to adjust for SES variables, and by study 
characteristic groupings for the purposes of sensitivity analysis.  
MIX 1.5 (Bax, Yu, Ikeda, Tsurata, & Moons, 2006) was used for all analyses 





Sensitivity analyses aggregated effect sizes by the following study 
characteristics: Ascertainment rate at follow-up; age at intelligence testing; cohort 
size; duration of follow-up; average birth year of the cohort; effect size measure (see 
Table 2.2 for group parameters).  
Ascertainment rate may bias the intelligence–mortality effect size if those 
who emigrate, and are therefore excluded from follow-up, differ on cognitive ability 
scores compared with those who remain within geographical regions for census. 
Follow-up rates were estimated based on the proportion of participants from the 
original cohort that were followed up and included in the final analyses, regardless of 
whether or not intelligence test scores were available for them. Studies were grouped 
on the basis of <80% or 80–100% ascertainment rates.  
Studies were also aggregated according to age at cognitive testing, first 
because the likelihood of an effect of bodily insults on intellectual function increases 
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with age and, with it, the risk of reverse causation bias in the intelligence– mortality 
link. Conversely, the validity of cognitive testing may be greater in older cohorts, 
and these may reflect more homogeneous results compared with results of younger 
children at intelligence testing for whom there is more measurement error.  
For the duration of follow-up, studies were divided on the basis of a median 
split of the years traced for mortality. Although there may be stronger grounds for 
assuming causality as the time period between intelligence testing and mortality 
increases, there is also evidence that, by older adulthood, the intelligence–mortality 
association loses significance (Hart et al., 2005).  
The reason for aggregating studies that reported either hazard ratios or odds 
ratios was to ensure that the treatment of these measures of association did not inflate 
the overall effect size.  
Studies were also grouped according to cohort size and decade of birth, as 
these may also have influenced heterogeneity across the studies. However, it was 
decided not to aggregate for population representativeness as one of our criteria 
ensured the exclusion of clinical samples. Nevertheless, due to two study cohorts 
being less representative of the general population (twins and gifted children) than all 
others, meta-analytic results are reported with and without their effect sizes 




Inspection of a funnel plot was used to assess publication bias, with standard 
error on the y-axis as recommended by Sterne and Egger (2001). Publication bias 





Systematic retrieval of studies 
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The electronic search resulted in 19,236 publications and, of these, the 
independent review process extracted shortlists of 73 and 69 relevant articles 
respectively (<0.4% of total publications), from which 90 nonduplicate publications 
were retrieved for closer inspection (see Figure 2.1 for review process). Among these 
64 failed to meet one or more inclusion criteria (see Appendix A for full reference 
list and reasons for exclusion). A further three studies that met inclusion criteria were 
identified from the reference lists of the remaining 26 papers, or from review articles 
or personal records (Deary, Whalley, & Starr, 2003; Furu, Lingarde, Ljung, Munck, 
& Kristenson, 1984; Link, Phelan, Miech, & Westin, 2008). Two out of 29 studies 
were excluded (Furu et al., 1984; Link et al., 2008) because insufficient data were 
obtainable to calculate the intelligence–mortality effect sizes. (Table 2.1 lists the 
characteristics of the final 27 studies). I excluded 11 articles from the meta-analysis 
because they overlapped with cohort data of another report (Hart et al., 2005; Deary, 
Whalley, & Starr, 2003; Batty, Gale, et al., 2008; Batty, Mortensen, Gale, & Deary, 
2008; Batty, Shipley, Gale, Mortensen, & Deary, 2008; Deary, Whiteman, Starr, 
Whalley, & Fox, 2004; Hemmingsson, Melin, Allebeck, & Lundberg, 2009; Kuh et 
al., 2004; Starr, Deary, & Whalley, 2008; Vagero & Modin, 2006; Weiss et al., 
2009). Justification for excluding these data were: 1) The overlapping reports of a 
sample were generally reported by the same research group resulting in consistent 
methods of sample selection and data linkage; and, 2) the majority of overlapping 
cohorts were of similar size and follow-up duration.  
 
Study descriptions for meta-analysis 
 
Sixteen prospective longitudinal cohort studies included 22,453 deaths among 
1,107,022 participants (see Appendix B for references). These were from five 
countries; UK (n = 7), USA (n = 5), Sweden (n = 2), Australia (n = 1) and Denmark 
(n = 1), ranging in size from 862 to 994,262 participants. Figure 2.2 illustrates these 
variables according to year of publication, showing a trend for larger cohorts 
accumulating in more recent years. Premorbid intelligence test scores were taken 
from school records (n = 10), military or national service conscription records (n = 
5), or a research database (n = 1). The average age at testing ranged from 7 to 20 
  47 
years, and length of follow-up ranged from 17 to 69 years. Six cohorts were all male 




A range of cognitive assessments were used across studies, and evidence was 
sought of their validity as standardized measures of intelligence. The concurrent or 
predictive validity of five tests used across nine of the study cohorts (Batty, 
Wennerstad, et al., 2009; Hart et al., 2003; Holsinger et al., 2007; Hemmingsson et 
al., 2006; Jokela, Batty, et al., 2009; Kuh et al., 2009; Lager, Bremberg, & Vagero, 
2009; O’Toole et al., 1988; Whalley & Deary, 2001) have been reported elsewhere 
(Batty, Deary, & Gottfredson, 2007). Here the evidence for psychometric validity 
among the seven remaining cohorts is described: 
 The Binet and Stanford-Binet tests used in two studies (Martin & 
Kubzansky, 2005; Deary, Batty, Pattie, et al., 2008) are well-established, 
age-standardized intelligence tests for children. Scores on the original 
Stanford–Binet test contain a single underlying factor of cognitive ability 
(Wright, 1939) and the Binet scale has concurrent validity with version 12 
of the Moray House intelligence test (r = 0.80) (Deary, Batty, Pattie, et 
al., 2008).  
 Two studies included selected tests from the well-validated Moray House 
series (Thomson, 1940). The first study incorporated Moray House tests 
57 and 58 in an 11-plus examination that also assessed language and 
arithmetic (Pearce, Deary, Young, & Parker, 2006). On this exam, total 
scores have shown well-established associations with childhood height at 
ages 9 and 13 years (Pearce, Deary, Young, & Parker, 2005). The second 
(Leon et al., 2009) used Moray House Picture Tests 1 and 2, which have 
also shown expected patterns of association with intrauterine and 
childhood growth (Lawlor et al., 2005).  
 The Harnquist test used in the Danish Metropolit study (Osler et al., 
2003) has shown concurrent validity: A general intelligence factor 
extracted from scores on the test at age 13 years strongly positively 
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correlated (r = 0.78) with a military classification intelligence test taken 
five years later (Härnqvist, 1968).  
 The Armed Forces Qualification Test (AFQT) used in another study 
(Jokela, Elovainio, et al., 2009) strongly correlates with other well-
validated IQ tests (median r with seven tests = 0.81), and scores on the 
four subtests show high loadings on a single g factor, from 0.81 to 0.87 
(Hernstein & Murray, 1994).  
 Finally, the Vietnam Experience Study (Batty, Shipley, Mortensen, 
Boyle, et al., 2008) used the Army General Technical test, which strongly 
correlates with verbal reasoning (r = 0.75) and visuospatial (r = 0.51) 
scores from the Weschler Adult Intelligence Scale (WAIS), a 




Records of mortality were ascertained prospectively in seven studies, either 
by linkage of study members to national register databases (Hart et al., 2003; 
Holsinger et al., 2007; Jokela, Batty, et al., 2009; Kuh et al., 2009; Pearce et al., 
2006) or by individual follow-up with study participants or their families (Martin & 
Kubzansky, 2005; Jokela, Elovainio, et al., 2009). In the remaining studies, incidence 
of death was ascertained retrospectively by access to national death registers—in 
Swedish cohorts record linkage used personal identification numbers rather than 
person names (Batty, Wennerstad, et al., 2009; Hemmingsson et al., 2006; Lager, 
Bremberg, & Vagero, 2009)—with the exception of two studies that did not report 
methods for extracting death records (O’Toole et al., 1988; Batty, Shipley, 
Mortensen, Boyle, et al., 2008).  Ten papers estimated the intelligence–mortality 
effect size as a hazard ratio with confidence intervals (see Table 2.2 for citations of 
these papers), two used odds ratios or logistic regression coefficients (Jokela, Batty, 
et al., 2009; Jokela, Elovainio, et al., 2009) and two reported the M and SD which I 
converted to an estimated OR (Holsinger et al., 2007; O’Toole et al., 1988). In 
response to email requests authors of the two further papers provided hazard ratios 
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(Kuh et al., 2009; Osler et al., 2003), as these were unreported in the original 
publications.  
 
Intelligence–mortality meta-analysis: Basic model 
 
In the basic model, a HR from each of the 16 studies was either, unadjusted (n 
= 2), adjusted for age (n = 3), adjusted for sex (n = 3), adjusted for age and sex (n = 
3), or unspecified (n = 5) (Table 2.1). However, there was a low degree of 
heterogeneity between the effect sizes of these models (Q = 17.7, I
2 
= 15.5%, p = 
0.28).  
In a fixed effects model, a one SD advantage in intelligence was associated 
with the lower risk of all-cause mortality (HR 0.76, 95% CI 0.75 to 0.77) (Figure 2.3 
shows this data in a forest plot). The exclusion of two studies (Holsinger et al., 2007; 
Martin & Kubzansky, 2005) based on selected samples (twins and gifted children) 
did not alter this estimate; neither did the exclusion of two studies that reported odds 
ratios and where incidence of death was between 20% and 40% (Holsinger et al., 
2007; O’Toole et al., 1988) (data not shown). The statistical weight of the largest 
study (Batty, Wennerstad, et al., 2009) was 70.5%; excluding this cohort from the 
model made a negligible change to the effect of intelligence on risk of mortality (HR 




Sensitivity analyses results are presented in Table 2.2. Age at intelligence 
testing may have had a small effect in predicting the risk of mortality. Aggregation of 
studies in which premorbid intelligence was tested at an average age of between 7 
and 12 years resulted in a small attenuation (16%) of the risk of mortality (HR 0.79, 
95% CI 0.76 to 0.82) compared with that of 18- to 20-year-olds (HR 0.75, 95% CI 
0.74 to 0.77). 
Studies of longer follow-up (40 to 69 years) showed a 20% attenuation of the 
risk of mortality as predicted by a one SD advantage in intelligence (HR 0.80, 95% 
CI 0.76 to 0.83), compared with those cohorts of shorter follow-up (HR 0.75, 95% CI 
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0.74 to 0.77). Furthermore, there was a trend for cohorts born in the 1910s and 1920s 
to show an attenuated effect size compared with those cohorts born in the 1930 to 
1960s. However, these older age cohorts were also those with a longer duration of 
follow-up.  
Ascertainment bias was unlikely to have affected the total aggregate HR. That 
is, studies of low ascertainment (62% to 79%) showed a similar aggregate effect size 
(HR 0.76, 95% CI 0.75 to 0.78) to that of studies with 80% to 100% ascertainment 
(HR 0.77, 95% CI 0.74 to 0.80).  
There was also no observable effect of cohort size on the magnitude of the 
intelligence–mortality association.  
The aggregate effect size for studies reporting odds ratios resulted in a higher 
risk of mortality as predicted by intelligence (OR 0.71, 95% CI 0.64 to 0.79) 
compared with the aggregate effect size from studies reporting hazard ratios (HR 
0.76, 95% CI 0.75 to 0.78). However, the four studies reporting odds ratios had 
among the lowest weightings of the 16 cohorts (0.42% to 1.08%), which may explain 




Examination of the funnel plot revealed only one study (Hart et al., 2003) on 
the outside of 95% CI parameters (Figure 2.4). Egger’s test of asymmetry supported 
a low risk of publication bias (Intercept = 0.10, 95% CI 0.72 to 0.91, p = 0.81), as did 
application of trim and fill adjustments in which only one missing study was 
estimated, and its imputation made no difference to the magnitude of the risk 
estimate (HR 0.76, 95% CI 0.75 to 0.78). 
 
Stratification by sex group 
 
Seven studies reported intelligence–mortality effect sizes for men and women 
separately, and their follow-up spanned 24 to 65 years (Table 2.2 includes these 
studies’ citations). During this period the absolute risk of death was 5.6% for women 
and 8.2% for men. Four out of the seven studies reported negligible sex differences 
  51 
(Leon et al., 2009; Jokela, Batty, et al., 2009; Kuh et al., 2009; Jokela, Elovainio, et 
al., 2009) (two of these formally tested Intelligence x Sex interaction effects), two 
reported a stronger effect for men (one reported a null effect in women with an 
intelligence-sex interaction effect) (Lager, Bremberg, & Vagero, 2009; Pearce et al., 
2006) and one reported a stronger effect in women (Whalley & Deary, 2001). 
However, fixed effects models were applied to aggregate the sex-specific HRs, given 
the evidence for low heterogeneity (Table 2.2). A one SD advantage in intelligence 
among women was associated with a 22% lower risk of all-cause mortality (HR 0.78, 
95% CI 0.73 to 0.84), whereas among men there was a 20% reduced risk of mortality 
per one SD advantage in intelligence (HR 0.80, 95% CI 0.76 to 0.85). Nevertheless, 
there was a high degree of overlap in the confidence intervals of these respective 
effect sizes. Egger’s test of asymmetry supported a lack of publication bias among 
sex-specific cohorts. 
 
Adjustment for childhood SES 
 
Nine studies that included 18,733 deaths, reported effect-size models adjusted 
for childhood SES, measured either by father’s occupation or income (Deary, Batty, 
et al., 2008; Hemmingsson et al., 2006; Jokela, Batty et al., 2009; Leon et al., 2009; 
Martin & Kubzansky, 2005; Osler et al., 2003; Pearce et al., 2006), the highest 
socioeconomic index recorded for either parent (Batty, Wennerstad, et al., 2009), or 
father’s education (Lager, Bremberg, & Vagero, 2009). Heterogeneity was very low 
in unadjusted (Q = 8.56, I
2
 = 6.6%, p = 0.38) and adjusted models (Q = 7.49, I
2
 = 
0.0%, p = 0.48).  
In a fixed effect basic model the HR for this subgroup of papers did not 
deviate from that for the 16 studies (HR 0.76, 95% CI 0.75 to 0.77). However, even 
after adjustment for childhood SES there was a very small attenuation (by 4%) of the 
effect size (HR 0.77, 95% CI 0.75 to 0.79) (Figure 2.5). Excluding the large study of 
over one million Swedish men had no effect on the aggregate effect size of the 
childhood SES-adjusted model, except to slightly widen the 95% CI parameters (HR 
0.77, 95% CI 0.74 to 0.80). Compared with the unadjusted model of this smaller 
group of studies in which there were 4,608 deaths (HR 0.77, 95% CI 0.74 to 0.80), 
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controlling for childhood SES had no effect on the intelligence–mortality gradient 
when the influence of this largest weighted study was removed. A tenth publication 
(Kuh et al., 2004) from the systematic review, which could not be included in meta-
analysis, reported data consistent with this finding; early-life socioeconomic 
inequalities did little to explain the inverse association between intelligence and all 
cause-mortality. 
 
Controlling for adult SES and education 
 
There was no evidence for publication bias among studies that controlled for 
adult SES or education. In five studies that adjusted for adult SES, there were 3,070 
deaths among 66,301 participants. SES was measured either by occupational social 
class (Hart et al., 2003; Hemmingsson et al., 2006; Jokela, Batty, et al., 2009; Deary, 
Batty, et al., 2008) or income (Batty, Shipley, Mortensen, Boyle, et al., 2008). The 
unadjusted effect size for this subgroup of studies (HR 0.76, 95% CI 0.72 to 0.79) 
matched that of all 16 studies. After adjustment for adulthood SES, the lower risk of 
mortality predicted by higher intelligence was attenuated by 33.5% from the basic 
model (HR 0.84, 95% CI 0.78 to 0.90) (Figure 2.5).  
Among the six studies that adjusted for educational attainment, there were 
16,023 deaths out of 1,026,742 participants. Again, the aggregate effect size for this 
subgroup of studies in an unadjusted model (HR 0.76, 95% CI 0.74 to 0.77) was no 
different from that for all 16 studies. After adjustment for education (HR 0.89, 95% 
CI 0.86 to 0.91), the effect of intelligence on mortality was reduced by 54.2% 
(Figure 2.5). Exclusion of the large Swedish cohort (Batty, Wennerstad, et al., 2009) 
from the model, as expected, widened the CI parameters (HR 0.87, 95% CI 0.81 to 
0.93), but still reduced the intelligence–mortality gradient by 45.8% from the 
unadjusted model. Two further studies from the systematic review (Hemmingsson et 
al., 2009; Kuh et al., 2004), excluded from meta-analysis due to the type of statistics 
reported, are consistent with our result. They observed attenuation effects by 
education of over one third, of the intelligence–mortality association. 
 
Multiple covariates 
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Eleven studies, including 15,148 deaths, reported effect sizes for the risk of 
mortality according to intelligence while adjusting for multiple variables (#s 3, 5, 7, 
11-12, 14-15 in Appendix A; see Table 2.1 for covariates). Among these cohorts, 
four showed entire attenuation of the intelligence–mortality effect size from 
unadjusted (or basic) models (Jokela, Batty, et al., 2009; Kuh et al., 2009; Jokela, 
Elovainio et al., 2009; Batty, Shipley, Mortensen, Boyle, et al., 2008). These studies 
tended to adjust for adult SES variables with the addition of other important 
covariates, including education (Jokela, Elovainio et al., 2009) or smoking (Kuh et 
al., 2009) among other CVD risk factors (Jokela, Batty, et al., 2009; Batty, Shipley, 
Mortensen, Boyle, et al., 2008). The remaining studies reported a smaller degree of 
attenuation from unadjusted models. Due to the varying number and nature of 




The present meta-analysis of 16 published prospective cohort studies, 
comprising over 1.1 million participants and 22,453 deaths, demonstrates and 
quantifies the consistently-reported association between higher premorbid 
intelligence and lower mortality risk. A one SD advantage in intelligence in 
childhood and youth was associated with a 24% lower risk of mortality. The effect 
was similar in men and women, and was not explained by socioeconomic differences 
in early life, as indicated by parental occupation or income. The association was 
attenuated by approximately a third after adjusting for adult SES and by 
approximately a half after adjusting for educational experience. Intelligence 
remained a predictor of mortality after these attenuating effects, and removal of one 
study that carried by far the largest weighting in the models (Batty, Wennerstad, et 
al., 2009) did little to change the magnitude of these effects.  
This is the first meta-analysis of studies examining the relationship between 
premorbid intelligence and all-cause mortality. A recent systematic review, which 
was based on nine identified at that time, reported the inverse association (Batty, 
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Deary, & Gottfredson, 2007). Since then the number of publications of the 
intelligence–mortality association has grown, and the 16 unrelated cohorts identified 
represent more than four times as many deaths. There was little evidence of 
publication bias, and so the estimated risk of mortality according to a one SD 
advantage in intelligence may be generalized to cohorts beyond those included in this 
meta-analysis, at least to those of the five countries included in the analyses. My 
treatment of odds ratios as hazard ratios in two studies where the absolute risk of 
death was 45%, which could have incurred statistical error, was not found to inflate 
the aggregate effect size. 
Heterogeneity was not apparent across the studies despite most using 
different assessments of premorbid intelligence. This may be because most omnibus 
intelligence tests of the types used in the identified studies show strong loadings on a 
general intelligence factor, or g (Carroll, 1993). The intelligence–mortality 
association was, however, slightly weaker among cohorts of younger ages at 
cognitive testing, and those of longer follow-up duration. As it was the same cohorts 
that were followed up beyond 40 years who were the youngest at intelligence testing, 
it is difficult to establish which factor would make the larger contribution to 
attenuating the intelligence–mortality association. However, it seems less likely to 
have been due to differences in the validity of intelligence tests taken at younger and 
older ages, given the equally low heterogeneity among these two cohort groupings. It 
may be that older cohorts at cognitive testing show a steeper intelligence–mortality 
gradient because of the increased likelihood of bodily insults, or, it is still possible 
that the association varies according to age at mortality, most likely due to cause of 
death. 
 
Lack of confounding by sex and SES at birth 
 
The observation of negligible differences between men and women in the 
relative risk of mortality as predicted by intelligence may be surprising given well-
documented sex differences in patterns of risk factors, onset and prevalence of 
specific diseases and life expectancies (Wingard, 1984). However, there were 
exceptions in individual studies, with differences between men and women reported, 
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although there seem to be cohort-specific explanations for these. In one study 
(Whalley & Deary, 2001) the lower relative risk among men was probably due to the 
rise in deaths of higher intelligence servicemen during World War II (Corley, Crang, 
& Deary, 2009). In another, the lower relative risk among women could have 
resulted from a lack of statistical power due to the small number of female deaths 
(Pearce et al., 2006). The result from an older birth cohort study (Lager, Bremberg, 
& Vagero, 2009) of a null association among women could have been influenced by 
a relatively higher incidence of smoking among well-educated women during an era 
before the health hazards of smoking were widely known. In general, however, data 
from large post-war birth cohort studies show negligible sex differences in the effects 
of intelligence in relation to risk of mortality, and results from the meta-analyses 
support this. Equivalent effect sizes by sex still do not mean that the mechanisms that 
explain the intelligence–mortality association act in equal measure for men and 
women, and it continues to be of interest to study sex differences in cognitive 
epidemiology. Differences in health behaviours, risk patterns and medical 
interventions should also be considered when comparing ethnic groups or diverse 
countries. However, there is currently a lack of cohort data to evaluate how such 
group differences influence the risk of all-cause mortality as predicted by premorbid 
intelligence. 
Socioeconomic conditions in early life, determined by parental occupation or 
income, were also unlikely confounders. Individual differences in cognitive ability 
appear to act independently of childhood social inequalities in predicting all-cause 
mortality. There may of course be alternative early-life factors contributing to 
confounding that were not covariates of the cohorts reviewed here. Among three 
studies that adjusted for birth weight in multivariate-adjusted models, one reported 
no change from unadjusted models (Leon et al., 2009), and two reported a risk 
attenuation of 1% and 4%, respectively, compared with models that adjusted for 
childhood SES (Osler et al., 2003) and education (Jokela, Batty, et al., 2009). 
However, recent evidence suggests that birth weight may not be the ideal indicator 
for exposures in the intrauterine environment, which carry their most critical 
influence on neurological and physiological development during the early prenatal 
period (Kelly, 2009). Other qualitative characteristics in early childhood may further 
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explain the relationship between premorbid intelligence and longevity (Kilgour et al., 
2009) including style of parenting and cognitive stimulation at home (Guo & Harris, 
2000), or the effects of diet. However, so far, the potential confounding of these 
early-life factors have not been demonstrated, and these other suggested variables are 
likely to be associated with parental intelligence.  
 
Attenuation of the intelligence–mortality association 
 
Education and adult SES were found partially to attenuate the risk of 
mortality according to a one SD advantage in intelligence. Premorbid cognitive 
ability may act via occupational status and wealth to reduce the risk of mortality, by 
providing a less hazardous work environment, a safer and more comfortable home 
environment, and the material means to access better and more immediate medical 
care. Furthermore, intelligence may be mediated by education to reduce the 
likelihood of death, perhaps by increasing a person’s receptivity to health education 
messages (thereby reducing negative behaviours such as smoking and excess alcohol 
consumption, and promoting exercise and healthy eating), and by improving 
comprehension of medical terminology and instruction that impacts on disease 
management and prevention. Nevertheless, the results to date cannot tell us for 
certain whether education and adult SES are simply partial mediators of the 
association between intelligence and mortality, or whether the results reflect 
overadjustments if both factors are partial surrogates for intelligence, or if these 
variables confound intelligence–mortality associations (Batty & Deary, 2005). 
Structural equation modelling can examine for statistical mediation, and one study to 
employ this technique reported that the effect of a general intelligence factor on 
mortality was entirely mediated by income, education and poor physical health in 
adulthood (Weiss et al., 2009). However, in this study, with cognitive ability 
measured at age 20 years, the association between intelligence and mortality could 
also have been partially confounded by education. In this chapter’s meta-analysis, 
two out of five studies that adjusted for adult SES (Hemmingsson et al., 2006; Batty, 
Shipley, Mortensen, Boyle, et al., 2008), and three out of six studies adjusting for 
education (Batty, Wennerstad, et al., 2009; Jokela, Elovainio, et al., 2009; Batty, 
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Shipley, & Mortensen, et al., 2008) had intelligence test scores measured in later 
youth (19 to 20 years of age), when most people have completed education. There is 
evidence for a causal association from childhood intelligence scores to later 
educational achievement in longitudinal studies, and it is also likely educational 
experience can boost cognitive test scores to some extent (Deary & Johnson, 2010). 
Therefore reciprocal dynamic pathways between intelligence, education and adult 
SES need to be considered. 
Few studies in the meta-analysis adjusted for both education and adult SES in 
the same model. It is suggested that both factors may overlap in their attenuation 
effects on the intelligence–mortality association (Link et al., 2008), but there is also 
evidence to show that they are not interchangeable, and have independent effects on 
health outcomes (Geyer et al., 2006; Martikainen, Blomgren, & Valkonen, 2007). 
Among three studies to control simultaneously for adult SES and education, the 
relative risk of mortality was entirely attenuated (Jokela, Batty, et al., 2009; Kuh et 
al., 2009; Jokela, Elovainio, et al., 2009). Interpretation of these findings should also 
consider the likelihood of overadjustment. In studies that reported complete 
attenuation effects of the intelligence–mortality gradient after multivariate 
adjustments, in addition to controlling for socioeconomic and educational variables, 
it was noted that three studies adjusted for smoking (Jokela, Batty, et al., 2009; Kuh 
et al., 2009; Batty, Shipley, Mortensen, Boyle, et al., 2008), two adjusted for alcohol 
consumption (Jokela, Batty, et al., 2009; Batty, Shipley, Mortensen, Boyle, et al., 
2008) and there were further adjustments made for psychiatric illness (Batty, 
Shipley, Mortensen, Boyle, et al., 2008), parental interest in a child’s education 
(Jokela, Batty, et al., 2009), or the quality and care of a household (Kuh et al., 2009). 
These potential explanatory factors are worthy of further investigation, particularly 
as two of these (smoking and alcohol consumption) are important risk factors for 




The present meta-analysis was unable to consider cause of death in the 
intelligence–mortality association, but this would seem an important area for future 
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systematic review, particularly as it was likely to have driven the stronger effect sizes 
of cohorts followed to younger ages in adulthood. For example, it may be that 
intelligence has a stronger relation to mortality caused by external events such as 
accidents (O’Toole et al., 1988), more prevalent among younger adults, than cause-
specific mortalities more typical in later life (Hart et al., 2003). Studies have already 
replicated the inverse association between premorbid intelligence and cardiovascular 
disease-related mortality, with increased effect size magnitudes for coronary heart 
disease-related deaths compared with stroke-related deaths (Batty, Wennerstad, et al., 
2009; Batty, Mortensen, Andersen, et al., 2005; Batty, Shipley, Mortsensen, Gale, & 
Deary, 2008; Hemmingsson, Essen, Melin, Allebeck, & Lundberg, 2007; Lawlor et 
al., 2008) (Batty, Mortensen, Andersen, et al., 2005). The relationship between 
childhood cognitive ability and risk of cancer mortality is also likely to vary by type 
(Hart et al., 2003). For example, smoking-related cancers might carry a stronger 
association with intelligence (Hart et al., 2003; Taylor et al., 2005) than other cancer 
types (Batty, Mortsensen, Gale, et al., 2009). Specific causes of death are therefore 
likely to be crucial in providing explanations as to why intelligence predicts life 
expectancy, and larger cohorts with increased numbers of cause-specific mortalities 
will help to clarify this issue. 
In the present study it was found that education and social position in 
adulthood are factors that may help to account for the intelligence–all-cause 
mortality association. However, the extent to which these SES indicators act as 
partial surrogates for intelligence, or mediators and/or confounders of the 
intelligence–mortality association requires formal testing. Future longitudinal studies 
of mortality risk with repeated measures of intelligence, education, and adult SES, 
spanning childhood to adulthood could contribute to this. Twin studies to determine 
the extent to which intelligence shares genetic and environmental causes with health, 
education, and social class, in predicting mortality, will also help to inform this issue. 
With evidence of associations between cognitive performance and education 
showing substantial heritability (Bartels, Rietveld, Van Baal, & Boomsma, 2002; 
Johnson, McGue, & Iacono, 2006) it is possible that these variables may share some 
genetic effects in predicting death. Although early-life SES did not help to explain 
the intelligence–mortality association and birth weight is another unlikely 
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confounder, future studies could explore alternative early-life variables, in particular 
the intrauterine environment, and how these might simultaneously determine 
neurological and physiological integrity, in interaction with genetic influences, 
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Table 2.1 Characteristics of 27 longitudinal cohort studies of premorbid intelligence and all-cause mortality. 
 
 
Study Country,  
study name 









Cohort N Deaths, n IQ test,  
cohort type 
Model adjustments 












(2 to 17) 
2,309 523 AGCT, 
conscription 
Basic model: Unspecified 
Multiple adjustments: Post-school course, no 
of jobs; and during 2-year service history: 
AWOL offence, alcohol offence, duration of 
hospital stay, motor vehicle charge 
*Whalley and 
Deary (2001) 
UK, SMS32 Aberdeen 
Cohort 
M & F 1921 11 1932-1997 
(1 to 65) 
M  1,153  
W  1,032 
M  646  
W  438 
Moray House 
No. 12, school 
Basic model: Age  
Deary et al. 
(2003) 
UK, SMS32 Aberdeen 
Cohort 
M & F 1921 11 1932-1997 
(1 to 65) 
M  1,139 
W  1,032 
M  633 
W  438 
Moray House 
No. 12, school 
― 
*Hart et al. 
(2003) 
UK, SMS32 and Mid-
span studies 
M & F 1921 11 1970-2001 
(38 to 69) 
922 422 Moray House, 
school 
Basic model: Sex and age  
Adult SES: Basic model + adult social class  
Multiple adjustments: Adult SES model + 
deprivation 




M 1953 12 1968-1998 
(3 to 33) 
7,308 522 Harnquist, 
school 
Basic model: Unspecified 
Childhood SES: Father’s social class  
Multiple adjustments: Childhood SES model + 
birth weight 
Deary et al. 
(2004) 
UK, SMS47 Six Day 
Sample 
M & F 1936 11 1968-2000 
(21 to 53) 
908 125 Binet test, 
school 
― 
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Kuh et al. (2004) UK, National Survey of 
Health and 
Development (British 
1946 birth cohort) 
M & F 1946 8 1971-2000 
(17 to 46) 
M  2,192 
W  2,057 
M  133 




Hart et al. 
(2005) 
UK, SMS32 and Mid-
span studies 
M & F 1921 11 1970-2001 
(38 to 69) 






USA, Terman Life 
Cycle Study 
M & F 1903-16 6-18 (11) 1922-1986 
(1 to 64) 
862 293 Stanford-Binet, 
school 
Basic model: Sex 
Childhood SES: Poor health and father’s 
occupation  
*Hemmingsson 
et al. (2006) 
Sweden, Army 
Conscripts 
M 1949-51 18-20 (19) 1971-2000 
(1-31) 
49,262 2,022 SEB 1967, 
conscription 
Basic model: Unadjusted 
Childhood SES: Father’s occupation at age 9-
11 
Adult SES: Adulthood socioeconomic position 
Multiple adjustments: All above models 




Birth Cohort Study) 
M 1953 (18) 1980-2002 
(9 to 31) 
6,318 204 SEB, 
conscription 
― 




M & F 1947 11 1959-2003 
(1 to 45) 
M  357 
W  360 
M  30  
W  19 
Moray House 
Nos. 57 & 58, 
school 
Basic model: Unspecified 
Childhood SES: Father’s social class at birth 
(mother’s if unavailable) 




USA, NAC-NRC Twin 
WWII Veterans 
M 1917-27 17-21 (19) 1967-2004 
(22 to 59) 
984 385 AGCT / GCT, 
conscription 
Basic model: Unspecified 




M 1947 (19) 1985-2000 
(18 to 33) 
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*Batty, Shipley, 
Mortensen, 






M 1947 (20) 1985-2000 
(18 to 33) 
4,316 241 Army General 
Technical, 
conscription 
Basic model: Age  
Education: Educational level attained 
Adult SES: Occupational prestige, educational 
grade & family income 
Multiple adjustments: Basic model + adult SES 
model + rank, ethnicity, depression, BMI, pulse 
rate, posttraumatic stress disorder, somatic 
disease, martial status, alcohol consumption, 
blood pressure, blood glucose, generalised 
anxiety disorder, smoking, FEV1 
*Deary et al. 
(2008) 
UK, SMS47 Six Day 
Sample 
M & F 1936 11 1968-2003 
(21 to 56) 
1,181 193 Binet test, 
school 
Basic model: With and without sex (no 
difference) 
Education: Years of education 
Adult SES: Occupational social class 
Multiple adjustments: Sex and dependability  
Starr et al. 
(2008) 
UK, SMS32 Aberdeen 
Cohort 
M & F 1921 11 1932-2007 
(1 to 75) 
M  202 
W  152 
M  102 
W  56 
Moray House 
No. 12, school 
― 
Batty, 




M 1947 (20) 1985-2000 
(18 to 33) 









M 1947 (20) 1985-2000 
(18 to 33) 









M 1950-76 16-26 (18) 1971-2001 
(1 to 30) 
994,262 14,498 SEB, 
conscription 
Basic model: Age, year of birth, conscription 
testing centre 
Childhood SES: Parental socioeconomic index 
(highest of either parent), height 
Education: Educational level attained + 
multiple adjustments (see below) 
Multiple adjustments: Basic model + childhood 
SES model + body mass index, blood 
pressure, psychiatric and somatic illness 
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*Jokela, 
Elovainio et al. 
(2009) 
USA, National 
Longitudinal Study of 
Youth 
M & F 1957-64 16-23 (19) 1980-2004 
(0 to 24) 
M  5,682 
W  5,639 
M  248 




Basic model: Sex, birth year, ethnicity, health 
status 
Education: Basic model + years of education 
and marital status 
Multiple adjustments: Education model + 
household income 
*Kuh et al. 
(2009) 
UK, National Survey of 
Health and 
Development (British 
1946 birth cohort) 
M & F 1946 8, 11, 15 1971-2005 
(10 to 51) 
4,128 M  195  
W  137 
NFER tests, 
school 
Basic model: Sex 
Multiple adjustments: Basic model + father’s 
social class, mother’s & father’s education, 
care of house & child, adult housing quality & 
tenure, adult social class, household income, 
smoking, education.  




M 1947 (20) 1985-2000 
(18 to 33) 





et al. (2009) 
Sweden, Army 
Conscripts 
M 1949-51 18-20 (19) 1990-2003 










UK, National Child 
Development Survey 
(British 1958 birth 
cohort) 
M & F 1958 11 1969-2004 
(1 to 35) 
14,132 M  213  
W  116 
NFER tests, 
school 
Basic model: Unspecified 
Childhood SES: Father's occupational class 
Adult SES: Occupational class 
Education: Educational level attained 
Multiple adjustments: All previous models + 
child covariates (family difficulties, family size, 
problem behaviour, birth weight, height, 
mother's interest in child education, father's 
interest in child education), and adult 
covariates (marital status, psychosomatic 
symptoms, smoking, alcohol consumption, 
body mass index) 
*Leon et al. 
(2009) 
UK, ACONF M & F 1955 7 1970-2007 
(8 to 45) 
11,603 M  426  
W  235 
Moray House 
Picture Tests 
Nos. 1 & 2, 
school 
Basic model: Age, sex 
Childhood SES: Perinatal factors (which didn't 
alter the basic model), father's social class at 
birth, family size 
Multiple adjustments: All previous models + 
childhood height and weight 
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M & F 1927-28 10 1939-2003 
(1 to 65) 
M  832 
W  698 
M  363 
W  176 
Hallgren test, 
school 
Basic model: Unadjusted 
Childhood SES: Father’s education 
Education: Educational level attained 
 
Note. Studies appear in publication date order; those marked with an asterisk are included in the meta-analysis. ACONF = Aberdeen Children of the 1950s; AFQT = Armed Forces Qualification Test; 
AGCT = Army General Classification Test; GCT = General Classification Test; NFER = National Foundation for Educational Research; SMS32 = Scottish Mental Surveys of 1932; SMS47 = Scottish 
Mental Surveys of 1947; SEB = Swedish Enlistment Battery; M = men; W = women. 
a 
If years of follow-up and/or dates were not reported these were estimated according to the theoretically longest time period. 
b 
Study included all deceased and a random sample of survivors from the original cohort, twice as large as the deceased group. 
c 
Years since cognitive testing is an estimate: In correspondence Holsinger et al. reported that the vast majority of conscripts would have been 17 to 21-years-old at testing. 
d 
Years since cognitive testing and birth-year are approximations based on the mean age of participants at the beginning of follow-up in 1985-86. 
e 
Models for sex groups and those that adjusted for adult SES and multiple variables are based on a shorter follow-up period (23-46 years) and therefore a smaller sample size (N = 10,620).
 
 65 
Table 2.2 Sensitivity analysis: Summaries of all-cause mortality risk in 





















Basic model 16 All 22,453 0.76 (0.75-0.77) 0.28 15.5  
Age (M) at IQ 
    7-12 yrs 





3-4, 7, 9-12, 14-16 















   < 80% 
   ≥ 80% 








1-2, 4, 9, 14-16 



















Effect size   
   HR 





















   < 1,000 
   1,000 – 10,000 






4, 6, 12, 15 
1, 3, 9-10, 13-14, 16  



















   < 40 years 





1-2, 5, 7-8, 13-14 














Cohort birth year 
   1910s-20s 
   1930s-40s 






4, 6, 10, 12, 16 
1, 3, 9, 15 





















   Female 





















   Child SES  
   Adult SES 






2-3, 5, 7, 10-12, 14-15 
1, 3-5, 7 






















 54.2%  
 
Note. All hazard ratios are estimated from fixed effects models. 
a 
Percentage of variation across studies due to heterogeneity. 
b 
Insufficient data prevented estimation of ascertainment rate at follow-up. 
c 
Number of deaths reported for men and women exclude data from Jokela, Elovainio, et al. (2009) which was 
unreported. 
d 
Removing by far the largest cohort (Batty, Wennerstad, et al. 2009) gave attenuation effects by childhood SES of 
0.0% and by education of 45.8%. 
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Figure 2.1 Flow diagram of articles selected for systematic review and meta-analysis. 
 
 19 236 Potentially Relevant Publications Extracted  
90 Publications Retrieved for Detailed Scrutiny 
19 146 Publications Excluded Based on Title/Abstract 
64 Publications Excluded Based on Detailed Review 
24 Outcome Variable was Cause-Specific Mortality/ Morbidity 
16 No Novel Empirical Data 
10 Outcome Variable was Risk Factor/Health Behaviour 
 7 General Intelligence Measured in Adulthood  
 4 Clinical or Unrepresentative Sample  
 2 Cognitive Measure not Indicator of General Intelligence  
 1 IQ-Mortality Association Unreported 
  
3 Publications Identified from References  
2 Publications Excluded Based on Insufficient Data 
 
16 Publications Included in Meta-Analyses 
11 Studies Excluded Due to Overlapping Cohort Data 
 





Figure 2.2 Publication rate of longitudinal cohort studies on premorbid 





Note. Circles are shaded to represent country of origin and scaled proportionately to cohort 


















Figure 2.3 Risk of total mortality per one SD advantage in intelligence test 






Note. Squares mark cohort-specific effect sizes, which are proportional to the statistical 
weight (i.e. inverse variance), and diamond indicates the aggregate effect size. Horizontal 























Figure 2.4 Funnel plot of hazard ratios and standard errors demonstrating 





























Note. Diagonal lines indicate 95% CI of the aggregate hazard ratio (shown by vertical line) 
from all studies combined. One study (Hart et al., 2003) is an outlier of the CI parameters. 
 
 70 
Figure 2.5  Risk of total mortality per one SD advantage in intelligence test 
scores after adjustment for: (a) Childhood SES, (b) Adult SES 






Note. Squares mark cohort-specific effect sizes, which are proportional to the statistical 
weight (i.e. inverse variance), and diamonds indicate the aggregate effect sizes for studies 




Genetic covariance of intelligence and academic 
achievement in a UK-population cohort 
 
The role of educational inequality in understanding the link between 
intelligence differences and mortality risk cannot be underestimated; most studies in 
cognitive epidemiology control for its effects (if data on years in education or 
academic attainment exist). In the previous chapter it was observed that controlling 
for educational variables reduced the IQ-mortality effect size by half. This is one of 
the strongest attenuation effects reported in cognitive epidemiology, which could be 
a mediation effect, confounding, or both. However, as discussed, education may also 
act as a partial surrogate for cognitive abilities in such models, thus attenuation 
effects are overadjusted. This latter possibility may be validated by behaviour genetic 
twin studies, which report substantial heritability of the association between 
cognitive performance and education variables (Bartels et al., 2002; Johnson et al., 
2006). However, these studies have relied upon preselected pairs of twins that may 
not be a fully representative sample of the background population. Selection bias 
may be generous to additive genetic effect estimates. This chapter and the next, 
present behaviour genetics studies from two whole population samples of 
schoolchildren, including random samples of twins and singletons, to estimate the 
heritability of education-intelligence associations. The present chapter presents data 
from 2004, from the UK.  
 
Intelligence and education: A strong phenotypic association 
 
Intelligence test scores, and academic achievement measured at the same age 
or older, correlate strongly (r > .60) in national samples of schoolchildren (Bartels et 
al., 2002; Deary et al., 2007). The underlying causes of this association however are 
a subject of current debate. This is for several reasons. First, understanding the 
distinction between constructs of intelligence and academic achievement is of 
theoretical importance (Luo, Thompson, & Detterman, 2003). Second, if intelligence 
is directly causal to educational outcomes, and/or vice versa, this influences how 
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their independent effects on health and social outcomes (Calvin, Deary, et al., 2011; 
Lleras-Muney, 2005; Strenze, 2007) are modelled and interpreted in life course 
epidemiology (Deary & Johnson, 2010; Richards & Sacker, 2011). Third, the extent 
to which their association is genetically or environmentally determined has real-life 
implications for education and health policy (Petrill & Wilkerson, 2000). In the past 
few decades, family-based research largely on twins (Bartels et al., 2002; Petrill & 
Wilkerson, 2000; Kovas, Haworth, Dale, & Plomin, 2007; Thompson, Detterman, & 
Plomin, 1991; Wadsworth, DeFries, Fulker, & Plomin, 1995; Wainwright, Wright, 
Geffen, Luciano, & Martin, 2005), has provided evidence that a significant 
proportion of the phenotypic association between these two traits is due to genetic 
factors—as measured by genetic covariance. However, such studies may risk 
sampling and measurement bias, questioning the precision of their estimates. In the 
present study a whole population indirect twin design method is used to quantify 
additive genetic and environmental effects on the intelligence-education association 
using a large contemporary UK cohort with non-self-selected sampling. 
 
Univariate heritability of two traits  
 
 General intelligence is a highly stable and heritable trait (Deary et al., 2009). 
Across all studies, additive genetic effects account for, on average, about half of the 
variance in cognitive test scores (Devlin, Daniels, & Roeder, 1997; Deary et al., 
2006). These estimates become higher when measurement bias is low (Plomin, 
DeFries, McClearn, & McGuffin, 2009), and with increasing age from childhood to 
adulthood. For example, in the largest twin study to date, involving 11,000 twin pairs 
from four countries, heritability accounted for 41% of cognitive test score variance 
among 9 year-olds, 55% among 12 year-olds, and 66% of the variance observed in 
17 year-olds. Shared environmental factors accounted for 33%, 18% and 16% 
respectively (Haworth et al. 2010). These concurrent trends are also reported by 
longitudinal childhood studies (Bartels et al., 2002; Kovas et al., 2007), and are 
evident for both verbal and nonverbal intelligence (Hoekstra, Bartels, & Boomsma, 
2007). In the present study, a Dutch cohort includes data from three age groups, 
allowing us to consider this shift in genetic influence on intelligence over time. 
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Academic achievement is a more recent subject for behaviour genetics among 
general populations, but it too shows a significant heritable component. In the first 
study of a representative sample, the variance due to additive genetic effects in age-
standardised language and mathematics achievement scores of 6 to 12 year-olds was 
40% (Kovas et al., 2007, using data from Thompson et al., 1991). Since then, 
consistently high estimates have been reported from twin cohorts, with genetic 
inheritance accounting for in the region of 50% to 70% variance in, either, 
educational years, achievement test scores, or attainment levels (Bartels et al., 2002; 
Kovas et al., 2007; Baker, Treloar, Reynolds, Heath, & Martin, 1996; Johnson et al., 
2006).  
 
Twin studies of genetic covariance 
 
Given the high correlation between intelligence and educational performance 
in national cohorts, and the significant heritability on each trait, it was always likely 
that, at least some genetic factors driving academic achievement were shared by 
those influencing intelligence trait variance (Martin, 1975). To test this, multivariate 
models using twin studies have produced estimates of the proportion of the 
phenotypic correlation between two traits due to genetic factors and due to the shared 
and non-shared environment respectively. In such studies genetic covariance 
estimates have been high, explaining a majority of the phenotypic association. 
Among 190 Dutch twin pairs, bivariate models applied to educational test scores at 
age 12 and IQ scores at ages 5, 7, 10 and 12 years (Bartels et al., 2002) observed 
additive genetic covariance that increased with age (40%, 75% and 83% among 5, 7 
and 9 year-olds respectively), but became weaker again at age 12 (41%), with shared 
environment mainly accounting for the remaining association. An Australian study of 
17 year-old students, including 256 monozygotic (MZ) and 326 dizygotic (DZ) twin 
pairs, reported high additive genetic covariance between the Queensland Core Skills 
Test and verbal and performance IQ scores; 72% and 75% respectively (Wainwright 
et al., 2005). However, the educational measure in this study may have been more 
aligned to conventional intelligence tests of deductive and inductive reasoning than 
to tests of educational curricula. Finally, the Twins‘ Early Development Study 
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(TEDS) analysed associations between teacher-rated academic attainment (in 
English, mathematics and science) and intelligence test scores of nearly 5,000 MZ 
and DZ twin pairs born in England and Wales between 1994 and 1996, each assessed 
at ages 7, 9, and 10 years (Kovas et al., 2007). Phenotypic correlations between traits 
were moderate and relatively stable over time (r = .37 to .41), and additive genetic 
covariance accounted for between 63% and 90% of these associations, with shared 
environment explaining the remaining covariance. Furthermore, these heritable 
effects were stronger among the oldest (83% to 90%) relative to youngest children 
(63% to 73%). 
 
Selection bias in twin studies 
 
It has therefore already been shown that additive genetic factors account for 
the majority of the phenotypic association between childhood intelligence and 
educational measures (at least from about 7 years), and that the degree of genetic 
covariance may increase with age. However, particular issues of sampling and 
measurement bias may limit the generalisability of these study estimates to 
background populations including non-twins. First, ratios of MZ to DZ twins are 
higher among twin study volunteers, relative to the general population of twins, a 
factor which, if not adjusted for, may significantly influence genetic effect estimates, 
most likely in the direction of underestimation (Lykken, McGue, & Tellegen, 1987). 
Second, the average cognitive abilities of volunteers tend to be higher than in the 
general population, including in twin samples (cf. Kovas et al., 2007; Rietveld, van 
Baal, Dolan, & Boomsma, 2000; Thompson et al., 1991; Wainwright et al., 2005); 
attrition in longitudinal studies also leads to higher ability and socioeconomic 
groups. These factors can have the converse effect of inflating heritability estimates 
(Turkheimer, Haley, Waldron, D’Onofrio, & Gottesman, 2003). The TEDS cohort 
reported attrition rates at 9 and 10 years, and so it cannot be ruled out that the 
increased heritability estimates with age in this study are in part influenced by of this 
form of self-selection bias.  
Different testing procedures for phenotypic measurement may also influence 
genetic covariance estimates. The TEDS study had available various methods to 
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measure intelligence at different ages, including a telephone interview at age 7 years, 
parent-administered tests at 9, and internet-based tests aged 10. In the other 
longitudinal study to report genetic covariance estimates, a different intelligence test 
at ages 5, 7, and 10 years was used (Revisie Amsterdamse Kinder Intelligentie Test) 
compared to the revised Wechsler Intelligence Scale for Children (WISC-R) at 12 
years (Bartels et al., 2002). This may have contributed to the discordant result of an 
increase in genetic covariance from age 5 to 10 years, and then a lower estimate at 
age 12. Although statistical adjustment can be made for sampling bias effects or 
weak inter-method reliability, analysing genetic covariance among non-self-selected 
twins, and using consistent methods of intelligence testing for investigating 
differential age effects, can be a more direct and reliable approach (Luo et al., 2003).  
 
The present study 
 
 This study uses a twin extraction method applied to a national dataset from 
England, to remove the issue of self-selection bias of twins. The method was used 
previously to estimate univariate heritability of intelligence (Benyamin, Wilson, 
Whalley, Visscher, & Deary, 2005) and validated to a high level of accuracy 
(Webbink, Roeleveld, & Visscher, 2006). As this procedure also identifies 
individuals who are non-twins (“singletons”), their data is included to account for 
trait variability in the general population—a method rarely employed in the twin 
design. In this cohort all assessments of intelligence and academic achievement were 
group-administered within schools; the intelligence test has been well validated, and 
academic attainment was measured according to the national curricula of the UK in 
2004.  These factors may help to minimise measurement bias in the present study.  
Additional to the main investigation of estimating genetic covariance between 
intelligence and academic achievement scores among a large UK cohort, these novel 
data are used to explore genetic components of specific cognitive abilities in relation 








The cohort has been characterised in a previous report (Calvin, Fernandes, 
Smith, Visscher, & Deary, 2009). It originates from a cross-sectional linkage of 
routinely collected academic performance data from the UK Government's 
Department for Children, Schools and Families, and cognitive ability test data from 
2004, maintained by a national school test provider (GL Assessment). The 
participants were 178,599 11 year-old boys and girls (M = 11 years 2 months; SD = 
3.5 months), from 1,531 state and specialist schools in England, representing 93% of 
local education authorities.  
 
Academic and intelligence assessments 
 
Intelligence performance was measured in September to October 2004 using 
the age-standardised Cognitive Abilities Test — Third Edition (CAT3) of verbal 
reasoning (VR), nonverbal reasoning (NVR) and quantitative reasoning (QR) 
abilities (Smith, Fernandes, & Strand, 2001). Using principal components analysis a 
single unrotated general intelligence factor (g) was extracted and retained for 
analysis. The subtest score loadings on g were as follows: QR = .87, NVR = .85, VR 
= .8l.  
Academic achievement data were taken from performance levels on Key 
Stage 2 curriculum tests in English, mathematics, and science, routinely group-
administered within schools, using pencil and paper tests, during May 2004. The 
whole battery lasted five and a half hours (Directgov, 2011). These tests were 
designed to ensure that government targets for educational standards are met in 
England and Wales. Each individual had a rating from 2 to 5 recorded for each 
subject, reflecting raw scores in the ranges <21, 21-26, 27-32, and >32 respectively. 
These ratings were used as educational achievement scores in the analysis. A single 
educational factor score (e) was extracted from principal components analysis, 
accounting for 75% of the total score variance. This score was retained for analysis. 
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The subject score loadings on this general educational factor were as follows: 




In this UK dataset twin status was allocated if two individuals matched on 
surname, date of birth, and school ID. Eighty eight individuals were removed 
because they were identified as triplets or quadruplets (for example, when more then 
two individuals matched on all three criteria), and the rest were assigned singleton 
status. Twins constituted 1.8% of the present study’s cohort of singletons and twins 
from England—a somewhat smaller proportion than the 2.5% of individuals born as 
twins among total numbers of twins and singletons born in England and Wales in 
1993 (Dunn & Macfarlane, 1996), which may be due for example to members of a 






The intelligence and education data were screened for missing data and 
normality, and assessed for univariate and bivariate outliers. If a member of a twin 
pair was excluded due to missing or outlier scores, their cotwin was also removed. 
As the educational data showed negative skew, scores of 2 were recoded as 3. 
Univariate outliers were values beyond three SDs from the mean, and bivariate 
outliers were detected if Mahalanobis distance was equal or higher of the critical 





Descriptive statistics and phenotypic correlations were produced using PASW 
Statistics 17.0.3. Phenotypic correlation coefficients were first calculated for the total 
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cohort, and then repeated, with the exclusion of one member from every designated 
twin pair, so that each data point was entirely independent. 
ASReml Release 3.0 software (Gilmour, Gogel, Cullis, & Thompson, 2009) 
was used to estimate variance components and genetic and environmental effects in 
univariate and multivariate linear mixed models with the restricted maximum 
likelihood method (Visscher, Benyamin, & White, 2004). Without known zygosity in 
the present study’s data, variance components for opposite-sex (OS) and same-sex 
(SS) twin pairs were derived instead of those for DZ and MZ twin pairs (see 
Benyamin et al., 2005; Scarr-Salapatek, 1971; Visscher et al., 2004). This method 
uses the knowledge that all OS twins are DZ and depends on the assumption that 
twice the proportion of OS twins is the proportion of DZ in the population
1
. 
Essentially the estimated proportions of covariance between twin pairs, attributed to 
additive genetic (A), shared environment (C), and unique environment (E) effects 
(Neale & Cardon, 1992), are weighted by the estimated proportion of MZ twins 




   OSOSMZSS ppp  1/21   
where OSp  is the proportion of OS twins among total twin pairs 
 
In the present study’s UK cohort this parameter estimate was 0.53, based 
upon estimates of the proportion of MZ twins among total twin pairs of 36.2% in 
England, which can be compared to national statistics of 35.8%, reported by 
Imaizumi (2003).  
In linear models sex and age were entered as fixed effect variables, to take 
out variation due to systematic effects. Given the inclusion of singleton data in the 
present study (unusual for a standard ACE twin design), the variables pair and SS 
pair were entered as random (latent) effects. The variable pair was a unique 
identifier assigned to each individual in the data unless it was shared by a member of 
                                                 
1
 This assumption is based upon the further assumption of a 1:1 sex ratio and equal survival, 
stemming from Weinberg’s differential rule (Weinberg, 1901) 
2
 Scarr-Salapatek (1971) 
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a twin pair. The variable SS pair was also a unique identifier given to each individual 
unless shared by a member of a SS twin pair: 
 
y = μ + pair + SS pair + residual 
With var(y) = var(pair) + var(SS pair) + var(residual)   
 
In terms of covariances between twin pairs this implies: 
 
cov(SS pair) = var(pair) + var(SS pair) 
cov(OS pair) = var(pair) 
 
The estimated variance components are therefore linear functions of the covariances 
of the SS and OS twin pairs, and their expectations are: 
 
E[var(SS pair)] = cov(SS pair) – cov(OS pair) 
E[var(pair)] = cov(OS pair) 
 
Models of the underlying variance components in the population (e.g., A, C 
and E) are linear combinations of the covariances of SS and OS pairs, and therefore 
linear combinations of the estimated variance components. 
In post-analytic procedures, variance components from REML were 
transformed and weighted using pMZSS to estimate variation due to additive genetic 
(h
2
), shared environment (c
2
) and unique environment (e
2
) effects among individual 
traits. These estimated parameters and the transformed and weighted cross-trait 
variance components were then used to estimate genetic covariance between traits 
(Biv h
2
)—the proportion of their phenotypic correlation due to additive genetic 
factors (or the ratio of genetic to phenotypic covariance)—as well as covariance due 
to shared environment (Biv c
2
) and unique environment (Biv e
2
) effects. Sampling 
variances were calculated from a first order Taylor series of the likelihood function 
about the maximum likelihood estimates. Appendix C presents the formulae used in 






Comparison of singletons, opposite-sex twins and same-sex 
twins 
 
Negligible differences were observed in the means and standard deviations of 
singletons, opposite-sex (OS) twins and same-sex (OS) twins on all cognitive and 
educational variables, in the British dataset (see Table 3.1), consistent with a 





Table 3.1 includes the intra-class correlations for OS and SS twin pairs; that 
these were higher for SS pairs, which would include all MZ twins and some DZ 
twins from the total sample, compared to OS twins who were all DZ, indicates 
additive genetic influences on all academic and intelligence variables. This was 
confirmed by the univariate estimates of additive genetic and environmental effects 
(see Figure 3.1).  In the UK g was strongly heritable at age 11 (h
2
 = .70 ±.14―which 
herein denotes the estimate and the standard error). Verbal and nonverbal reasoning 
scores showed higher heritability estimates (h
2
 = .79 ±.14, and .70 ±.16, respectively) 
than quantitative reasoning scores (h
2
 = .50 ±.15). Academic achievement in 
England’s 11 year-olds was strongly influenced by additive genes, and the 
heritability estimate for the education factor score (h
2
 = .75 ±.14) was equivalent to 
that of the intelligence factor, g. Among specific academic subjects, English was 
most strongly influenced by additive genetic effects (h
2
 = .81 ±.16), followed by 
mathematics (h
2
 = .66 ±.16) and science (h
2






Phenotypic correlations among all cognitive and academic variables were all 
positive and statistically significant (p < .05), with effect sizes ranging between r = 
.52 to .84, see Table 3.2). High genetic correlations with low standard errors were 
observed between cognitive subtest scores and academic attainments (rG = 0.58 to 
0.97) (see Table 3.3). Correlations of shared environmental effects were markedly 
high for some cross-trait pairings, for example of verbal reasoning with mathematics 
and science (rC = 0.86 ±.36 and 1.0 ±.29, respectively), and quantitative reasoning 
with these two subjects (rC = 1.00 ±.32 and 1.00 ±.33). By contrast, shared 
environment correlations were low for nonverbal reasoning with mathematics and 
science achievements (rC = 0.05 ±.90 and,  0.24 ±.59, respectively), although in these 
latter models the standard errors were high.  
A substantial proportion of the intelligence-education phenotypic correlations 
in the cohort were due to additive genetic influence, indicated by high genetic 
covariances (Biv h
2
) in the range 0.53 to 1.00, with standard errors of between 0.13 
and 0.21 (see Figure 3.2). These were consistently high between verbal reasoning 
and academic achievements (genetic covariance, Biv h
2
 = 0.77 to 1.00), as well as 
nonverbal reasoning and the achievement scores (Biv h
2
 = 0.94 to 0.98). Where 
environmental effects influenced phenotypic associations between quantitative 
reasoning and academic achievement, shared environment was somewhat more 
important in explaining the relationship (shared environment covariance, Biv c
2
 = 
0.22 to 0.34), than was the unique environment (Biv e
2




The main aim of this study was to report on genetic and environmental 
influences on associations between intelligence test scores and academic 
achievement scores in a large UK-wide cohort of schoolchildren. Although this is a 
relatively well-researched hypothesis in the behaviour genetics literature, the 
sampling method is novel in this context, providing cross-trait estimates using data 
on non-self-selected twin pairs and including trait distributions of singletons, thus 
eliminating self-selection bias. This method gives confidence when generalising 
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estimates to the background population. The substantial cross-trait heritabilities in an 
England cohort are consistent with the two most comparable previous studies of 
similarly aged children (Bartels et al., 2002; Kovas et al., 2007) and a third study of 
older children (Wainwright et al., 2005), in which pre- and/or self-selection of twin 
pairs may have increased genetic estimates. A strong additive genetic influence on 
intelligence and academic achievement associations is indicative of a more 
fundamental cognitive trait that is genetically influenced, and which drives a 
substantial proportion of the association between the two rather than, for example, 
individual differences in educational opportunity causing variance in intelligence test 
performance. Some evidence suggests that processing speed might be a reliable 
indicator of this low-level antecedent trait (Luo et al., 2003; Luciano et al., 2001), 
although in one study this variable shared a lower genetic correlation with academic 
achievement relative to other cognitive ability tasks, including memory and spatial 
reasoning (Thompson et al., 1991). It was also found that shared environment 
explained most of the remaining variance in England; that is, for the association 
between g and academic subject achievements, replicating previous studies’ results 
(Bartels et al., 2002; Kovas et al., 2007; Wainwright et al., 2005).  
 Among twin studies of the association between cognitive performance and 
academic achievement, fewer have looked beyond a general intelligence score to 
using more specific functional tests of cognition. In one study, performance on 
verbal, spatial and memory tasks showed consistently high genetic correlations with 
language and mathematics achievement scores, and a processing speed task showed a 
relatively lower genetic correlation with academic achievement (Thompson et al., 
1991). In another, a higher genetic correlation between verbal IQ and achievement 
scores was reported, relative to a performance IQ measure, although additive genetic 
effects explained an equally high proportion of the phenotypic association in both 
cases (Wainwright et al., 2005). In the present study’s UK cohort, very high genetic 
correlations were observed between verbal reasoning and English language 
achievement, and nonverbal reasoning with mathematics and science achievements, 
which were greater than for other combinations of cognitive and academic variables. 
However, consistent with Wainwright et al. (2005) the present study observed 
equivalent and consistently very high genetic covariances between all three subject-
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specific achievement scores and nonverbal and verbal reasoning respectively. This 
may further validate the proposition that additive genetic influences on a general 
cognitive processing trait drive associations with educational achievements, and that 
the effect of schooling in explaining variance in psychometric g, at least in primary 
school education, is a weakened proposition (Luo et al., 2003).  
Although it was possible to look at performance on three distinct academic 
subjects in relation to specific cognitive subtest scores, the data were restricted so 
that it was not possible to consider different measures within academic subjects, 
which may differentially affect genetic covariance estimates. For example, in a U.S. 
twin study of elementary schoolchildren mathematical fluency and problem solving 
but not computational mathematics shared genetic covariance with cognitive ability 
(Hart, Petrill, Thompson, & Plomin, 2009). Studies such as this one, in an expanding 
area of behaviour genetics research with increasing complexity of multivariate 
models, include related performance measures such as reading, thereby deriving 
more reliable heritability estimates for the associations between cognitive ability and 
specific academic abilities once these covariates are controlled for. With the 
population-level cohort data available in the present study however, specific 
educational performance measures, and reading, could not be explored.  
 There are several strengths of the present study design worth highlighting, 
which must be counterbalanced with the weaknesses of the specific approach taken 
by this whole population twin study design. However, as the next chapter’s Dutch 
study uses the same methodology, and bears many similarities to the present study’s 
UK study—including age of cohort and equivalent measurements of intelligence and 
academic achievements—these are left for the Discussion section of Chapter 4, along 
with a comparison of these two studies’ results.  
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  Skew Kurtosis  t 
 Singletons 
n = 170,996 
OS twin 
members   
n = 990 
SS twin 
members     








Cognitive ability          
VR 0.00 (0.99) -0.06 (0.98) 0.00 (0.99)  -0.06 -0.06  0.51 0.72 
NVR 0.00 (1.00) -0.06 (0.97) 0.03 (0.99)  0.22 -0.40  0.43 0.61 
QR 0.00 (0.99) -0.04 (0.97) 0.01 (0.98)  0.14 -0.37  0.46 0.59 
g 0.00 (1.00) -0.06 (0.97) 0.01 (0.98)  -0.01 -0.44  0.53 0.71 
Education          
English 0.00 (1.00) -0.01 (1.00) 0.03 (1.01)  -0.11 -0.84  0.38 0.59 
Math 0.00 (1.00) -0.02 (1.00) -0.01 (0.99)  -0.15 -1.14  0.43 0.60 
Science 0.00 (1.00) 0.01 (0.97) 0.02 (0.98)  -0.49 -0.75  0.44 0.57 
e 0.00 (1.00) -0.01 (1.00) 0.01 (1.00)  -0.31 -0.83  0.49 0.69 
 
 
Note. e = education factor, g = general intelligence factor, Math = mathematics, NVR = nonverbal reasoning, OS = opposite sex, QR = quantitative 
reasoning, SS = same sex, t = intraclass correlation, VR = verbal reasoning  
a 
ANOVA resulted in no statistically significant differences between the groups on any performance measure (p < .05)
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Note. Pearson correlation coefficients are reported for the total cohort (N = 174,098), and all 
are statistically significant at p < .001. e = education factor; g = general intelligence factor; 
NVR = nonverbal reasoning; QR = quantitative reasoning. Analyses were repeated following 
a random split of twin pairs to remove a cotwin from the dataset, and thus entirely 










Note. Standard errors were not estimable for shared environmental correlations between English and intelligence test scores, due to a close-to-zero 
variance component and relatively large standard error in English. e = education factor; g = general intelligence factor; NVR = nonverbal reasoning; QR 
= quantitative reasoning; rG = genetic correlation; rC = shared environment correlation; VR = verbal reasoning. 
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Figure 3.1 Univariate estimates of additive genetic, shared and unique 






Note. Bar shadings indicate the proportions of additive genetic (h
2
; black), shared 
environment (c
2
; grey), and unique environment (e
2
; white) effects; error bars show the 




. e = education factor; g = general intelligence factor; NVR = 
nonverbal reasoning; QR = quantitative reasoning; VR = verbal reasoning. 
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Note. Bars represent phenotypic correlations and their shadings indicate their relative proportions due to additive genetic (black), shared environment 





) and environmental effects (Biv e
2
), which summed together equal 1.0. e = education factor; g = intelligence factor; NVR = nonverbal 
reasoning; QR = quantitative reasoning; VR = verbal reasoning. 
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Chapter 4  
Genetic covariance of intelligence and academic 
achievement in The Netherlands 
 
This chapter replicates the previous chapter in terms of hypothesis and 
design; that is, it uses the same twin extraction method and modelling techniques to 
estimate the proportion of phenotypic association between intelligence and academic 
achievement. However, in this study the cohort is derived from a population of Dutch 
schoolchildren. There are several factors that this cohort has in common with the 
previous study’s British schoolchildren, enabling a valid cross-national comparison 
of intelligence-education genetic covariance estimates: The cohorts are of similar 
age; they share similar academic achievement tests, including language and 
arithmetic, which are measured according to the national curricula of the country; 
and, they are extremely large. The Dutch cohort also contains singleton data, and has 
not been preselected for twin pairs; rather it has derived from a population-
representative study sample of Dutch schoolchildren. Furthermore, the present 
study’s cohort is of an age when only core school subjects are studied as part of the 
curricula, and therefore, again the issue of controlling for variation in educational 
experience is minimised. A novel aspect of the present chapter however is the 
different ages of schoolchildren in The Netherlands, albeit consistent measures of 
intelligence and academic achievement are used across age groups. This allows for 
the opportunity to make comparisons of the effect sizes in three age groups, and a 
consideration in shift of genetic influence on intelligence and educational success 
over time. This may be relevant given evidence for increasing genetic covariance 








This cohort of schoolchildren from The Netherlands has been described in 
detail in a previous publication (Webbink, Posthuma, Boomsma, de Geus, & 
Visscher, 2008). It derives from the longitudinal PRIMA Survey, which aims to 
answer questions about educational strategies and performance in primary education 
in The Netherlands (Driessen, Van Langen, & Oudenhoven, 1994; Driessen, Van 
Langen, & Vierke, 2004). The present study incorporated data from the first five 
waves of the survey, which took place biannually from 1994 to 2002, and included 
~60,000 pupils per wave. The PRIMA project targets a panel of ~600 schools at a 
time, stratified so that pupils from lower socioeconomic backgrounds are over-
sampled. Measures of school performance and cognitive ability are administered to 
all pupils in grades 4, 6 and 8, corresponding to ages 8, 10 and 12 years. A minority 
of schoolchildren were included in more than one wave, so that in the present study, 
~24% of those tested in grade 4 were also tested in grade 6 and, of these, ~7% were 
again tested in grade 8.  
 
Academic and intelligence measures 
 
The performance scores selected from this study are: General intelligence 
(IQ), as measured by two tests of nonverbal reasoning, specifically selected to 
minimise bias by socioeconomic status (Webbink et al., 2006), and, academic 
achievement scores in arithmetic (AR) and language (LA). Inter-method reliability 
among the same tests at different ages is reflected in high within-subject correlations 
among members of the cohort tested at more than one wave. Intraclass correlations 
are: IQ, .63 to 74, language, .62 to .76 and arithmetic, .70 to .83. Although in the 
present study, analyses are conducted separately for each age group, this evidence for 




A similar method of twin identification was adopted in the Dutch data 
compared to the UK study (Webbink et al., 2006), with individuals matched on 
surname, date of birth, and school, and with ‘year of survey’ as a fourth matching 
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variable due to the multiple-wave design. In 1990 the proportion of individuals born 
as a twin among twin and singleton births in The Netherlands, was approximately 
2.7% (Imaizumi, 2003). In the present cohort, twins constituted 2.0% of 8 year-olds, 
1.8% of 10 year-olds, and 1.6% of 12 year-olds, again showing a somewhat lower 
representation compared to national statistics. It is comparable with the lower rate 




The statistical methods of the present study match those of the previous 
chapter, including the treatment of outliers, use of software, and the univariate and 
multivariate models. Zygosity was also unknown in this cohort, and so ACE models 
included a weighting, which was the estimated proportion of MZ twins among SS 
pairs: 
   OSOSMZSS ppp  1/21   
Where OSp  is the proportion of OS twins among total twin pairs. 
 
The proportion of MZ twins among total twin pairs was estimated at 40.6% in 
the cohort, which is somewhat larger than the MZ twin birth rate in the Netherlands 
in 1990, recorded at 34.6% (Imaizumi, 2003). This resulted in an estimated 
weighting of 0.58 (averaged across age groups). 
In linear models, as well as controlling for sex and age, year of test was 
included as a fixed effect to take out variation due to its systematic effects. As with 
the UK cohort, singleton data were also included in all models. For formulae to 
estimate variance components the Results section of Chapter 3 may be referred to. 







Comparison of singletons, opposite-sex twins, and same-sex 
twins 
 
Negligible differences were observed in the means and standard deviations of 
singletons, opposite-sex (OS) twins and same-sex (SS) twins on all cognitive and 
educational variables, in the Dutch datasets (see Table 4.1), consistent with a 




Table 4.1 includes the intra-class correlations on variable performance within 
OS and SS twin pairs; that these were higher for SS pairs, which would include all 
MZ twins and some DZ twins from the total sample, compared to OS twins who 
were all DZ, indicates additive genetic influences on all education and intelligence 
variables. This was confirmed by the univariate estimates of additive genetic and 
environmental effects (see Figure 4.1).  The Dutch data support evidence that 
additive genetic effects on intelligence test performance increase with age, in the 
present study from 8 years (h
2
 = .43 ±.23) to 12 years (h
2
 = .67 ±.31). The data also 
show an unexpectedly low heritability estimate at age 10 years (h
2
 =.24 ±.29), with a 
larger influence of shared environmental effects (c
2
 =.29 ±.04) than might be 
expected given the existing literature. 
In Dutch schoolchildren, language attainment showed greatest additive 
genetic influence in the younger cohort (h
2
 = .74 ±.27) compared to ages 10 and 12 
(h
2
 = .43 ±.29 and .53 ±.31, respectively). Of the effect remaining, unique 
environmental influences were more important than shared environment. Arithmetic 
performance was largely heritable at 8 and 10 years (h
2
 = .67 ±.27 and .73 ±.29 
respectively), and unique environment explained the remaining variance. At age 12, 
additive genetic effects were relatively less important in explaining variance in 
arithmetic achievement (h
2
 = .36 ±.27), and shared environment was more influential 
than at younger ages (c
2






Phenotypic correlations among all cognitive and education variables, in the 
Dutch cohort, were all positive and statistically significant (p < .05). These effect 
sizes were smaller (r = .36 to .47) than compared with the England cohort, but the 
magnitude of associations was consistent across different ages. For example, at ages 
8, 10 and 12, IQ-language correlations were r = .38, .36 and .36, and IQ-arithmetic 
correlations were r = .44, .47, and .47, respectively. On the other hand, correlations 
between the two educational subjects in The Netherlands showed an increase with 
older age groups, r = .43, .50 and .55, respectively. Intelligence was more strongly 
associated with arithmetic attainment compared to language attainment in both 
national cohorts.  
Table 4.2 shows the genetic correlations between intelligence and education 
variables in The Netherlands. Genetic correlations between IQ and language, and IQ 
and arithmetic, were moderate across all ages (rG = 0.31 to 0.58), with the exception 
of the cross-trait genetic correlation between IQ and language at age 8 (rG = 0.82), 
which was higher, and more consistent with the UK data. An unexpected finding was 
that although shared environment correlations for IQ and educational attainment 
were negligible (rC = 0.00 ±0.00) at 8 years and 12 years, among 10 year-olds they 
were high (rC = 0.74 ±0.56 for language; 1.79 ±3.02 for arithmetic), albeit with very 
high standard errors.  
Figure 4.2 shows the genetic and environmental covariance estimates from 
the Dutch cohort. To consider the 8 and 12 year-old data first, these show that the 
language-IQ phenotypic associations were largely explained by additive genetic 
effects at both ages (Biv h
2
 = 1.00 ±.43 and 0.92 ±.59 respectively). Additive genes 
also explained the majority of the phenotypic association between arithmetic and IQ 
within these age groups (Biv h
2
 = 0.63 ±.51 at age 8 and 0.64 ±.42 at age 12), and the 
remainder was explained more by the shared than the unique environment (Biv c
2
 = 
0.30 and 0.20; Biv e
2
 = 0.07 and 0.16 respectively). In contrast, at age 10, shared 
environment was more influential than additive genetic effects on the IQ and 
education phenotypic association (Biv h
2
 = 0.33 ±.52, Biv c
2
 = 0.49 ±0.38 for 
language, and Biv h
2
 = 0.36 ±.38, Biv c
2






The additive genetic covariance estimates between intelligence test 
performance and academic achievement scores from the present study’s Dutch 
cohort, are at the high end of those reported from preselected twin study samples 
(Bartels et al., 2002; Kovas et al., 2007; Wainwright et al., 2005); at least, this is 
what was observed from the youngest and oldest age groups from the cohort. The 
remaining variance was explained mostly by effects of shared environment, which is 
again consistent with these previous studies. In a Dutch twin study of preselected 
twin pairs where zygosity was known, the genetic covariances (here meaning the 
proportion of the phenotypic correlation explained by additive genetic effects) 
between intelligence test scores at ages 7 and 10, and academic achievement at age 
12, are similar in magnitude to those of the present study’s 8 and 12 year-old cohorts 
where intelligence and academic achievement were measured contemporaneously 
(Bartels et al., 2002). However, the authors of this study, describing a sudden drop in 
genetic covariance between age 12-intelligence and academic achievement as 
“remarkable” (p. 550), interpreted it as shared environment influencing phenotypic 
associations in an age- and time-specific way. The present study observed a sudden 
drop in genetic covariance at age 10 rather than 12, although there were large 




Comparison of estimates from two European countries 
 
Lower genetic covariances, albeit with larger standard errors, were estimated 
in the Dutch relative to British cohort. There may be several explanations for this. 
One influence might be that the CAT-3 intelligence test used on the British cohort 
was designed to minimise demand on verbal skills (Smith et al., 2001), making it a 
less culturally biased intelligence indicator, and thus perhaps optimising the 
heritability estimates. An additional explanation for the relatively lower estimates in 
the Dutch cohort may be in its stratified sampling that increased representation of 
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low socioeconomic groups in the PRIMA Survey—particularly as lower heritability 
estimates for intelligence have been reported in these groups (Turkheimer et al., 
2003). Nevertheless, there was notable consistency across the two cohorts‘ 
equivalent age groups; for example, in the additive genetic covariance estimates of 
intelligence with language and arithmetic/mathematics respectively, among 12 year-
olds in The Netherlands and 11 year-olds in England. Another consistency was the 
greater additive genetic influence on intelligence-language associations, relative to 
intelligence-arithmetic associations, which is reported in the existing literature (Luo 
et al., 2003; Kovas et al., 2007). 
 
Age effects on genetic covariance estimates 
 
The different age groups of the Dutch schoolchildren provided the 
opportunity to consider changes in the magnitude of additive genetic influence on 
intelligence—education associations from age 8 to age 12, albeit using cross-
sectional inference. Despite a general trend for genetic covariance to increase with 
age (Bartels et al., 2002; Kovas et al., 2007; Petrill & Wilkerson, 2000), one study 
reported a considerable decrease in the genetic covariance from 10 to 12 years 
(Bartels et al., 2002). The present chapter’s findings showed no significant change in 
genetic covariance estimates between the youngest and oldest age groups however, 
and again, this may be because their standard errors were typically very large. It has 
been suggested that an initial increase in additive genetic influence at elementary 
school age may reflect emergent functionality of higher level cognition or a 
transition from rote learning to more complex academic engagement (Wainwright et 
al., 2005). Longitudinal twin studies running into secondary education would help to 
demarcate the ages at which additive genetic influences on intelligence-academic 
achievement associations shift in their relative importance. 
 
Implications of the twin extraction method, and its strengths 
 
 Several key sources of potential bias were minimized in these last two 
chapters, including measurement bias (using well-standardised tests administered in 
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the stable classroom environment) and self-selection bias (random sampling from 
national cohorts). However, the twin extraction method could itself have incurred 
error, although a validation study reported a low risk of statistical bias using this 
method (Webbink et al., 2006). Error that did occur was due to false negative rather 
than false positive detection. Twins may have been under-detected in the present 
study (if for example, a cotwin was absent on the day of testing, had missing data, or 
attended a different school), particularly as a somewhat lower proportion of total 
twins were observed relative to national twin birth rates. This may compromise how 
twin population-representative the two cohorts might be. However, false negatives 
would have had to affect MZ twin pairs to a greater or lesser extent than DZ twins, in 
order to have influenced our effect sizes, and there is little to indicate that this might 
have been the case. Furthermore, estimates of the proportions of MZ twins among 
total twin pairs were similar to national birth statistics for the appropriate years 
(Imaizumi, 2003), albeit there was a slight overestimation of the MZ twin proportion 
in the Dutch cohort. A second potential source of error is the statistical approach, 
which is based on further assumptions than traditional approaches where zygosity is 
known. In particular, heritability estimates were derived from variance components 
of OS and SS twin pairs, weighted on the basis of statistical assumption. This was an 
estimation of the proportion of MZ twins among SS pairs, based upon the 
approximation that DZ twins represent two times the proportion of OS twins in the 
population, and assumptions of a 1:1 sex ratio among DZ twin births and an 
equivalent survival of male-male and female-female DZ twins. Furthermore, if there 
are sex-specific covariance estimates then the results risk bias. 
Without known zygosity it is not possible to directly validate the twin 
extraction method within these cohort studies. An indirect method however is to look 
for consistency between univariate estimates of intelligence and education 
heritabilities reported here, with those from the existing literature, which was in fact 
found. In the present study, Dutch heritability estimates for intelligence were 
consistent with previous studies of similarly aged children (Bartels et al., 2002; 
Kovas et al., 2007; Haworth et al., 2010). The relatively low heritability of 
intelligence estimated in 10-year-old schoolchildren, and a greater influence of 
shared environment compared to other age groups, did show overlapping standard 
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errors of these estimates. In England, intelligence heritability was in the higher range 
of the existing literature, and this may be due to the measure’s effective removal of 
cultural bias. However, different educational policies of The Netherlands and 
England may also influence disparities between these two countries’ heritability 
estimates. For example, the relatively lower heritability of intelligence test 
performance in The Netherlands may be influenced by a greater effort by that 
country’s government to create national equality in educational opportunities; Dutch 
schools receive additional personnel and resources for every additional pupil they 
teach who is from a disadvantaged background (Lindahl, Lindahl, Oosterbeck, & 
Webbink, 2007), which is likely to reduce genetic effects on the performance of tests 
taken in the school setting. On education, additive genetic effects on Dutch language 
were consistent with a previous estimate from the CITO test (Bartels et al., 2002), 
and heritability estimates of mathematics and science attainments in the British 
sample, were compatible with equivalent attainment scores in the UK TEDS study 
(Kovas et al., 2007). However, additive genetic effects accounted for 81% of the 
variance in English attainment compared to 60% in TEDS. The difference here may 
be that the present study’s education data were based on a nationally standardised 
test score, compared to teacher ratings of scholastic achievement in the TEDS 




The methods employed in these two latest chapters overcame some key 
caveats of interpreting additive genetic effect estimates from ACE models (Neale, 
2009), including use of large, non-preselected twin cohorts, and by incorporating 
singleton data in the models to account for trait variability in the general population. 
However, admittedly there are limitations of a standard twin design that the present 
studies share. First, the analytic method implicitly assumes that twin similarity due to 
common environmental effects is the same for MZ and DZ twins. A second 
assumption is that the genetic correlation between males and females is 1.0. 
Nevertheless, intelligence heritability estimates reported by twin studies depending 
on these first two assumptions, have recently been validated by the first genome-
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wide association study using biological samples of unrelated adults, which found that 
genetic variation explained ~50% of individual differences in fluid intelligence 
(Davies et al., 2011). Third, and specific to an analysis of twins where zygosity is 
unknown, is the assumption that among DZ twins the effect of shared environment is 
the same for SS and OS twin pairs. In future, biological samples collected from 
national twin registries will enable a more thorough investigation of familial factors 
in the covariance between intelligence and academic achievements (Kaprio, 2011). 
Preliminary studies have so far suggested similar chromosomal regions relating 
intelligence to reading (Luciano et al., 2006; Posthuma et al., 2005) and educational 
performance (Wainwright et al., 2006). Such findings would require replication 
however if they were to be validated, and a persistent challenge to molecular genetics 
research is the need for massive databases to achieve adequate statistical power in 
detecting small effects, of what are likely to be several implicated genes (Fisch, 
2009). A recent approach to assessing the phenotypic variation and covariation 
between traits, in respect of genetic influence, is Genome-wide Complex Trait 
Analysis or GCTA (Yang, Lee, Goddard, & Visscher, 2011) that uses genetic data 
from unrelated individuals (as cited previously in Davies et al., 2011). This new 





The observation of strong additive genetic covariance between intelligence 
test scores and academic achievements in two large national cohorts of elementary 
schoolchildren is consistent with previously reported estimates from self- and/or 
preselected twin study samples. The twin selection and analytic methods employed 
in this chapter, and the previous one, may therefore prove useful for other 
multivariate behaviour genetics studies using data from large representative groups 





















Age 8 n = 57,701 n = 336 n = 842       
IQ 0.00  (1.00) 0.03  (1.01) 0.10  (0.96)  -0.53 -0.28  0.30 0.42 
Language 0.00  (0.99) 0.05  (0.99) 0.06  (0.97)  0.13 0.28  0.32 0.53 
Arithmetic 0.00  (0.99) 0.03  (0.95) 0.04  (1.02)  0.23 0.03  0.30 0.48 
Age 10 n = 54,027 n = 300 n = 694        
IQ 0.01  (0.96) 0.06  (0.97) 0.05  (0.91)  -0.61 -0.03  0.36 0.43 
Language -0.03  (0.93) 0.07  (0.92) 0.02  (0.91)  0.18 -0.15  0.35 0.45 
Arithmetic -0.01  (0.95) -0.01  (0.95) 0.00  (0.93)  -0.03 -0.15  0.33 0.51 
Age 12 n = 51,531 n = 264 n = 594       
IQ 0.00  (1.00) 0.05  (0.98) 0.06  (0.96)  -0.50 -0.30  0.31 0.51 
Language 0.00  (1.00) 0.12  (1.06) 0.10  (0.97)  0.21 0.04  0.34 0.48 
Arithmetic 0.00  (0.99) 0.04  (0.98) 0.07  (0.93)  -0.02 -0.20  0.47 0.56 
 
Note. IQ = intelligence quotient; OS = opposite sex; SS = same sex; t = intraclass correlation.  
a 
ANOVA resulted in no statistically significant group differences on the assessments, with two exceptions: IQ at age 8 (F = 4.336, p = .013), with twins 
performing slightly above singletons in post-hoc tests (t = 1.919, p = .055); language performance at 12 years (F = 5.514, p = .004), with twins again 
performing above singletons (t = 3.059, p = .002).
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Note. IQ = intelligence quotient, rG = genetic correlation, rC = shared environment correlation 
Standard errors were not estimable for shared environmental correlations between IQ and education variables at 8 and 12 years, due to close-to-zero 





Figure 4.1 Univariate estimates of additive genetic, shared and unique 
environment effects on intelligence and academic achievement: 







Note. Bar shadings indicate the proportions of additive genetic (h
2
; black), shared 
environment (c
2
; grey), and unique environment (e
2
; white) effects; error bars show the 
























Figure 4.2 Covariance estimates of additive genetic, shared and unique 





Note. The covariances for the different age groups are with IQ. Bars represent phenotypic 
correlations and their shadings indicate their relative proportions due to additive genetic 
(black), shared environment (grey), and unique environment (white) effects. Values beneath 
the bars correspond to the covariance estimates for additive genetic (Biv h
2
), and shared 
(Biv c
2
) and environmental effects (Biv e
2














Childhood intelligence and midlife inflammatory and 
haemostatic biomarkers: The 1958 National Child 
Development Study 
 
Chapter 1 outlined evidence for the relationship between higher childhood 
cognitive ability and reduced cardiovascular disease (CVD) risk found in prospective 
longitudinal studies of large nationally representative cohorts (Batty, Mortensen, 
Andersen, et al., 2005; Batty, Shipley, Mortensen, Gale, et al., 2008; Deary, 
Whiteman, Starr, Whalley, & Fox, 2004; Lawlor et al., 2008). Whereas the 
mechanistic pathways for this association are not yet well understood, associations 
between intelligence and either constitutional and/or modifiable risk factors for CVD 
can reveal potential causal pathways, ultimately leading to testing hypotheses central 
to cognitive epidemiology (Deary, 2008). This chapter investigates the association 
between psychometric intelligence in youth and emerging CVD-risk biomarkers, at 
an age in adulthood before the onset of the majority of CVD-related morbidities.  
Using a nationally representative cohort from the UK, it also considers confounding 
and mediation effects on this behaviour-to-biology pathway.  
 
Psychometric intelligence and conventional CVD risk factors 
 
Childhood intelligence is inversely associated with adult blood pressure (BP), 
body mass index (BMI), blood triglycerides, obesity, blood glucose, and smoking 
(Starr et al., 2004; Batty, Gale et al., 2008; Der et al., 2009; Power, Jeffries, & 
Manor, 2010; Richards et al., 2009; Chandola et al., 2006; Batty, Deary, & 
Macintyre, 2007; Batty, Deary, Schoon, & Gale, 2007b; Taylor et al., 2003). This 
evidence largely comes from substantial longitudinal study cohorts from the UK and 
US. A moderate degree of the forward association between psychometric intelligence 
and CVD-morbidity is shown to be via clusters of physiological CVD risk factors 
(Batty, Shipley, Mortensen, Gale, et al., 2008; Wennerstad, Silventoinen, Tynelius, 
Bergman, & Rasmussen, 2010). Behavioural risk factors for CVD, such as smoking, 
 
 104 
count among some of the more substantive of mediators in the pathway, so far 
reported (Batty, Shipley, Mortensen, Gale, et al., 2008). However, looking outside 
conventional risk factors for CVD may help to explain additional variance in the 
effect of premorbid cognition on later vascular health.  
 
Premorbid cognition and systemic inflammation 
 
Recently two inflammatory biomarkers of CVD risk—C-reactive protein 
(CRP) and fibrinogen—that have been inversely associated with later adult cognitive 
function (Gimeno, Marmot, & Singh-Manoux, 2008; Komulainen et al., 2007; 
Teunissen et al., 2003) and positively associated with cognitive decline (Marioni, 
Strachan, et al., 2010; Rafnsson et al., 2010; Hoth et al., 2008), were also found to be 
inversely associated with premorbid intelligence. In a prospective cohort study, 
cognitive ability test scores at age 11 years accounted for much of the cross-sectional 
association between lower cognitive performance and higher CRP and fibrinogen 
levels at age 70 years (Luciano et al., 2009). This provided evidence of possible 
reverse causation in the inflammation-to-cognition pathway. It also raised, for the 
first time, the possibility that such biomarkers are potential mediators on a pathway 
linking childhood intelligence to CVD risk. 
The intention of the present chapter’s investigation of associations between 
childhood intelligence and emerging adult CVD biomarkers is not only to consider 
the likelihood of reverse causation in a younger cohort (cf. Luciano, 2010), but also 
to contribute to an understanding of causal mechanisms in cognition and vascular 
health outcome associations.  The biochemical survey of the National Child 
Development Study (NCDS) of 1958 (Power & Elliot, 2006) provides data on 
circulating inflammatory and haemostatic biomarkers of 45 year-olds―34 years after 
their completion of intelligence-type assessments. Among these biomarkers is CRP, 
an acute-phase protein and major inflammatory CVD biomarker with variance 
showing in healthy populations (Ridker, 2009). Elevated CRP has been associated 
with the increased risk of ischaemic stroke, peripheral arterial and coronary heart 
diseases, diabetes, hypertension, more severe outcome following heart attack, and 
death (Danesh, Collins, Appleby, & Peto, 1998; The Emerging Risk Factors 
 
 105 
Collaboration, 2010). The other low-grade inflammatory biomarker included in the 
survey is fibrinogen. This shows biological dependency with CRP, but it may be an 
independent risk marker for CVD due to its haemostatic properties, relating to 
platelet adhesion and aggregation, and fibrin formation (The Fibrinogen Studies 
Collaboration, 2007). Such mechanisms are involved in cerebrovascular disease, 
providing a rationale for the study of fibrinogen in relation to cognitive function 
(Luciano et al., 2009).  
 
Cognition and haemostasis 
 
The remaining biomarkers in the present study, d-dimer, tissue plasminogen 
activator (t-PA) antigen, and von Willebrand Factor (VWF) antigen, that are also 
indicators of haemostasis, are less routinely tested as CVD-risk indicators and 
perhaps for this reason their association with cognitive function has remained 
relatively unexplored. However, they are each independent biomarkers of specific 
CVD-type risk, in either healthy or clinical populations (Danesh et al., 2001; Lowe et 
al., 2004; Spiel, Gilbert, & Jilma, 2008; Woodward, Rumley, Welsh, MacMahon, & 
Lowe, 2007), and are therefore, in the context of the present study, worthy of 
investigation in association with premorbid intelligence. D-dimer, a marker of 
coagulation activation, has shown association with cognitive decline in older adults 
(Stott et al., 2010). However, whether the remaining two haemostatic measures relate 
to cognition remains hypothetical. VWF antigen is a blood plasma glycoprotein, 
which is a marker of endothelial disturbance, and plays a role in platelet aggregation 
and adhesion. It is particularly informative for existing CVD, rather than being 
predictive at a preclinical stage (Spiel et al., 2008). The glycoprotein t-PA antigen—
another marker of endothelial disturbance, and a major mediator of fibrinolysis—is 
predictive of increased CHD risk in healthy populations (Lowe et al., 2004). 
 
The present study  
 




1. The association between age 11 cognitive test scores and CVD biomarker 
levels in midlife, at an age before the risk of confounding by existing somatic 
disease considerably increases, and before the problem of survival bias.  
2. Potential confounding of this association by early life factors. 
3. Mediation pathways via established CVD risk factors in adulthood.  
 
In a recent study from the NCDS 1958 cohort, socioeconomic position in early 
life was associated with inflammatory and haemostatic markers in midlife; that is, 
higher occupational grades of the child’s parents conferred protection by their 
association with lower levels of these CVD biomarkers (Tabassum et al., 2008). 
Therefore, it is possible that any inverse association between premorbid intelligence 
and biomarker status is indirect and non-causal (Marioni, Deary, et al., 2010) if, for 
example, it is confounded by early life social inequalities. Tabassum et al (2008) 
reported that the accumulation of lifetime SES was a better predictor of blood 
biomarkers than either child or adult SES alone, and which was largely accounted for 
by health behaviours. Therefore, the present study adjusts for both early life and 
adult SES to assess the extent to which, respectively, they may confound or mediate 
the association between premorbid cognition and midlife inflammation and 
haemostasis.  
If mediation is a likely explanation for the forward association between cognition 
and biomarker status, then adjustment for CVD-risk factors, other than SES, should 
be made. It has been proposed that such mediation could either occur via vascular 
processes, or behavioural factors to do with lifestyle and health literacy, including 
smoking (Marioni, Deary, et al., 2010). If conventional CVD risk factors that relate 
to inflammation and haemostatic status are also associated with premorbid 
intelligence scores, this makes them likely candidates as potential mediating factors. 
Among the conventional risk factors that have been associated with psychometric 
intelligence in youth, body mass index (BMI), blood pressure, waist-to-hip ratio 
(WHR), and smoking, also show positive and significant associations with the 
inflammatory markers CRP and fibrinogen (Hamer & Stamatakis, 2008; Kaptoge et 
al., 2007; Nguyen, Lane, Smith, & Nguyen, 2009); therefore, in addition to adult 
SES mediation effects are tested by adjusting for these four risk factors.   
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Finally, with the availability of cognitive performance scores at age 50, the 
present study also has the opportunity to test:  
 
4. Potential reverse causation in the assumed forward association between 
midlife biomarkers and adult cognitive function, by controlling for childhood 
intelligence. 
 
Particular attention is paid to associations between each of the biomarkers, 
and specific cognitive test domains in adulthood. This is because of evidence that 
CVD-morbidity types relate to specific cognitive functions, rather than a general 
cognitive ability (Verhagen, Borchelt, & Smith, 2003). In the present cohort 
relationships are investigated between midlife biomarkers and verbal short-term 







Participants of the NCDS 1958 cohort, who were born in the UK during a 
single week in March 1958, were traced longitudinally to 2008 (Power & Elliot, 
2006). This is an ongoing longitudinal study that emanated from the Perinatal 
Mortality Survey of over 17,000 newborns, which at that time collated medical data 
from midwives’ records, and social and demographic information from mothers. Up 
to 2008 there were 8 sweeps of data collection following baseline, at ages 7, 11, 16, 
23, 33, 42, 46 and 50 years. Among 14,132 who had cognitive test scores at age 11 
years, 11,419 completed health and social questionnaires at age 42 and, of these, 
9,377 returned for a biomedical survey at age 45 that included the collection of blood 
samples, constituting 66% of the 11-year-old cohort, and 55% of the original 
perinatal survey. The adult cognitive battery taken at age 50 (described below), 




Cognitive ability at 11 and 50 years  
 
Childhood intelligence was assessed with a test devised by the National 
Foundation for Educational Research in England and Wales (Pigeon, 1964). Each 
multiple-choice item requires the correct selection of a missing word or figure from a 
verbal or abstract sequence. Total scores (out of 80) on this test show high test-retest 
reliability (r = .94) and validity in relation to educational tests (r = .69 to .93) 
(Douglas, 1964).  
Adult cognitive function was measured with computer assisted personal 
interviewing (CAPI), across four tests of attention and memory (ESDS, 2012), 
including: (1) Word list recall that involved learning a list of 10 words, each 
presented by a computerised voice at two-second intervals; the participant was 
scored on the number of words correctly recalled; (2) Delayed word recall, again 
scored out of 10, which was presented at the end of the cognitive test battery, and 
required recall of as many words from the original word list as possible; (3) Verbal 
fluency, which allowed one minute for the participant to name as many different 
animal species as possible. This task shows high test-retest reliability (r = .70) and 
positive correlations with vocabulary (r = .33) and word recognition tasks (r = .36) 
(Lang, Weiss, Stocker, & von Rosenbladt, 2007). And finally: (4) Visual processing 
speed was measured using a letter cancellation task, in which the participant was 
given one minute to cross out as many Ps and Ws from a randomly generated list of 
alphabet letters. Although speed and accuracy scores were recorded separately for 
this fourth task, the total number of correctly marked letters was used for the present 
study’s analysis (scored out of 65). Due to disruption of the testing environment 
affecting 688 participants’ scores (7.1%), according to the interviewers, these were 
excluded from the analysis.   
 
Inflammatory and haemostatic biomarkers 
 
Non-fasting venous blood samples were centrifuged for plasma, which was 
analysed for inflammatory and haemostatic biomarkers. These included: (1) CRP, (2) 
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fibrinogen, (3) D-Dimer, (4) t-PA antigen, and (5) VWF antigen. The methods for 
measuring these have been described elsewhere (Rudnicka, Rumley, Lowe, & 
Strachan, 2007). Associations among the biomarkers were all positive and reached 
the 95% level of statistical significance (0.56 > r > 0.15) with the exception of D-
dimer and t-PA where there was no association (see Appendix C for correlations). A 
data reduction technique was considered in order to produce a general 
inflammatory/haemostatic factor. However, the internal consistency among the 
biomarkers was inadequate (Cronbach’s α = 0.48), and principal components 
analysis did not suggest a clear general biomarker factor. Therefore the individual 
inflammatory and haemostatic measures were retained for analyses, and their 
statistical non-independence is acknowledged and considered in the interpretation of 
results.  
 
Covariates and CVD risk factors 
 
Gestational period (day) and birth weight (ounce) from medical records were 
included in the analyses as potential early life indicators of ‘system integrity’ 
(Whalley & Deary, 2001), which might contribute to the covariance between 
individual differences in cognitive ability and biomarkers for CVD. Background 
socioeconomic status (SES)—also recorded at birth—was based on the highest 
occupational grade of the household, and was also included in the analysis to take 
account of potential confounding. This was coded according to the 1951 General 
Register Office: professional (I), intermediate (II), skilled (III), partly skilled (IV) 
and unskilled (V). Values were reversed so that the highest SES score related to the 
highest professional category. 
The remaining covariates were included in models as potential mediators of 
the tested pathways. Adult SES was rated at middle age according to participants’ 
own occupational grades, and these were coded and reverse scored as background 
SES. Smoking behaviour was self-reported at age 42, and rated from 0 to 2 according 
to the following categories: ‘never smoked’, ‘occasional or ex-smoker’, and ‘regular 
current smoker’. The remaining CVD risk factors were measured at age 46, at the 
time of biomarker testing. Resting systolic blood pressure (BP) and diastolic BP 
 
 110 
were measured three times each, and the average of these six readings were used; the 
mean of systolic and diastolic BP has been found to be a better predictor of CVD 
than either one alone (Lewington, Clarke, Qizilbash, Peto, & Collins, 2002). Body 
mass index (BMI) and waist-to-hip ratio (WHR) were estimated with the following 
formulae:  
 
BMI = weight (kg) / height (m
2
) 






Childhood and adult cognitive test scores approximated a normal distribution, 
and were standardised for the purposes of analyses (M = 0, SD = 1). As childhood 
verbal and nonverbal scores were similar in their associations with the biomarkers, 
and they correlated highly (rs = .79), their combined score only was retained. All 
biomarker measures were significantly positively skewed, and were log-transformed, 
although descriptive data of raw scores are reported in Results. Biomarker outliers 
were identified beyond three standard deviations above or below the mean, and 
excluded from all analyses. All other measures followed a normal distribution, 
including both SES variables (treated as continuous variables in the analyses). One 
exception was smoking, where the distribution of participants in each subsequent 




All analyses were carried out using SPSS version 17.0. Independent samples 
t-tests and analysis of variance (ANOVA) tested for sex differences in continuous 
and categorical variables, respectively. Because no significant interaction effects of 
sex were observed in the large majority of intelligence-biomarker relationships, 
regression models were run for the total cohort only, and sex was included as a 
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covariate. After confirming linearity of all bivariate relationships linear regression 
examined the association between cognitive performance and the biomarkers, in 
basic and covariate-adjusted models. All covariates were entered as continuous 
variables. Regression coefficients (unstandardised) are reported with 95% confidence 
intervals, and squared partial correlations are used to calculate the change of 




basic model - partial r
2




When such models are compared sample sizes are equal, including only those 




I included a weighting in each model using the weighted least squares (WLS) 
regression method to adjust for attrition bias among the follow-up adult cohort, 
which had above average childhood cognitive scores compared with those of the 
original cohort (Atherton, Fuller, Shepherd, Strachan, & Power, 2008). For example, 
among those who responded to the biomedical survey, childhood IQ performance 
was on average 5.8 points higher than among those 11-year-olds lost to follow-up (t 
= -21.3, Cohen’s d = -0.37, p < .001). This weighted variable, calculated from 
logistic regression, represents the inverse probability of responding to the biomedical 
survey at age 45, as predicted by each respondent’s sex and childhood cognitive test 
score. In models where adult cognitive function was the outcome variable, the 
weighting was the reciprocal probability of having a cognitive test score at age 50, as 




Child and adult characteristics of the cohort appear in Table 5.1. Sex 
differences are highlighted where they were statistically significant (p < .05). Female 
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members of the cohort scored on average 2.3 points above male members on 
cognitive ability at age 11 (t = -6.78, Cohen’s d = -0.15, p < .001). In adulthood there 
were no significant sex effects on cognitive performance. In midlife, women had 
higher mean levels of the biomarkers CRP, fibrinogen and D-dimer, and men showed 
higher mean values for t-PA antigen and VWF antigen (sex differences were all 
statistically significant at p < .01).  
 
Childhood intelligence and adult inflammation, haemostasis 
 
Table 5.2 presents regression coefficients from basic models (adjusted for 
sex) and covariate-adjusted models, of the association between childhood 
intelligence and midlife biomarkers. In basic models a one SD advantage in 
childhood intelligence was associated with significantly lower levels of the five 
inflammatory and haemostatic biomarkers at midlife. The effect size (partial 
correlation) for this inverse association was greatest for childhood cognition and 
CRP (partial r = -0.13), or childhood cognition and fibrinogen (partial r = -0.14), as 
compared with the other three biomarkers: T-PA antigen (partial r = -0.08), VWF 
antigen (partial r = -0.08), and D-dimer (partial r = -0.07). A one SD increase in IQ 
was associated with a decrease of 1.08 mg/L CRP (non-log transformed value). 
The inclusion of early life factors to the models reduced the childhood 
intelligence-biomarker associations by 24 to 44%, although these models remained 
statistically significant (coefficients = -0.058 to -0.007, partial r = -0.10 to -0.04, p < 
0.05). Early life SES had by far the greatest influence on this attenuation effect, as 
compared with birth weight and gestational age (results not shown but available upon 
request).  
Further adjustment for multiple adult CVD risk factors reduced the childhood 
intelligence-biomarker gradients by 82 to 100%, and age-11 cognition was no longer 
statistically significant in predicting D-dimer, VWF antigen and t-PA antigen. In 
models that adjusted for each of the adult risk factor covariates individually, no 
single factor consistently better explained the cognition-biomarker association than 
the combined cluster of factors. However, BMI, SES, smoking and WHR each 
attenuated the basic models by 50 to 100% for each of the five biomarkers, whereas 
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adjustment for BP had a lesser effect, reducing the magnitude of the associations by 
a quarter to a half. 
 
Inflammation-Cognition in midlife: Reverse causation? 
 
Table 5.3 presents beta coefficients from models relating adult biomarker 
levels with adult cognitive test performance. In basic models (Model 1) inverse 
associations were observed; that is, higher inflammatory and haemostatic markers at 
age 45 were related to significantly poorer cognitive performance on the attention 
and memory tasks at age 50. The effect sizes (as partial correlations) were as 
follows: CRP (partial r = -.02 to -.09), fibrinogen (partial r = -.02 to -.09), D-dimer 
(partial r = -.03 to -.06), VWF antigen (partial r = -.03 to -.07), and t-PA antigen 
(partial r = -.01 to -.04). These were statistically significant associations with the 
exception of t-PA antigen with the Letter cancellation and Word recall tasks, and 
CRP and fibrinogen with Letter cancellation. After adjustment for childhood 
intelligence (Model 2) the biomarker-to-adult-cognition associations were 
substantially reduced.  The association between inflammatory biomarkers and adult 
cognitive function, after controlling for childhood intelligence, was altered by 
between two-thirds to full attenuation (CRP, 71 to 90%; fibrinogen, 67 to 98%). The 
association between the different haemostatic biomarkers and adult cognition 
showed attenuation effects of half or more after adjustment for childhood 
intelligence.  
To consider the independent associations of inflammation and haemostasis 
with later cognitive function, the blood biomarkers were entered simultaneously in to 
models to predict adult cognitive test performance, whilst controlling for childhood 
intelligence (data not shown). In these models, the haemostatic marker D-dimer 
maintained a statistically significant association (p < 0.05) with the verbal recall task, 
and VWF antigen remained significantly predictive of the verbal fluency and delayed 
word recall tasks (p < 0.05). Among the inflammatory markers, CRP and fibrinogen 
remained significantly predictive of immediate and delayed verbal recall 






Childhood cognitive ability is inversely associated with levels of five low-
grade inflammatory and haemostatic CVD risk factors measured 34 years later.  
These statistically significant associations show small effect sizes, yet they may still 
have clinical relevance. For example, if a CRP level above 3 mg/L indicates double 
the risk of coronary heart disease compared to <1 mg/L in adult populations (Pearson 
et al., 2003), then the decrease of 1.08 mg/L in association with a one standard 
deviation increase in intelligence test scores, observed in the present study, is not 
trivial. The magnitude of the intelligence associations with CRP and fibrinogen are 
similar to those from the only other study so far to investigate this longitudinal 
relationship (Luciano et al., 2009). The observed associations between cognitive 
ability in youth, and adult D-dimer, t-PA antigen and VWF antigen, which were also 
statistically significant, are novel and require replication.  
 
Evidence for behavioural mediation, not confounding 
 
Early life SES, as measured by parental occupation, which correlates with 
cognitive ability (Deary et al., 2005) and has previously shown inverse associations 
with the present study’s biomarkers (Tabassum et al., 2008), did not adequately 
explain the association. This is consistent with studies reporting a minimal degree of 
confounding by childhood SES in either intelligence-biomarker (Karlsson, Ahlborg, 
Dalman, & Hemmingsson, 2010) or intelligence-CVD associations (Batty, 
Mortensen, Andersen, et al., 2005; Batty, Wennerstad, et al., 2009; Wennerstad et al., 
2010), albeit that relatively larger attenuation effects were observed than these 
studies. Instead, the relation of childhood intelligence and adult biomarkers was 
more likely explained by mediation from lifetime health behaviours—or indicators of 
these—that are among established CVD risk factors. After controlling for these 
individually and collectively, intelligence-biomarker associations were substantially 
reduced. These considerable attenuations are consistent with those from studies that 
have controlled for multiple CVD risk factors in associations between childhood 
intelligence and CVD morbidity (Batty, Shipley, Gale, et al., 2008), and biomarkers 
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and later cognitive function (Luciano et al., 2009). A mediation effect of WHR in the 
present study, for example, could indicate that lower childhood intelligence is related 
to a reduction in physical activity and poorer dietary choices (Batty, Deary, Schoon, 
& Gale, 2007a), leading to excessive inflammatory and/or haemostatic status 
(Giugliano, Ceriello, & Esposito, 2006; Kasapis & Thompson, 2005) if, indeed, 
WHR is more strongly influenced by lifestyle behaviours than genetic factors. 
Similarly, smoking that has previously been related to lower premorbid intelligence 
(Batty, Deary, & Macintyre, 2007; Batty, Deary, Schoon et al., 2007b; Taylor et al., 
2003)—and which in the present study reduced up to half of the variance in the 
intelligence-biomarker associations—could be a mediating factor via inflammation 
or blood viscosity (Ambrose & Barua, 2004). However, as adult CVD risk factors 
were assessed at a similar age to the biomarkers in the present study, there is a limit 
to the inferences one can make about directions of causation among these variables. 
The substantial attenuation effects observed after adjusting for adult SES are 
consistent with studies that control for adult SES indicators in models relating 
premorbid intelligence to all-cause mortality (Lawlor et al., 2008; Jokela, Elovainio, 
Singh-Manoux, & Kivimaki, 2009; Jokela, Batty, Deary, Gale, & Kivimaki, 2009; 
Kuh et al., 2009). However, in this case, there is the possibly of overadjustment due 
to the significant covariance between cognitive and socioeconomic indicators.  
 
Alternative explanations for unexplained variance 
 
An alternative explanation for intelligence-biomarker associations could be 
the presence of a shared antecedent factor, consistent with the system integrity 
hypothesis (Deary, 2008). For example, a biological predisposition towards increased 
systemic inflammation, either genetically determined and/or realised at conception 
(Marioni, Strachan et al., 2010), may underlie an indirect association between 
cognitive and vascular processes. This is an interesting possibility, given the inverse 
association between premorbid intelligence and other adult conditions including 
depression and diabetes (Der et al., 2009; Gale et al., 2008), which share in common 
higher circulating inflammatory markers compared to control groups (Dehghan et al., 
2007; Leonard, 2007); it is also plausible given the high heritability estimates of 
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intelligence test scores (Plomin et al., 2009) and CRP, and fibrinogen levels 
respectively (Su et al., 2008). The five biomarkers reported in the present chapter are 
either directly or indirectly linked to inflammatory processes (Woodward et al., 
2007), and show a degree of biological dependency. However, as they can also show 
biological variation (Rudez et al., 2009) it is unclear if their significant associations 
with childhood intelligence in the present study were due to inflammatory factors 
alone, or whether haemostatic factors are independently related, perhaps due to their 
association with neuronal blood flow. Haemostatic biomarkers are risk markers for 
CVD (Woodward et al., 2007; Danesh et al., 2001), vascular dementia, Alzheimer’s 
disease (Gallacher et al., 2010; van Oijen, Witteman, Hofman, Koudstaal, & 
Breteler, 2005) and peripheral atherosclerosis (Tzoulaki et al., 2006), even after 
controlling for the effects of circulating inflammation (Woodward et al., 2007), and I 
found evidence for independent associations between haemostatic markers and later 
cognitive function, after adjusting for inflammatory biomarkers. Still, childhood 
intelligence in the present study explained a greater proportion of variance in the 
inflammatory biomarkers compared with those directly related to haemostatic 
function. Exploring a genetic linkage between systemic inflammation and cognition 
is therefore a worthwhile endeavour, despite that, in the largest study to date, genetic 
variants associated with inflammatory biomarkers were not found to relate to 
childhood intelligence (Marioni, Deary et al., 2010). 
 
Strengths and limitations 
 
Among the strengths of the present study are its large nationally 
representative cohort and the substantial follow-up period. Given access to childhood 
cognitive data on those individuals lost to follow-up by midlife, I was able to control 
for potential attrition bias in the models with the use of weighting, to derive effect 
sizes that may be more generalisable to the background population. The 
measurement of biomarker data at midlife, compared to older age in the only other 
previous study (Luciano et al., 2009), means that a greater proportion of people at 
risk for CVD were likely captured, but before disease onset, giving temporal 
precedence to biomarkers on a pathway linking intelligence and CVD risk 
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(O’Connor et al., 2009) (although testing such mediation effects is out with the 
design of the present study). The inclusion of adult cognitive performance scores in 
this cohort study gives further exposure to the possibility of reverse causation in 
inflammation-to-cognition associations reported in the cognitive ageing literature, 
while also indicating specific cognitive functions (for example, verbal memory) that 
may be affected by inflammatory and haemostatic status once premorbid intelligence 
is taken account of.  
The present study has a few main design limitations that must be addressed 
here. First, in the absence of inflammatory and haemostatic biomarker data from 
childhood, causal inferences are more limited about pathways linking childhood 
intelligence to adult biomarker status. In a previous cross-sectional cohort study of 
young healthy adult men, intelligence test scores inversely related to erythrocyte 
sedimentation rate (Karlsson et al., 2010)—an indirect measure of fibrinogen 
(Batlivala, 2009)—at an age before adverse health behaviours may have become 
established lifetime behavioural patterns that greatly increase CVD risk. To control 
for baseline CVD biomarker status in the present study would have been to elucidate 
more clearly the directions of association between cognitive function and biomarker 
status. Second, adjustment for childhood intelligence in associations between CVD 
biomarkers and adult cognition was limited by the difference in cognitive test 
batteries administered in youth and adulthood. In a previous study (Luciano et al., 
2009) the significantly positive association between inflammatory status and 
cognition in adulthood, which was entirely attenuated after adjustment for a 
childhood score on the exact same task, was convincing evidence to the field of 
cognitive ageing research of possible reverse causation. Nevertheless substantial (and 
sometimes full) attenuation effects were still observed after adjustment for 
performance on the non-identical cognitive test at age 11, and relationships in which 
there was relatively less attenuation are areas worthy of future investigation in 
cognitive ageing. For example, increased D-dimer levels have previously been 
related to greater cognitive decline among older adults (Stott et al., 2010), 
independent of inflammatory biomarkers, and the present study support this finding, 
reporting for the first time on the significant association between this haemostatic 
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biomarker and verbal memory while controlling for general intelligence in 
childhood.  
Other systemic inflammatory biomarkers were missing from the present 
study, for example cytokines, which may be stronger predictors of CVD events in 
older adults than the acute-phase proteins tested in the present study (Ramos, 
Pellanda, Gue, & Portal, 2009). It is not known, for example, whether adult 
interleukin-6 status—a cytokine that regulates the synthesis of CRP (Gimeno, Ferrie, 
et al., 2008)—would show a similar magnitude of association with premorbid 
intelligence. A consideration of a wider collection of acute-phase proteins and 
cytokines in relation to individual differences in premorbid cognition may profit this 
area of research (Luciano, 2010).  
The study may also have benefited from a wider range of cognitive tests in 
adulthood to properly assess the effects of the blood biomarkers on specific cognitive 
function, while controlling for reverse causation by adjusting for premorbid 
intelligence. Therefore I was unable, for example, to test for replication of the 
previously reported positive association between CRP and fibrinogen, and processing 
speeds (Luciano et al., 2009). However, the present study’s finding that these 
biomarkers, along with D-dimer and VWF antigen, are predictive of verbal memory 




The present study emphasises the complex bidirectional associations that may 
occur between cognitive factors and systemic inflammation and haemostasis. It is 
highly plausible that intelligence differences in childhood relate to CVD biomarkers 
by acting via lifestyle behaviours as the present data support, just as it is also likely 
that changes to systemic inflammation and haemostasis in adulthood will have 
detrimental effects to specific cognitive processes over time. But whether there is an 
antecedent factor that carries greater influence in driving intelligence-CVD 
biomarker associations, relative to the bidirectional causal processes that carry out 




Table 5.1 Descriptive statistics of study variables: 1958 National Child  
  Development Study. 
 
 N M SD  
Cognitive measures     
     Total cognitive score, age 11 8,126 45.4  15.4
 a 
     Word recall, age 50  6,627 6.7  1.4  
     Verbal fluency, age 50 6,627 22.6  6.3  
     Letter cancellation, age 50 6,528 21.8  5.8  
     Delayed recall, age 50 6,581 5.6  1.8  
Biomarkers, age 45     
     CRP (mg/L) 6,660 2.1  3.2
 a 
     Fibrinogen (g/L) 6,621 2.9  0.6
 a 
     D-dimer (ng/mL) 6,563 183.4  112.0
 a 
     t-PA antigen (ng/mL) 6,625 5.2  2.7
 b 
     VWF antigen (IU/dL) 6,648 122.4  40.3
 b 
Covariates     
     Gestation (day) 7,051 281.2  11.8  
     Birth weight (ounce) 7,542 117.8  18.0
 b 
     BMI (kg/m
2
) 7,980 27.3  4.9
 b 
     WHR (cm) 8,059 0.9  0.1
 b 
     BP (mm hg) 7,908 101.0  15.5
 b 
  Percent (%)   
     Childhood SES, low to high 6,454 12.8; 15.2; 52.0; 16.7; 3.2   
     Adult SES, low to high 7,769 3.6; 12.8; 41.4; 37.0; 5.3 
   c
  
     Smoking, never; occasional; current 7,874 46.0; 29.8; 24.3   
     Sex, female 4,095 50.4   
 
 
Note. BP = mean blood pressure [systolic + diastolic / 2]; BMI = body mass index; CRP = C-
reactive protein; SES = socioeconomic status; t-PA = tissue plasminogen activator; VWF = 
von Willebrand factor; WHR = waist-hip ratio.  
a 
Significantly higher M for female versus male groups, p < .001 
b
 Significantly higher M for male versus female groups, p < .01 
c 
A greater proportion of men than women were in the higher SES groups (Pearson’s 
2
 = 
210.5, p < .001).
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N = 4,245 
Fibrinogen 
N = 4,219 
D-dimer 
N = 4,183 
t-PA antigen 
N = 4,226 
VWF antigen 
N = 4,235 
 B  95% CI  B  95% CI  B  95% CI  B  95% CI  B  95% CI  
Model 1
a
 -0.069   ( -0.086 , -0.053 )*** -0.011 ( -0.014 , -0.008 )*** -0.011   ( -0.018 , -0.004 )** -0.014   ( -0.021 , -0.007 )*** -0.008   ( -0.013 , -0.004 )*** 
Model 2 -0.058   ( -0.074 , -0.041 )*** -0.010   ( -0.013 , -0.007 )*** -0.009   ( -0.016 , -0.001 )* -0.011   ( -0.018 , -0.003 )** -0.007   ( -0.012 , -0.002 )** 
Model 3 -0.023   ( -0.039 , -0.007 )** -0.004   ( -0.007 , -0.001 )** 0.000   ( -0.008 , 0.007 )  0.004   ( -0.003 , 0.012 )    -0.002   ( -0.007 , 0.003 )  
 
 
Note. The beta coefficient represents a one SD advantage in childhood intelligence associated with a unit decrease in the log transformed biomarker value. 
Asterisks indicate statistically significant models, *p < 0.05; **p < .01; ***p < .001. The changes in the F statistic from Models 1 to 2 and Models 2 to 3 are all 
statistically significant (p < .05). 
a 
Model 1 is the basic model adjusting for sex and weighted for attrition; Model 2: Basic model + early life factors (gestation, birth weight and childhood 
socioeconomic status; Model 3: Model 2 + adult covariates (adult socioeconomic status, mean blood pressure, body mass index, smoking and waist-to-hip ratio) 
 
Table 5.3 Regression coefficients (and 95% CI) for associations between adult blood biomarkers and cognitive performance 
after 5 years.  
 
  Word recall Delayed recall Verbal fluency Letter cancellation 
 Model a B  95% CI  B  95% CI  B  95% CI  B  95% CI  
CRP 1 -0.169   ( -0.221 , -0.118 )*** -0.148   ( -0.199 , -0.097 )*** -0.128   ( -0.180 , -0.076 )*** -0.039   ( -0.090 , 0.012 ) 
 2 -0.088 ( -0.138 , -0.039 )*** -0.066   ( -0.115 , -0.017 )** -0.041   ( -0.090 , 0.009 ) 0.014   ( -0.036 , 0.064 ) 
Fibrinogen 1 -1.066 ( -1.379 , -0.753 )*** -1.096   ( -1.407 , -0.784 )*** -0.840   ( -1.158 , -0.522 )***  -0.282   ( -0.593 , 0.028 )  
 2 -0.584   ( -0.886 , -0.283 )*** -0.607   ( -0.905 , -0.309 )*** -0.322   ( -0.626 , -0.018 )*  0.036   ( -0.271 , 0.343 )  
D-dimer 1 -0.255   ( -0.376 , -0.135 )*** -0.167   ( -0.287 , -0.047 )** -0.153   ( -0.275 , -0.031 )*  -0.150   ( -0.269 , -0.031 )*  
 2 -0.157   ( -0.272 , -0.043 )** -0.068   ( -0.182 , 0.045 ) -0.049   ( -0.164 , 0.067 )  -0.086   ( -0.203 , 0.031 )  
t-PA antigen 1 -0.092   ( -0.210 , 0.027 ) -0.102   ( -0.220 , 0.016 ) -0.182   ( -0.302 , -0.061 )**  -0.057   ( -0.174 , 0.061 )  
 2 0.022   ( -0.091 , 0.135 ) 0.014   ( -0.098 , 0.125 ) -0.062   ( -0.176 , 0.052 )  0.015   ( -0.100 , 0.131 )  
VWF antigen 1 -0.414 ( -0.600 , -0.229 )*** -0.494   ( -0.678 , -0.310 )*** -0.425   ( -0.613 , -0.237 )***  -0.192   ( -0.375 , -0.009 )*  
 2 -0.253   ( -0.430 , -0.076 )** -0.332   ( -0.507 , -0.157 )*** -0.255   ( -0.433 , -0.076 )**  -0.089   ( -0.268 , 0.091 )  
 
Note. CRP = C-reactive protein, t-PA = tissue plasminogen activator, VWF = von Willebrand factor.   
All models adjust for sex, and include sample sizes in the range: N = 5,327 to 5,489 (Model 1 and Model 2 are matched on sample size). The regression 
coefficient is the effect of a one unit increase in the log transformed biomarker value in relation to a one SD decrease in the adult cognitive variable; 95% 
CI are in parentheses. Asterisks indicate statistically significant models, *p < 0.05; **p < .01; ***p < .001. The change in the F statistic from Model 1 to 
Model 2 is statistically significant in each case. 
a 




Direction of association between cognitive reaction times 




My basis for the empirical study in Chapter 5 was the observation, from 
several nationally representative cohorts, of a significant inverse association between 
premorbid intelligence test performance and adult risk of cardiovascular disease 
morbidity or related-mortality, with the strength of association greater for coronary 
heart disease than stroke according to current evidence (Calvin, Batty, & Deary, 
2011). The chapter explored biological mechanistic pathways of the association that 
have so far not been well understood. I found that intelligence in childhood relates to 
several inflammatory and haemostatic biomarkers, albeit the associations are small. 
That this biological mechanism should explain a significant degree of variance in the 
association between cognitive function in youth and later risk of vascular-related 
health problems may be indicative of mediation by lifestyle behaviours, whereby 
people with lower cognitive abilities tend later to have more inflammation. An 
alternative proposition is that of system integrity (Deary, 2008). It is possible that 
these two influences coexist. The present chapter seeks to investigate further the 
potential likelihood of a system integrity explanation, alongside lifetime influences, 
in the pathway from cognitive ability to later inflammatory and haemostatic status. It 
does this using a different cohort that has used cognitive reaction times rather than 
psychometric intelligence at baseline, as these measures bear a closer association to 
neuronal integrity, and importantly, are less confounded by educational and 
socioeconomic influence.  
 
Processing speed: A step closer to neuronal integrity 
 
The system integrity hypothesis (Deary, 2008) would assert that the 
association between IQ-type test scores and CVD risk is primarily driven by a shared 
antecedent biological trait. That is, the population covariance between neuronal 
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system integrity—measured using cognitive testing by proxy—and blood biomarkers 
of the inflammatory system, has a biological (and likely genetic) basis. The empirical 
testing of such hypotheses in cognitive epidemiology and the interpretation of 
findings may however be limited by use of the most common cognitive trait measure 
in cohort studies, the IQ score, or general intelligence factor score, g. Whereas there 
is validity for g as a biological trait and proxy measure of brain integrity—
heritability accounts for 50% of its variance in human populations, and more when 
only adult samples are studied (Davies et al., 2011)—as a psychometric test 
invention it may be prone to bias and/or confounding by educational and cultural 
exposures. An alternative cognitive measure widely viewed as a closer proxy 
measure of neuronal integrity, but perhaps used with less frequency than intelligence 
tests in large cohort studies, is mental processing speed.  
 
Processing speed vs. psychometric intelligence 
 
Processing speed is commonly operationalised using cognitive-experimental 
tests, including simple or choice reaction time tasks, or inspection time tasks. 
Performances on these tests show reliability, with evidence of stability over short- 
and long-term follow-up for mean speed and intraindividual variability (Deary & 
Der, 2005; Hultsch, MacDonald, Hunter, Levy-Bencheton, & Strauss, 2000). They 
also show validity by significantly correlating with intelligence scores in population 
samples (Deary, Der, & Ford, 2001; Deary, Johnson, & Starr, 2010), for which the 
association is found to be substantively heritable according to behaviour genetics 
evidence (Luciano et al., 2001). Compared to scores on psychometric intelligence 
tests, however, processing speed indices may be more valid proxy measures of 
neuronal integrity and function for a few reasons. First, these lower level functional 
tasks are more independent of acquired knowledge, and so are less likely to carry the 
risk of confounding by socioeconomic and/educational background, by comparison 
with intelligence test performance. This is supported by their weak associations with 
socioeconomic indicators, including education and occupational class (Anstey, Dear, 
Christensen, & Jorm, 2005), as compared to relatively stronger associations between 
IQ test scores and SES variables (Deary, Der, & Ford, 2001).  
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Second, age trends for the slowing of processing speed (Der & Deary, 2006) 
tend to run in parallel with normal ageing trajectories of changes and/or loss to 
neuronal function and structure (Powers, 2011), whereas performance on higher level 
cognitive reasoning tasks remain intact for longer and are probably less sensitive to 
subtle neuronal change. In meta-analysis of 91 studies the correlation between age 
and processing speed was r = .52, compared to a correlation of r = .40 for the 
association between age and cognitive reasoning ability (Verhaeghen & Salthouse, 
1997). More recently in a population-representative sample of 7,130 adults from the 
United Kingdom Health and Lifestyle Survey, Der and Deary (2006) plotted lifetime 
trajectories of simple and choice reaction time speeds and intraindividual variances, 
providing evidence that with increasing age reaction time performance becomes 
slower and more variable—which has been otherwise termed ‘inconsistent’ (Hultsch 
et al., 2000).  
Third, imaging studies from the cognitive neuroscience of ageing literature 
provide empirical evidence that changes in processing speed relate to alterations 
occurring at the neuronal level, particularly in respect to white matter integrity 
(Madden, Bennett, & Song, 2009). Specifically, increased white matter integrity is 
significantly associated with faster (Deary, Bastin, et al., 2006; van den Heuvel et al., 
2006) and less variable processing speeds (Fjell, Westlye, Amlien, & Walhovd, 
2011; Jackson, Balota, Duchek, & Head, 2012) in non-pathological ageing cohorts of 
adults. Furthermore, in some studies, processing speed tasks are significantly 
associated with brain white matter integrity—using local or cross-regional 
measures—whereas general intelligence scores are not (Gunning-Dixon & Raz, 
2000; Penke et al., 2010; Rabbitt et al., 2007). One example comes from a study of 
132 healthy older adults in Scotland, reporting that a general component of white 
matter integrity derived from principal components analysis of measures from eight 
regional tracts, significantly related to an information-processing speed factor but not 
a general intelligence factor derived from standardised intelligence tests (Penke et 
al., 2010). In these studies of older cohorts, of course, somatic disease (e.g. 
hypertension or CVD) or ageing itself may entirely confound the observed 
associations between imaging measures of white matter integrity and behavioural 
processing speed. However, at least one study has reported on significant 
associations between white matter integrity and processing speed in young healthy 
adults (Madden et al., 2004), suggesting that processing speed indices may reflect 
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neuronal integrity throughout the life course. This evidence, along with current 
understanding that faster information processing speed between brain regions is 
pivotal to the development of higher level cognitive abilities, means that studying 
reaction times in the context of cognitive epidemiology is of empirical value.   
In this chapter a cohort study is presented which examines the association 
between processing speed and blood biomarkers of inflammation in three differently 
aged adult cohorts. Issues such as potential confounding, and age-effects on both 
parameters, are important points of consideration in the interpretation of findings. 
Indeed, the findings from measures taken in earlier adulthood may be most reliable 
in terms of indicating optimal and unbiased neuronal system integrity.  
 
Processing speed in cognitive epidemiology  
 
The use of processing speed in testing hypotheses central to cognitive 
epidemiology is an underdeveloped area of research. Two studies to date have 
reported on the association between experimental processing speed and risk of death 
in longitudinal cohort studies, both observing that slower and more variable reaction 
times at baseline were significantly predictive of all-cause mortality (Shipley et al., 
2006; Deary & Der, 2005). In one study reaction time showed stronger predictive 
validity than that of general intelligence (Deary & Der, 2005). This was the west of 
Scotland Twenty-07 study in which reaction times at age 56 years were predictive of 
all-cause mortality risk within a 14-year follow-up (Deary & Der, 2005). The hazard 
ratios for simple and choice reaction time tasks in predicting mortality (HR 1.33 and 
1.41) were of similar magnitude to the hazard ratio when general intelligence was the 
predictor in univariate analysis (HR 1.42).  However, after adjustment for reaction 
time the effect of general intelligence was attenuated to non-significance. This led 
the authors to suggest system integrity as a possible explanation for the intelligence-
mortality association, with low-level cognitive function (processing speed) 
explaining IQ’s association with death. The lead author of this article also recently 
proposed reaction time as a potential biomarker for premature death (Deary, 
Johnson, et al., 2010, p. 227). One other study has reported on the association 
between processing speed and mortality risk, using a psychometric rather than 
experimental cognitive measure. In the Canadian Study of Health and Aging an 
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inverse association between total performance on four subtests of the Weschler Adult 
Intelligence Scale (WAIS-R) and mortality risk in adults over 65 years, was due to 
performance on a single measure, the digit symbol substitution task (Hall, Dubin, 
Crossley, Holmqvist, & D’Arcy, 2008). The authors reported that a one SD decrease 
in digit symbol score was associated with a 28.6% increase in hazard for mortality 
after ten years, after adjusting for age, sex and education. Although digit symbol is 
widely regarded as a psychometric test of processing speed (Deary, Johnson, et al., 
2010) it is also said to place high demand on executive function, and it is this 
cognitive domain that the authors attributed to the association with mortality.  
 As in the burgeoning literature on associations between psychometric 
intelligence and behavioural or physical risk factors for morbidity or mortality in 
longitudinal cohort studies, there is also opportunity to consider cognitive processing 
speed as a predictor of health outcomes (albeit this may be a more modest exercise 
given the fewer cohort studies that include experimental processing speed in test 
batteries). To date, large cohort studies reporting on behavioural and biological 
correlates of processing speed have largely looked at the associations 
contemporaneously. For example, the Australian community survey of 7,485 adults 
in their early twenties, forties and sixties, known as the PATH Through Life Project, 
reported cross-sectional associations between social and biological markers and 
reaction time variables. This study found that, besides years in education and age that 
held the strongest associations with reaction times, greater grip strength, forced 
expiratory volume, visual acuity, and a lack of diabetes, were most strongly 
associated with faster and more consistent simple and choice reaction times (Anstey, 
et al., 2005). In the same study, hypertension, stroke, smoking, and physical activity 
showed no significant relations with processing speed. Despite the cross-sectional 
design of this study, the authors interpreted their findings in a specific causal 
direction; that is, the significant physical markers predicted reaction time 
performance, rather than vice versa. This directional pathway has emerged from the 
cognitive ageing literature, as is evidenced from the summary of evidence to date 
relating inflammatory and haemostatic biomarkers and cognitive processing speed, 
described in the next section.  
 




The findings from Chapter 5 provide an example of why directions of 
causation should not be assumed and applied from cross-sectional studies, or even 
short-term longitudinal studies, given the likelihood of reverse causation. In the 
present chapter’s study, the association between baseline processing speed, and 
inflammatory and haemostatic biomarkers measured 20 years later, is a first for the 
literature. All other studies looking at direct relations between these behavioural and 
biomarker parameters have studied them either contemporaneously, or in the reverse 




Although studies looking at CRP levels and subsequent global cognitive 
function or decline report significant findings (for a review see Kuo et al., 2005), 
associations with follow-up processing speed are less conclusive. For example, in the 
Longitudinal Aging Study Amsterdam, of 1,284 adults aged 62 to 85 years, no 
association was observed between CRP and psychometric processing speed after 
three years’ follow-up (Dik et al., 2005). A null finding was also reported from the 
Edinburgh Artery Study of 452 adults aged on average 62 years: CRP showed no 
relation to processing speed measured 12 years later with the digit-symbol coding 
task, although there was a significant association between Interleukin-6 (IL-6) and 
this psychometric performance task (Rafnsson, Deary, Smith, Whiteman, Rumley, et 
al., 2007). In cross-sectional studies however higher CRP and related inflammatory 
biomarkers have been associated with slower processing speeds. In a sample of 88 
men and women (average age 57 years) from the Maastricht Aging Study (MAAS), 
higher CRP related to poorer performance on a Stroop task, a psychometric measure 
of processing speed – although the association was dependent on age, sex and 
educational background (Teunissen et al., 2003). In the Sydney Memory and Ageing 
Study (MAS) of 873 community-dwelling adults aged 70 to 90 years, higher 
systemic inflammation as measured by interleukin-12 was associated with poorer 
performance on two psychometric tests of processing speed (Trail Making Test A 
and Digit-Symbol coding), whereas there was no relation to other cognitive function 
domains such as executive function and memory (Troller et al., 2011).  And in a 
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Scottish study of over one thousand 70 year-old men and women higher levels of 
CRP related to poorer performances on three out of four simple and choice reaction 
time tasks (Luciano et al., 2009). In this study, two out of three of these associations 
were attenuated to non-significance after adjusting for age-11 cognitive ability, 





Perhaps less attention has been given to associations between the haemostatic 
biomarker fibrinogen and processing speed, although a few studies are worthy of 
mention. In the Edinburgh Artery Study as described above, high fibrinogen (unlike 
CRP) was significantly associated with poorer digit-symbol performance after 12 
years, although this did not remain significant after adjusting for a contemporaneous 
measure of premorbid cognitive ability (Rafnsson, Deary, Smith, Whiteman, 
Rumley, et al., 2007). In the Caerphilly Study of over 1,500 men aged 55 to 69 years, 
of cross-sectional design, participants in the highest fibrinogen quartile were 
significantly slower on a choice reaction time task compared to those in the lowest 
quartile of the haemostatic biomarker (Elwood, Pickering, & Gallacher, 2001). 
Contemporaneous associations between fibrinogen and four reaction time variables 
were also reported by authors of the Scottish study as described in the previous 
paragraph (Luciano et al., 2009). They found that three out of four reaction time 
performances significantly related to fibrinogen in this older adult sample, and these 
associations were not explained by premorbid intelligence measured at age 11. A 
recent meta-analysis of four studies of older adults (including some of the 
aforementioned) validated the significant association between fibrinogen and 
processing speed task performance at an aggregate correlation of r = 0.76 (Quinn et 
al., 2011). 
 
The present study 
 
If there is an underlying biology to premorbid cognition-inflammation 
relations, then an association should be observable between reaction time and 
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inflammation, if processing speed is the intermediate phenotype between higher-
level cognitive reasoning ability and neuronal integrity (Deary, Bastin, et al., 2006), 
and if ultimately, neuronal integrity is shown to reflect overall bodily integrity. 
However, it is likely that, even if an underlying determinant exists of the association, 
lifestyle factors will play an important role in mediating the association between 
cognition and systemic inflammation over the life course. Using reaction times in 
place of intelligence test performance, in testing mediation pathways to systemic 
inflammation, also has an added advantage. Given the strong covariance between IQ 
and socioeconomic status indicators, statistical overadjustment may occur in models 
that control for socioeconomic factors. This could give rise to a potential 
misconception that social factors play a larger role in explaining pathways from 
premorbid cognition to CVD-related outcomes, than in reality they do. By using 
reaction time as a measure of cognition, which correlates less with SES than 
intelligence test scores do, this likelihood of overadjustment is reduced. 
This is the first study to report on the association between reaction times and 
inflammatory biomarkers where the former take temporal precedence. The study 
makes use of large representative cohorts of adults from the west of Scotland, and 
the associations can be investigated in three distinct age groups. The aims of the 
present study are as follows: 
 
1. To investigate associations between baseline measures of cognition—
namely simple and choice reaction time (RT) mean and variability—and 
inflammatory biomarkers 20 years later, in three distinct aged cohorts, 
with and without adjustment for covariates.  
2. To investigate contemporaneous associations between inflammatory 
biomarkers and reaction time measures, and to test for reverse causation 








The study cohorts derive from the west of Scotland Twenty-07 Study, an 
investigation of individuals assessed longitudinally for twenty years between 1986-7 
and 2007 (Benzeval et al., 2009). Three distinct aged cohorts recruited into the study, 
intended to be approximately 16, 36 or 56 years old at baseline (‘wave1’), were 
assessed another four times at specific time points during two decades (these are 
known as ‘waves2’, ‘3’, ‘4’ and ‘5’). The present study includes data from wave1 
and wave5 only. The original purpose of the research was to improve understanding 
of the determinants of health inequalities in Scotland, exploring socioeconomic 
indicators, age and demographic characteristics, and physical health indicators. 
Assessments at baseline (wave1) and follow-up (wave5) involved cognitive testing 
including reaction time tasks, self-reported and objective physical health measures, 
and life circumstance questions on occupations and education. General intelligence, 
using a cognitive test battery, was also measured at both waves in the 1932-born 
cohort only. At wave5, study participants were invited to consent to give blood for 
biomarker analysis.  
Figure 6.1 gives a flow diagram of the study’s sample selection. A total of 
4,510 participants were recruited into the study at wave1, including people born 
around 1932 (N = 1,551), 1952 (N = 1,444), and 1972 (N = 1,515). Twenty years 
later (wave5) 2,604 had remained in the study that represented 42.7%, 69.2% and 
62.2% of the original 1932, 1952, and 1972 birth cohorts. After excluding those who 
provided proxy or postal-only interviews at wave5, the sample size reduced to 2,568. 







Simple and four-choice reaction time. A reaction timer was used to measure 
information processing speed at wave1 and wave5 (see Figure 6.2 for illustration), 
including simple- and a four-choice-reaction time tasks. The apparatus is described 
in detail by Deary, Der, and Ford (2001). The simple reaction time task required the 
participant to press a ‘zero’ button on the timer box as quickly as possible, when a 
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zero appeared in a LCD screen positioned at the top left of the box. In the four-
choice reaction time task a digit from ‘1’ to ‘4’ appeared in the screen for each trial, 
and the participant was required to press the correspondingly labelled button as 
quickly as possible. Eight practice trials preceded a block of 20 simple reaction time 
trials as well as the block of 40 four-choice reaction time trials. These tests lasted 10 
to 15 minutes in total. The stimuli were presented at delays of between one and three 
seconds after each previous response. Individual’s reaction time means and standard 
deviations were recorded in milliseconds for the simple and 4-choice tasks—based 
on correct responses only. For the purposes of the present study these four variables 
are known as: (1) SimpleRT m, (2) simpleRT sd, (3) choiceRT m, (4) choiceRT sd. 
All bivariate correlations among these four at baseline, or at wave5, were positive 
(.72 > r > .13, p < .05), and in all but one pairing they were highly statistically 
significant (p < .001). The within-task variables were most highly correlated with 
one another (simpleRT m and sd, .63 > r > .58; choiceRT m and sd, .66 > r > .31), as 
were the intra-individual means for simple and choiceRT (.51 > r > .45), but less so 
the intraindividual standard deviations (.21 > r > .16). The total number of correct 
responses was retained, and I used these to exclude individuals with a considerable 
error rate on choiceRT (>25%).  
General cognitive reasoning. At wave1 and wave5 general intelligence was 
measured—in the 1932 cohort only—using Part 1 of the Alice Heim 4 (AH4) test 
(Heim, 1970). This is a pencil-and-paper test and was administered to each 
individual in the study with a researcher present, and timed for ten minutes. In AH4 
there are 32 items of verbal reasoning ability assessed by multiple-choice question 
and 33 items of numeric reasoning presented as short-answer questions, giving a 
total achievable score of 65. The test shows good reliability (test-retest consistency, r 
> .80) and performance on the various components of the test strongly correlated 
with a general intelligence factor, r ≥ .80 (Heim, 1970). In the present study the 
verbal and numeric reasoning scores were highly correlated (r > .80) and therefore I 






Of the 2,568 participants who attended the wave5 interview 2,310 (90%) 
provided written consent to give blood for the purposes of biomarker analysis (see 
Figure 6.1). The criteria for non-eligible participants included: Pregnant women, 
clotting or bleeding disorders, recent mastectomy, and those respondents on renal 
dialysis. Non-fasting intravenous blood was taken using an arm tourniquet, and up to 
eight samples each were collected from 2,242 participants. Among these C-reactive 
protein mg/L (CRP) was analysed from a sample collected in a 6mL plain tube 
(yellow), and fibrinogen g/L was analysed from a separate sample collected in a 5mL 
citrate tube (light blue). These were sent to the Department of Clinical Biochemistry 
at the Glasgow Royal Infirmary, Glasgow, Scotland for analysis within four days.  
I made adjustments to the biomarker data where participants reported use of 
certain medications. CRP increased by 0.2mg/L if respondents had reported taking 
statins at wave5 (based on data from Albert, Danielson, Rifai, & Ridker, 2001). 
Levels of fibrinogen increased by 6% for women reporting use of hormone 
replacement therapy, based on consistent data reported by De Souza, Stevenson, 
Davy, Parker Jones, & Seals (1997) and Stefanick et al. (1995). Whereas there is 
evidence that HRT increases CRP levels by at least 80% (Cushman et al., 1999; 
Silvestri et al., 2003; Walsh et al, 2000; van Baal et al, 1999), I considered this an 
extreme adjustment. For example, if, in the 1952 cohort where there was the largest 
proportion of women taking HRT, CRP data reduced by a factor of 1.8 in cases of 
HRT-use, the mean level for HRT users would fall significantly below the mean of 
women not on HRT, M = 2.3 ±0.3 vs. 4.1 ±0.3, t = 4.5, p < .001. Therefore I decided 
to leave CRP levels unadjusted for HRT, but to use a dummy variable in regression 
models for women in the 1952 cohort (1 = HRT use; 0 = no HRT). As so few women 
in the 1932 and 1972 cohorts used HRT I excluded these cases (n = 3 and 5, 
respectively). Another drug intervention that may have affected CRP levels is oral 
contraceptives (Cauci et al., 2008). Again, due to insufficient evidence it was not 
possible to make a systematic adjustment for this medication. Instead, in the 1972 
cohort where 91 participants reported taking oral contraceptives at wave5, I included 
a dummy variable for its use, in the analysis (1 = oral contraceptive-use; 0 = no oral 
contraceptives). This did not affect the 1932 and 1952 cohorts in which no 
participant reported taking oral contraceptives. 
In the 1972, 1952 and 1932 birth cohorts, CRP and fibrinogen at wave5 were 






A range of potential covariates at wave1 and wave5 were tested for their 
association with baseline cognition, including waist-to-hip ratio (WHR), heart rate, 
blood pressure, smoking, medication use
3
, education, and socioeconomic status 
variables. Those that were significantly associated (p < 0.05) with one or more 
reaction time variable and the outcome variable—in correlation or between-group 
tests (see Appendices E and F for effect sizes)—within one or more of the three 
cohorts
4
, were included in the analyses. The following variables measured at baseline 
and wave5 were included in the models:  
Current smoker: dichotomous variable of ‘yes’ or ‘no’. 
Resting heart rate (beats per minute): taken manually by a nurse. 




: the Head of Household’s occupational class, coded by 
the Registrar General Social Class Definition of occupations (1980). Values on this 
socioeconomic status (SES) variable were reversed, so that high scores were 
congruous with high status: unskilled = 1, partly skilled = 2, skilled manual = 3, 
skilled non-manual = 4, intermediate = 5, professional = 6.  
The number of years spent in full-time education, which was recorded at 
wave5 only, and which I found to be a significant covariate.  
In the 1932 cohort, baseline AH4 scores significantly correlated with the 
same variables as for reaction times in this cohort. In addition, AH4 scores were 
significantly lower in aspirin-users versus non-users at wave1 (M = 25.3 ±1.2 vs. 
30.9 ±0.6, t = 3.6, p < .001), and so I included a dummy variable for aspirin use in 
models where AH4 performance was an independent variable.  
 
                                                 
3
 Medications included anti-depressants, anti-hypertensives, aspirin, beta-blockers, diabetes 
medication, SSRIs and statins 
4
 For comparison purposes of the results from the three aged cohorts it was decided to include the 
same covariates in all models, even if covariates were non-significant in models of a particular cohort. 
5
 Socioeconomic status indicators measured in the study included occupational level, income, and 
housing tenure. However, due to strong associations between these three variables and their consistent 
associations with baseline cognitive performance, I selected the variable which had the least missing 





Exclusion and outlier criteria 
 
ChoiceRT data were excluded from analysis if the errors exceeded 25% 
(more than ten errors in the 40 trials). This affected seven participants at wave1 and 
one participant at wave5 from the 1952 birth cohort, two individuals at wave5 from 
the 1932 cohort, but none among the 1972 cohort. Inflammatory biomarker data were 
removed from the analysis according to the following exclusion criteria recorded at 
wave5, which would likely have affected blood status (see Figure 6.1. for numbers 
excluded):  
 
 Accident or surgery within 31 days 
 Blood samples not analysed within four days of being taken 
 Participant use of oral corticosteroids 
 Participant use of HRT 
 
I identified extreme outliers of biomarker data by inspection of box plots, and 
excluded these from the analytic models where the biomarker data were continuous. 
This affected three cases in the 1932 cohort only, where CRP levels were found to be 




Normal distributions were evident for the majority of variables. Exceptions 
included CRP and reaction time variables. C-reactive protein showed positive skew 
in all three cohorts and I therefore log transformed this variable to produce a near-
normal distribution. The large majority of reaction time M and SD data were also 
positively skewed and so I used their log-transformed values in the second set of 
analyses, where they were modelled as outcome variables.  
AH4 scores were standardised as Z scores (M = 0, SD = 1) to enable a 
comparison with effect sizes of previous studies, as were reaction time means and 
standard deviations when they were used as predictor variables in the analysis. As 
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well as being used as a continuous outcome variable, I recoded CRP as a 
dichotomous variable, so that high CRP was defined as >3mg/L, and values below 
this were classified as being normal range CRP. This threshold has been associated 
with an increased risk of coronary heart disease in normal adult populations (Pearson 
et al., 2003). I did not however recode the fibrinogen variable, given the lack of 




The analyses are based on cohorts of participants with complete data for: (1) 
One or more reaction time measure at wave1; (2) One or both inflammatory 
biomarker measures at wave5; (3) Covariates at both waves as described in the 
previous section. Tables specify the sample sizes for each set of analysis. Models 
were run for each age group separately due to different historical and social 
conditions affecting young, middle- and older-age groups born 20 or 40 years apart.  
I used PASW Statistics 17 to carry out all statistical tests. After conducting 
exploratory correlation analysis, I investigated associations between cognition and 
inflammatory biomarkers in the following ways:  
 
1. Multiple linear regressions in which wave1 cognition was modelled to predict 
a one-unit difference in the inflammatory biomarker at wave5. 
2. Logistic regressions to estimate odds ratios based on cognition at wave1 for 
the risk of high CRP at wave5.  
 
In both sets of analyses, the basic model (Model 1) was adjusted for age only, 
whereas in subsequent models I adjusted for potentially confounding and mediating 
variables. For example, Model 2 included significant covariates at baseline that were 
CVD risk factors, and which may confound cognition-to-biomarker associations, as 
discussed earlier. In Model 3 I adjusted further for education—a significant correlate 
of cognition which shows substantial mediation effects in cognitive epidemiological 
studies. I Model 4 I included CVD risk factors at wave5 to investigate potential 




3. In a third and final set of analysis multiple linear regressions modelled 
contemporaneous associations between cognition and inflammatory 
biomarkers at wave5, and then the magnitude of attenuation after including 
baseline cognition, to assess the extent of any potential reverse causation.   
 
In the results of linear regression models, unstandardised beta coefficients are 
reported with their 95% CI, as well as partial correlations to give an indication of 
effect size of the association between the cognitive and biomarker variables. To 
estimate a change in the proportion of variance explained from the basic model to 
one adjusted for covariates (with equal sample sizes), the squared partial correlations 




basic model - partial r
2




In logistic regression ORs and 95% CI are reported. Changes in variance 
explained by odds ratios in adjusted models are calculated as a proportion of the odds 




All models included an inverse-probability weight to control for potential 
attrition bias at wave5 (M = 2.23, 95
th
 centile = 4.08, maximum value = 19.24). 
Appendix G describes the methodology involved in computing this weight variable, 
which was the estimated probability that, among survivors at wave5, a participant 
completed the wave5 interview and provided a blood sample. It was calculated by S. 
Seaman at the MRC Biostatistics Unit in Cambridge UK, using logistic regression 
with several covariates that included, but were not limited to, sex, cognitive ability, 
socioeconomic status, health indices, and smoking. I decided it was unnecessary to 
truncate these weights, given that the maximum value was less than 20 times the 
average weight, ensuring stability of estimates from the final analyses (Seaman and 






Table 6.1 compares baseline characteristics of the 1932, 1952, and 1972 
analytic cohorts with their respective groups of participants who reached wave5 but 
were excluded from the analysis.  No statistically significant differences were 
observed between excluded and study participants on any of the baseline measures 
that included cognition, cardiovascular risk factors and socioeconomic indicators. 
However, a significantly lower proportion of women from the 1972 cohort were 
observed in the analytic cohort (2 = 4.49, p = 0.034), due to the exclusion of 
pregnant women from the blood collection.  
Table 6.1 also allows a comparison of the present study’s three age groups 
according to baseline characteristics. Although this is not a principal issue of the 
study’s hypotheses, a descriptive comparison is helpful in the interpretation of any 
age-specific findings.  In the three analytic cohorts baseline reaction times were 
fastest on average in the 1972 cohort, and slowest on average in the 1932 cohort. The 
oldest aged sample also showed greater variability on simple and choiceRT tasks, 
and the 1952 cohort were least variable on choiceRT but equal to the younger sample 
on simpleRT sd. WHR was highest in the middle age group, and lowest in the 
younger group. The greatest proportion of smokers at baseline was among the 1952 
cohort (42%), followed closely by the 1932 cohort (34%). As expected the 1972 
cohort were infrequent smokers (17%) at age 16 years. As expected from educational 
policy changes in Scotland, 1972 cohort had spent the most time in education (M = 
13.9 years) and the 1932 cohort were the earliest school-leavers (M = 10.6 years).    
 
Baseline cognition and twenty-year later inflammation 
 
Several interaction effects were observed in basic models between sex and 
RT variables at wave1 in predicting inflammatory status at wave5 (Appendix H lists 
these significant interactions). These were tested due to the reported sex differences 
in reaction time performance and inflammatory biomarkers. I therefore decided to 
run the models separately for men and women. Table 6.2 includes descriptive 
characteristics of men and women for each of the three cohorts, and reports any 
statistically significant sex differences (p < .05).  Women aged 36 and 56 years (1932 
and 1952 cohorts at wave1, and 1952 and 1972 cohorts at wave5) showed 
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significantly less consistency on choiceRT at baseline compared to men. There were 
no other sex differences on reaction time variables, apart from women of the 1952 
cohort showing slower baseline simpleRT than men. Sex differences were also 
observed on inflammatory biomarker levels at wave5. On average women of the 
1952 and 1972 cohorts were significantly higher on CRP and fibrinogen than men. 
An equal proportion of men and women smoked within each of the three cohorts, 
although more men than women were smokers at wave5 among the 1972 cohort. 
WHR was lower among women than men across all cohorts, and this is to be 
expected. Heart rate was generally higher among women. Men and women spent an 
equivalent time in education, within each of the three cohorts. 
Tables 6.3 and 6.4 report unstandardised beta coefficients for the prediction 





In the youngest men, performance on two out of four reaction time measures 
was associated with CRP status at follow-up. That is, in a basic age-adjusted model 
faster and more consistent choiceRT at age 16 years significantly predicted lower 
CRP levels at age 36 years (partial r = .13 and .17). A one SD advantage in choiceRT 
m and sd were associated with decreases of 1.14 mg/L and 1.18 mg/L CRP 
respectively (values are antilog transformed). These effects were largely attenuated 
when adjusting for baseline covariates that included smoking and occupational status 
(by 77.9% and 60.8% respectively; individual attenuation effects by smoking and 
SES were equivalent) and were no longer statistically significant (partial r = .06 and 
.11), and some further attenuation was observed in the fully adjusted models (partial 
r = .04 and .08). In women of the 1972 cohort, one out of the four reaction time 
measures was related to CRP in the basic model. A one SD reduction in simpleRT 
variability at wave1 was associated with a reduction of 1.24 mg/L CRP at wave5 
(partial r = .18, p < .001). This effect size attenuated by 23.9% in the fully adjusted 
model (Model 4) and remained statistically significant (partial r = .14, p < .005).  
There were no significant associations between reaction time variables and 






In three-quarters of models associations between baseline RT performances 
and CRP status at wave5 were in the expected direction but non-significant; that is, 
faster and more consistent reaction times related to lower CRP in men and in women 
born around 1952. Faster and more consistent RT was significantly associated with 
lower levels of fibrinogen in men, in three out of four models, simpleRT m (partial r 
= .15, p = 0.004), choiceRT m (partial r = .12, p < .030), and simpleRT sd (partial r = 
.12, p = .027). The effect of simpleRT speed on fibrinogen attenuated by 17.5% in a 
fully adjusted model, and remained statistically significant (partial r = .14, p = 
0.010). The effects of choiceRT m and simpleRT sd on fibrinogen, were attenuated 
to non-significance (45.3% and 35.7% reductions) in models that adjusted for 
baseline CVD risk factors, including smoking, occupational status and heart rate. 
Among women, reaction time performances at baseline bore no relation to fibrinogen 




No significant associations were observed among men and women in the 
1932 cohort between baseline reaction times and wave5 CRP, with one exception. In 
men, more consistent choiceRT was significantly associated with higher CRP at 
follow-up (partial r = -.17, p = .017). This effect increased slightly in magnitude in 
adjusted models, and by 50% in the fully adjusted model (partial r = -.21, p = .004). 
Similarly, there was no relation between RT and fibrinogen in this oldest cohort, 
with one exception, again in the unexpected direction and in men. Faster simpleRT 
was associated with higher fibrinogen after 20 years (partial r = -.17, p = .020). 
Adjustment for baseline and wave5 covariates increased the magnitude of effect 
(model4) by approximately one third (partial r = -.19, p = .009). 
In the 1932 cohort higher AH4 scores at baseline were associated with higher 
CRP levels twenty years later among men (coefficient = -.079, 95% CI = -.136 to -
.022, partial r = -.193, p = .007, n = 198). However, this association largely 
attenuated (82.3%) after adjustment for baseline covariates that included smoking 
status, occupation, WHR, and aspirin use (-.040, 95% CI -.110 to .031, partial r = -
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.080, p = .268). There was no association among women (-.011, 95% CI -.157 to 
.035, p = .652, n = 267). There were no statistically significant associations between 
baseline AH4 scores and fibrinogen at wave5 in men (-.083, 95% CI -.198 to .033, p 
= .160, n = 192) or women (-.035, 95% CI -.052 to .121, p = .429, n = 257).  
 
Cognition and elevated C-reactive protein 
 
The proportions of men and women with high CRP at wave5 were 21.6% and 
35.2% in the 1972 cohort, 32.8% and 40.6% in the 1952 cohort, and 40.3% and 
39.9% in the 1932 cohort (see Table 6.2). The greater proportion of women than men 
with high CRP in the 1972 and 1952 cohorts reached statistical significance. 
Interaction effects were observed in logistic regression models that predicted high 
CRP, between sex and several reaction time variables, in the 1972 and 1932 cohorts 
(see Appendix H for list of significant interactions). Therefore, odds ratios are 
reported for men and women separately in all cohorts. 
Tables 6.5 and 6.6 show odds ratios for baseline RT predicting high CRP, for 
men and women respectively. The RT variable data used in these models were 
inverted so that better reaction time performances (faster and less variable) were 




In the 1972 male cohort, performances on three out of four RT tasks were 
related to the reduced risk of high CRP at wave5. That is, faster choiceRT and more 
consistent simple and choiceRT at baseline were significantly associated with the 
reduced risk of high circulating CRP twenty years later (OR 0.71 to 0.79, p < .01). 
These effect sizes were attenuated after adjusting for baseline smoking and 
occupational status, by between 48% and 68%, and although these remained inverse 
associations in all adjusted models, they were no longer statistically significant. 
Among females of the 1972 cohort, one out of four reaction time variables was 
predictive of CRP status at follow-up; simpleRT sd was significantly associated with 
the reduced odds of high CRP status (OR 0.69, 95% CI 0.58 to 0.83), which 
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attenuated by only 6% in the fully adjusted model and the effect remained 




In men of the 1952 cohort, inverse associations were observed between three 
out of four RT variables and risk of high CRP, although none was statistically 
significant. In women, two out of four of the basic models were statistically 
significant. Faster simple and choiceRT predicted the reduced risk of high CRP after 
twenty years (OR 0.85, 95% CI 0.72 to 0.99, and OR 0.82, 95% CI 0.70 to 0.97, 
respectively). These effect sizes were reduced by 40% and 72% respectively after 




Reaction times did not predict high CRP in men and women of the 1932 
cohort, with one exception. In men, more variable choiceRT related to the increased 
odds of high CRP (OR 2.01, 95% CI .47 to 2.74, p < .001). The magnitude of this 
effect remained constant in the fully adjusted model.  
Higher AH4 scores at wave1 were related to the reduced odds of high CRP at 
wave5, a highly statistically significant effect in men (OR 0.66, 95% CI 0.52 to 0.83, 
p < .001), and close to significant in women (OR 0.84, 95% CI 0.70 to 1.01, p = 
.068). After controlling for baseline CVD covariates the effect in men was no longer 
statistically significant (OR 0.81, 95% CI 0.61 to 1.06, p = .122). 
 
Cognition-to-inflammation: Reverse causation? 
 
Table 6.7 presents correlation coefficients for the associations between 
reaction time variables at wave5 with respective performance scores at baseline, by 
sex. The large majority of the positive associations were highly statistically 
significant (p < .001). Across all three cohorts, choiceRT m showed greatest stability 
over 20 years (r = .37 to 62), and simpleRT m and choiceRT sd showed a similar 
range of stability coefficients (r = .25 to 44 and r = .28 to 40 respectively), with the 
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exception of choiceRT sd among 1932 cohort males (r = .16). SimpleRT sd was 
consistently the least stable over 20 years (r = .09 to .27). The 1952 cohort, where 
reaction times at age 36 and 56 years were correlated, showed the highest 
coefficients, whilst the 1932 cohort (56 and 76 years) showed the weakest 
correlations. 
Next, linear regression models were run where this time the biomarkers were 
independent variables, and wave5 reaction times were the outcome variables. I then 
tested for reverse causation by adjusting for baseline reaction times. There were no 
interaction effects between sex and inflammatory biomarkers, according to linear 
regression models predicting wave5 reaction times, with one exception. In the 1952 
cohort sex interacted with CRP to predict choiceRT sd (-.153, 95% CI -.099 to -.011, 
p = .014). However, the direction of association between CRP and choiceRT sd was 
similar for men and women (see Appendix H), and therefore regression models were 
run for the total cohorts, rather than dividing by sex group as in the previous 
analyses.  
Table 6.8 presents the beta coefficients for associations between 
contemporaneous RT and inflammatory status, with and without adjustment for 
baseline RT. There were no significant cross-sectional associations between CRP 
and fibrinogen and reaction times in the 1972 and 1932 birth cohorts. However, in 
the 1952 cohort at wave5 higher CRP levels were associated with three out of four of 
the RT measures, slower simpleRT (partial r = .11, p = .002) and choiceRT (partial r 
= .13, p < .001), and more variable choiceRT (partial r = .15, p < .001). These 
associations were not explained by reverse causation; that is, after adjustment for RT 
performance at wave1, effect sizes increased either by 15.1% at most or were 
attenuated by 17.5% at most, and the contemporaneous associations remained 
statistically significant. In this cohort, higher fibrinogen was also associated with the 
same three reaction time performances, slower simpleRT (partial r = .08, p = .020) 
and choiceRT (partial r = .07, p = .045), and more variable choiceRT (partial r = 
.099, p = .006). After adjustment for baseline RT the association between choiceRT 
m and fibrinogen attenuated to non-significance (reduction of 47.8%). Reverse 
causation explained less of the associations between simpleRT m,  and choiceRT sd 
and fibrinogen respectively, and these models attenuated by only 9.4% and 11.8%.  
In the 1932 cohort (n = 419) higher AH4 scores at wave5 were significantly 
associated with lower CRP (regression coefficient = -3.21, 95% CI -5.84 to -0.58, 
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partial r = -.115, p = .017). This effect fully attenuated after adjustment for baseline 
AH4 performance (0.19, 95% CI -1.34 to 1.72, partial r = .012, p = .806). I found no 
association between wave5 fibrinogen and contemporaneous AH4 performance 




The present longitudinal cohort study is the first to investigate the direction 
and strength of association between baseline cognitive processing speed, and 
inflammatory and haemostatic status at long-term follow-up. Using three specific age 
groups in adulthood from a representative regional sample, the results may be used to 
make inferences about the nature of these associations throughout the life course, in 
the general population. The testing of reverse causation in the contemporaneous 
associations at wave5 of the study provides supplementary data for further informing 
this issue. 
As hypothesised, faster and less variable baseline reaction times were 
associated with reduced CRP status after 20 years, albeit significant results were 
restricted to the youngest cohort and effect sizes were small—congruent with the 
existing literature. Furthermore, the adjustment of baseline covariates reduced the 
effects to non-significance among men. In women of the 1972 cohort, for whom only 
simpleRT variability related to CRP, the effect remained statistically significant in 
fully adjusted models.  The relation of faster and more consistent baseline processing 
speed to lower fibrinogen after twenty years was significant among 1952 cohort 
males only, and the relation with simpleRT speed was independent of CVD 
covariates, education, and socioeconomic status. The contemporaneous associations 
between faster and less variable simple and choiceRT and the inflammatory and 
haemostatic biomarkers observed in the 1952 cohort were independent of reaction 
time performances from twenty years past. In the 1932 cohort where there was 
additional information on cognitive function, with baseline scores from a 
psychometric intelligence test, reverse causation fully accounted for the inverse 
association between the AH4 ability score and CRP measured contemporaneously at 
age 76 years. That is, after controlling for the cognitive ability score from age 56 




Choice reaction time predicts CRP 20 years later in young 
men 
 
The effect sizes in the present study’s 1972 male cohort, of a one SD change 
in the choiceRT variables in association with a unit change in CRP (partial r = .13 
for speed and r = .17 for variability), equate to the direction and magnitude of 
associations from two previous longitudinal cohort studies reporting a one SD 
increase in baseline psychometric intelligence scores in relation to a unit reduction in 
the follow-up inflammatory biomarker. The first is the NCDS study, as reported in 
the previous chapter, which found a significant inverse association between age 11 
cognitive ability and CRP status after 34 years, with a partial r of .13 (see also 
Calvin, Batty, Lowe, & Deary, 2011). The second, the Vietnam Experience Study, 
reported an inverse association between intelligence test scores at age twenty years 
and erythrocyte sedimentation rate—a stable inflammatory biomarker—nearly 
twenty years later in men, of the magnitude partial r = .20 (Phillips et al., 2011). 
Unlike in the present study however, the cognition-to-inflammatory 
biomarker associations in these two previous studies retained statistical significance 
in fully adjusted models. This is quite likely due to the increased statistical power 
from their larger sample sizes, because the magnitude of the effect sizes (partial 
correlations) across studies is similar from equivalent models accounting for multiple 
covariates. For example, in the present study partial correlations for the effects of 
choiceRT speed and variability on CRP, in fully adjusted models, were partial r = .04 
and .08 respectively.  The equivalent effect sizes in the two aforementioned studies 
where intelligence test scores were the predictor were partial r = .04 and .07 
respectively (Calvin, Batty, Lowe, et al., 2011; Phillips et al., 2011).  
 
Sex differential effects 
 
The effect sizes for choiceRT on CRP in males were not seen among females 
of the 1972 cohort. However, in women less variable simpleRT predicted lower CRP 
twenty years later (partial r = .22). This effect remained statistically significant after 
accounting for all potential covariates, and in the logistic model a one SD advantage 
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in simpleRT predicted a 26% reduced odds of elevated CRP. The strength of 
association from this predictor is perhaps surprising, given the low stability of 
simpleRT sd compared to that of the other three reaction time variables in Twenty-07 
(see Deary & Der, 2005, and the correlation coefficients reported in this chapter). 
There may be systematic differences between men and women in response to the 
simpleRT task that may yet explain the effect. In older adult cohorts at least, women 
compared to men are more variable but also more accurate on reaction time tasks 
(Der & Deary, 2006; Reimers & Maylor, 2006). However, in the 1972 cohort there 
were no sex differences in any of the RT variables, which might have led to insights 
in to this finding.    
 
Mediation by smoking 
 
An explanation as to why reaction times predicted CRP in men but not 
women might be interpreted from the observed attenuation effects in linear and 
logistic models after adjustment for smoking—at baseline (Model 2) and again at 
wave5 (Model 4). Although smoking prevalence was similar for men and women, 
the effects of smoking on inflammatory status may not have been. In a longitudinal 
cohort study of 2,590 adults aged 30 to 89 years, smoking among men predicted 
more than double the risk of elevated CRP levels after four years, but there was no 
effect of smoking on CRP among women (Onat, Can, & Hergenç, 2008). This 
implies that cigarette smoking could explain a substantive degree of the association 
between processing speed and CRP in the present study. Whether smoking is a 
confounder of the association, or mediates the effect, is another matter. However, 
several reasons would suggest that it is more likely to be a mediating variable in the 
context of the present study. If smoking was a confounder it would need to have a 
causal effect on processing speed as well as CRP. However, the 1972 cohort were 
just 16 years’ old at baseline, and therefore would be unlikely to have smoked for a 
significant period before wave1 for it to have had adverse impact on processing 
speed. Furthermore, evidence from meta-analysis of eleven randomized controlled 
trials suggests that smoking has a short-term advantage for reaction times 
(Heishman, Kleykamp, & Singleton, 2010). That there is much greater evidence for 
the reverse direction of association, that lower cognitive reasoning ability predicts 
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the increased likelihood of smoking in subsequent years (Batty, Deary, & Macintyre, 
2007b; Batty, Deary, Schoon, & Gale, 2007c; Taylor et al., 2003), leads to the 
inference that smoking might be a mediator in the models.   
 
Cohort-specific effects  
 
ChoiceRT performance starts to slow from early adulthood, and increases in 
variability in one’s 30s (Der & Deary, 2006). Therefore the choiceRT measures in 
the study’s 1972 cohort may better reflect optimal performance than the older 
cohorts—or at least they may be more reliable proxies for ‘premorbid’ neurological 
integrity. This means that using the 1972 cohort to test causal pathways from 
processing speed to inflammation has the greatest validity among the three age-
specific cohorts. The lower effect sizes and frequent null associations from the 
results of 36 and 56 year-olds at baseline may therefore be due to age-specific effects 
and/or comorbidities, thus their departure from best-ever (the most ‘system 
integrity’-indicative) cognitive function. Nevertheless, in logistic regression faster 
simpleRT and choiceRT were still significantly protective from elevated CRP status 
among women in the 1952 cohort, reducing the odds by 15% and 18% respectively.  
 
Reverse findings in older adults 
 
An unexpected finding was from the oldest cohort—those who were 56 years 
at baseline and 76 at follow-up—where two significant effects were observed in men 
in the opposite direction to what I expected. In a linear model more consistent 
choiceRT predicted higher CRP, and in a logistic model more consistent simpleRT 
related to an increased risk of high CRP status. Both of these effects were 
statistically significant in the fully adjusted models. I noted a similar effect with 
simpleRT m and fibrinogen in the oldest men too. That these should be real effects 
with biological plausibility is questionable, and several alternative explanations must 
first be ruled out.  
The first possibility refers to sampling and survival bias. Despite the 
inclusion of attrition weighting in all analytic models, the 1932 cohort lost the 
greatest proportion of its original sample to mortality (over a third), and so there may 
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be factors specific to survival, and participant compliance, that caused the effect. For 
example, it is possible that a subgroup of the original sample with high cognitive 
ability in their fifties who developed high risk CVD profiles, survived longer than 
peers who also carried a high CVD-risk profile but whose cognitive performance was 
slower and more variable at the same age; therefore a disproportionately higher 
number of these male participants were retained in the study. If this was the case 
however, I might have expected higher functioning adults to be successfully 
managing their health problems with increased medication use, but I found no 
evidence that baseline cognitive function predicted prescription drug-use at wave5. 
Second, a related issue concerns the study sample, selected from a region in 
the UK with the highest recorded mortality rate since the 1950s (McCartney, Collins, 
Walsh, & Batty, 2011). This phenomenon is a complex social and public health issue 
known as the Glasgow effect. In the Twenty-07 study where the age at wave5 of the 
1932 cohort was beyond the average life expectancy for many areas within this 
region, survivors are exceptional and therefore results of the older cohort may not be 
generalisable to the Scottish nation or UK as a whole. In support of this is that mean 
fibrinogen levels in the three aged cohorts were higher than pooled data from 31 
population-based cohort studies (The Fibrinogen Studies Collaboration, 2007). 
Third, the unexpected findings may also be due to the inconsistent 
performance of biomarkers in older populations. Specifically, CRP and fibrinogen in 
older age groups versus middle-age adults may have less predictive validity for CVD 
outcomes or related-mortality (Kritchevsky, Cesari, & Pahor, 2005), although less is 
known about how these biomarkers perform in older age due to the relatively fewer 
studies. If the variables themselves are to be viewed as unreliable for the oldest 
cohort in this study, then the results for this group are implausible. Finally, the 
unexpected results may have arisen by chance, particularly given the number of tests. 
The issue of multiple testing is discussed further down.  
 
RT associations with fibrinogen in mid-adulthood 
 
I observed another specific age-cohort effect in models predicting fibrinogen. 
The association between reaction time measures and this biomarker were significant 
only for men of the 1952 cohort. Given that better performance on three out of four 
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reaction time variables were significantly predictive of lower fibrinogen levels 
twenty years later (partial r = .12 to .15), is evidence that these effects are due to 
more than chance alone. CRP and fibrinogen levels increase at the same rate 
throughout the life course (Ferrucci et al., 2005), and so it is unlikely that their 
unique age-trajectories are responsible for reaction times relating specifically to CRP 
in young adulthood and to fibrinogen in mid-adulthood. Instead it is possible that 
more than one mechanistic pathway may account for the role of cognition in 
predicting health outcomes.  
An alternative explanation is that smoking again plays a mediating role in the 
associations between reaction time and fibrinogen in 1952 men. In a review of 31 
international prospective cohort studies, the effect of smoking on fibrinogen levels in 
men was reported to be twice that of women (The Fibrinogen Studies Collaboration, 
2007). Indeed after adjustment for baseline smoking and occupational status in two 
out of the three significant basic models, the predictive effects of processing speed 
on fibrinogen were non-significant, and further attenuation effects were seen after 
adjustment for smoking status (along with other covariates) at wave5. The exception 
was that simpleRT speed at age 36 continued to significantly predict fibrinogen at 
age 56 in men, in the fully adjusted model, leaving open the possibility of potential 
mechanisms beyond the physical effects of smoking. If cigarette use is a strong 
mediator in pathways linking processing speed to fibrinogen, then it is not clear why 
I did not observe its effect in the younger cohort, unless the adverse effects of 
smoking on CRP levels occur at a faster rate to those affecting fibrinogen. 
 
Is there potential for system integrity? 
 
The potential for system integrity to in part explain significant associations 
between higher-level cognitive function and inflammation and haemostasis, remains 
plausible given that this study’s results show similar effect sizes with arguably 
lower-level cognitive tasks than intelligence tests. As discussed, reaction times and 
psychometric intelligence are strongly correlated, and their association highly 
heritable (Luciano et al., 2001). ChoiceRT measures were more predictive than 
equivalent simpleRT measures, and given that this more demanding processing 
speed task also more strongly relates to neurological measures of white matter 
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integrity (Penke et al., 2010), is further support for system integrity theory, albeit 
these data are only so far available for older adult cohorts. Faster choiceRT is also 
more strongly predictive of low-risk mortality than simpleRT (Deary & Der, 2005), 
and as is also clear, it is a more stable performance variable. It should therefore be 
the focus of continued research in this field.  
However, the sensitivity of both behavioural and biomarker measures to 
lifetime insults (from ill-health or adverse health behaviours) and normal ageing 
processes, makes testing a system integrity hypothesis problematic. This is 
particularly the case in older adult groups, and in the present study’s 1932-born 
cohort. Furthermore, appreciating the underlying cause of the association between 
cognition and inflammation, and potential direction of causation, is limited in the 
present study by the absence of baseline biomarker status. Testing the 
contemporaneous relationships between processing speed and CVD biomarker, for 
reverse causation, is still an effective way of informing this issue however. That 
better performance on three out of four reaction time variables at age 56 related to 
lower CRP and fibrinogen at the same age, and that the majority of these associations 
were not explained by reaction time performances 20 years earlier, tells us a few 
things: (1) System integrity cannot fully explain the nature of these associations, and 
which is clear from the evidence above; (2) It is not only underlying cognitive 
function that drives the association between processing speed and these biomarkers 
in later life. 
Given the substantial attenuation effects observed in covariate-adjusted 
models, and particularly the likely mediating role of smoking in the younger cohort, 
it is proposed that a behavioural lifestyle model explains a greater proportion of the 
effect in cognition-to-biomarker pathways than system integrity. On the other hand, 
some effects retained statistical significance even after adjusting for socioeconomic 
status, education, and CVD risk factors. This suggests that it may be premature to 
reject the system integrity hypothesis in explaining relations between cognitive 






It is novel for a large population cohort study to have the combination of 
behavioural processing speed measures and biomarker data (and separated by an 
extensive follow-up period) such as in the Twenty-07 cohort, and this is a main 
strength of the present study. It is the first investigation to assess cognitive 
processing speed as a predictor of inflammatory and haemostatic status after 
longitudinal follow-up, thus contributing to a body of literature that has depended 
upon psychometric intelligence test scores as the principal measure of cognitive 
function. As IQ-type test performance can be influenced by educational and social 
contexts, reaction time as a measure of premorbid cognitive function may be less 
confounded by socioeconomic factors, albeit it is more sensitive to ageing effects. 
Second, the present study included these data points for three distinct age groups in 
youth and adulthood. This allows inferences to be made about the generalization of 
cognition-biomarker associations over the life course, and as perhaps illustrated 
above this is a dynamic and shifting relationship. More important, the inclusion of 
the younger cohort means that reaction time performance is measured at a premorbid 
phase before ageing effects adversely affect optimal processing speed. In contrast, in 
the 1932-born cohort the effects of ageing are being detected more than etiological 
processes. To illustrate this point, I observed in the oldest cohort for which AH4 test 
scores were available, stable psychometric intelligence at age 56 entirely accounting 
for the contemporaneous association between CRP and the AH4 score at age 76, 
whereas reaction times that are more sensitive to ageing processes did not show such 
reverse causation, at least for those significant contemporaneous associations in the 




There are limitations to the present study that must be discussed here.  
First, although the Twenty-07 study was intended as a representative sample 
of adults living in the west of Scotland region, and sample sizes are large, the oldest 
cohort especially may not be representative of similarly aged cohorts from other UK 
regions, given the increased health problems associated with this area of Scotland. 
Therefore the results derived from adults born in 1932 may not be generalisable to 
the broader background population.  
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Second, in any longitudinal study where the baseline occurs in adulthood, 
there is always the issue of confounding by influences occurring prior to the study. 
For example, full-time education in these older samples would have been completed 
prior to the study onset, and could have driven the associations between cognition 
and inflammation; educational achievement is related to increased inflammatory 
status in adult life (Gimeno, Ferrie, et al., 2008), although any effect of education on 
processing speed is as yet unknown. Although I attempted to overcome the issue of 
overadjustment for education, by using a cognitive variable with less cultural bias, 
the cost of using RT in adulthood was that it may have been more susceptible to 
confounding in the older cohorts. This means that results from the youngest cohort 
are at lowest risk of confounding, and ultimately more reliable.  
Third, I conducted multiple testing which may have incurred, in particular, 
type 1 error, and therefore the results are interpreted with caution. For example, in 
basic models an association between two or more reaction time variables with the 
biomarker outcome was given greater importance, than associations that were simply 
held with one out of four reaction time performance levels.  
Finally, the study would have benefited not only from a measure of 
biomarker status at baseline (emerging studies that include blood sampling will 
enlighten this issue), but it would have also been informative to include additional 
biomarkers each of inflammation and haemostasis. Replication studies of this area 
would certainly be strengthened by the inclusion of multiple markers. For example, 
interleukin-6 is viewed as a more reliable biomarker of habitual inflammatory status, 
and is a more robust predictor of CVD, cancers and diabetes, compared to CRP (for a 
review see Singh & Newman, 2011). 
 
Conclusion 
   
Just as premorbid psychometric intelligence has predicted a range of CVD 
outcomes in longitudinal studies—including emerging risk markers—cognitive 
processing speed operationalised using simple and choice reaction times and 
intraindividual variances, are also predictive when measured in youth. Given the 
possible closer affinity to neuronal integrity of low-level processing speed – versus 
general intelligence – this study’s findings could lend greater validity to system 
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integrity theory. However, this explanation is made less compelling in the current 
findings by evidence that smoking may be a strong mediator of the association. An 
advantage in choice reaction time performance may underlie the development of 
higher reasoning capability, which ultimately leads to the decision to not take up 
smoking or to quit, in more cases than not. Such pathways can be tested more 
formally if cohort studies choose to test on a range of cognitive variables over time. 
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Table 6.1 Baseline characteristics of included and excluded participants: Twenty-07. 
 
 
 1972 cohort  1952 cohort  1932 cohort  
 Included Excluded  Included Excluded  Included Excluded  
N 759 183 p
a
 843 156 p 528 135 p 
Female, N (%)   404  (53.2) 114  (62.3) .03 458  (54.3) 84 (53.8) .56 298  (56.4) 86  (63.7) .24 
Cognitive measures                
SimpleRT m 291.6  56.5 299.8  80.3 .50 309.4  74.6 301.9  72.1 .21 340.4  108.8 347.2  126.5 .76 
SimpleRT sd 71.9  47.5 76.8  61.7 .60 65.2  41.7 62.0  38.5 .73 84.5  60.2 92.8  68.7 .70 
ChoiceRT m 567.1  69.3 568.2  72.4 .41 615.4  80.9 609.8  89.0 40 704.0  105.3 708.0  111.4 .97 
ChoiceRT sd 111.1  32.1 109.0  31.5 .42 112.2  29.5 110.3  29.4 .26 127.7  33.6 127.9  32.7 .83 
AH4           30.2  11.6 28.7  10.6 .33 
Covariates                
Smoker, N (%) 125 16.5 26  14.2 .87 349  41.4 80  51.3 .19 179  33.9 53  39.3 .61 
WHR 0.85  0.07 0.87  0.10 .85 0.88  0.09 0.89  0.09 .46 0.86  0.08 0.86  0.08 .56 
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 1972 cohort  1952 cohort  1932 cohort  
 Included Excluded  Included Excluded  Included Excluded  
N 759 183 p
a
 843 156 p 528 135 p 
Heart rate 72.9  10.0 73.1  10.6 .41 70.9  9.8 72.5  11.0 .08 71.2  9.1 72.9  9.6 .20 












































































































Note. Values are means and standard deviations, except for categorical variables where the group size (and percentage) are shown. Sample sizes vary according to missing data on each variable.  
a
 Independent samples t-tests compared included versus excluded groups, with the exception of sex and smoking group differences which were based on chi-square. No statistically significant group 




Table 6.2 Cohort characteristics by sex group: Twenty-07. 
 
 1972 cohort  1952 cohort  1932 cohort  
 Men 
n = 355 
Women 
N = 404 
 Men 
N = 383 
Women 
N = 460 
 Men 
N = 229 
Women 
N = 299 
 
 M SD M SD p
a
 M SD M SD p M SD M SD p 
Wave1 cognition                
SimpleRT m 289.3  56.7 293.4  56.3 .322 302.0  68.3 315.8 79.2 .005 347.8  114.4 336.2  105.2 .237 
SimpleRT sd 75.5  53.6 68.6  41.2 .054 62.9  35.8 66.9  45.8 .236 84.1  60.2 85.9  62.1 .716 
ChoiceRT m 566.9  69.0 566.9  69.8 1.00 614.8  79.0 616.2  82.4 .821 711.7  94.9 698.2  112.2 .080 
ChoiceRT sd 109.9  30.9 112.1  33.1 .359 107.6  28.2 116.0  30.0 < .001 119.4  30.8 133.9  34.4 < .001 
Wave1 covariates                
Smoker, N (%) 59  (16.6) 66  (16.3) .916 174  (45.8) 180  (39.2) .055 87  (38.0) 93  (31.1) .098 
WHR 0.90  0.06 0.81  0.05 < .001 0.96  0.06 0.81  0.05 < .001 0.93  0.05 0.81  0.05 < .001 
Heart rate 70.7  10.2 74.8  9.4 < .001 69.4  10.2 72.1  9.3 < .001 70.9  8.8 71.4  9.3 .591 

































































































Wave5 outcomes                
 
 156 
CRP 2.33  3.02 3.67  5.17 < .001 3.28  4.12 4.50  7.12 .021 4.77  6.84 4.70  5.52 .399 
High CRP, N (%) 76  (21.6) 141  (35.2) < .001 125  (32.8) 185  (40.6) .021 91  (40.3) 116  (39.9) .085 
Fibrinogen 3.19  0.57 3.41  0.73 < .001 3.48  0.67 3.62  0.71 .004 3.65  0.77 3.81  0.72 .021 
Metabolic syndrome, N (%) 90  (25.6) 64  (16.0) .001 152  (40.6) 156  (35.1) .100 66  (29.5) 142  (47.8) .014 
Wave5 cognition                
SimpleRT m 275.1  53.1 275.1  50.5 .987 298.1  74.8 301.8  76.2 .370 361.9  187.6 370.6  151.3 .188 
SimpleRT sd 49.6  36.4 52.3  34.1 .307 73.4  121.3 76.3  154.2 .184 126.8  267.6 138.7  277.1 .135 
ChoiceRT m 533.3  69.7 537.9  62.3 .343 633.8  89.7 637.2  99.7 .634 801.5  216.2 805.1  176.7 .697 
ChoiceRT sd 86.4  24.9 96.0  26.1 < .001 115.6  50.5  130.9  85.3 < .001 185.9 213.5 202.0  262.1 .118 
Wave5 covariates                
Education 13.9  3.3 14.0  3.0 .889 12.9  3.4 12.5  2.9 .060 10.5  3.0 10.7  2.7 .486 
Smoker, N (%) 112  (31.7) 93  (23.0) .007 90  (23.5) 125  (27.2) .216 14  (18.1) 43  (14.4) .254 
WHR 0.92  0.06 0.83  0.07 < .001 0.96  0.06 0.85  0.07 < .001 0.96  0.06 0.87  0.07 < .001 



















































































































Note. Values are means and SD (italics), except for categorical variables where group sizes (and percentages) are shown. Sample sizes vary according to missing data on each variable. 
a 
Chi-squared test was used for dichotomous variable group differences (e.g. smoking), and t-tests were conducted on all other variables which were treated as continuous variables; log-transformed 
values of the reaction times were used.    
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Table 6.3  Regression coefficients (and 95% CI) for associations between baseline reaction times and inflammation after 20 years: Men. 
 
 
 CRP  Fibrinogen 
 
SimpleRT m SimpleRT sd ChoiceRT m ChoiceRT sd  SimpleRT m SimpleRT sd ChoiceRT m ChoiceRT sd 
1972 cohort N = 329 to 330  N = 323 to 325 
Model 1 
.038  [-.013,  .089]  
p = .139 
-.003  [-.045,  .040]  
p = .903 
 .058  [ .011,  .104] 
p = .015  
 .071  [.027,  .116] 
p = .002  
 .049  [-.021,  .119] 
p = .170  
.022  [-.037,  .080] 
p = .466  
.004  [-.061,  .069] 
p = .903 
.008  [-.054,  .071] 
p = .795  
Model 2 
.005  [-.044,  .054] 
p = .837  
-.017  [-.058,  .028] 
p = .403  
.027  [-.019,  .072] 
p = .254  
.043  [-.001,  .087] 
p = .054  
 .039  [-.033,  .111] 
p = .288  
.016  [-.043,  .074] 
p = .598  
-.007  [-.074,  .059] 
 p = .828  
-.002  [-.066,  .062] 
p = .951  
Model 3 
.003  [-.047,  .052] 
p = .914  
-.018  [-.059,  .022] 
p = .373  
.024  [-.022,  .070] 
p = .315  
.040  [-.005,  .084] 
 p = .080  
 .040  [-.032,  .113] 
 p = .271  
.016  [-.043,  .075] 
 p = .587  
-.006  [-.073,  .061] 
 p = .860  
.000  [-.065,  .065] 
p = .998  
Model 4 
-.005  [-.055,  .045] 
p = .837  
-.024  [-.065,  .017] 
p = .246  
.018  [-.028,  .064] 
p = .446  
.034  [-.011,  .079] 
 p = .135  
 .022  [-.050,  .093] 
p = .554  
.004  [-.054,  .062] 
 p = .886  
-.020  [-.086,  .047] 
 p = .558  
-.014  [-.078,  .051] 
p = 680  
1952 cohort N = 348 to 353  N = 343 to 348 
Model 1 
.026  [-.024,  .076] 
p = .303  
-.003  [-.058,  .052] 
p = .916 
.029  [-.017,  .076] 
p = .215  
.019  [-.027,  .065] 
p = .425  
  .111  [ .035,  .187] 
p = .004 
.090  [ .009,  .171] 
p = .030  
 .081  [ .009,  .152] 
 p = .027  
.054  [-.017,  .125] 
p = .135 
Model 2 
.012  [-.038,  .063] 
p = .633  
-.018  [-.073,  .036] 
p = .513 
.007  [-.041,  .056] 
 p = .767  
.004  [-.042,  .050] 
 p = .864  
  .105  [ .029,  .181] 
p = .007  
.070  [-.010,  .150] 
p = .087  
.060  [-.013,  .134] 
p = .108  
.026  [-.044,  .096] 
p = .463  
Model 3 
.006  [-.044,  .056] 
p = .822  
-.015  [-.068,  .039] 
p = .595 
.002  [-.046,  .050] 
 p = .937  
.002  [-.044,  .047] 
 p = .941  
  .105  [ .029,  .181] 
p = .007  
.071  [-.009,  .151] 
p = .084  
.060  [-.014,  .134] 
p = .113  
 .026  [-.044,  .096] 
 p = .469  
Model 4 
.001  [-.049,  .050] 
p = .979  
-.025  [-.078,  .028] 
p = .356 
-.003  [-.050,  .044] 
 p = .903  
-.010  [-.056,  .035] 
 p = .657  
  .097  [ .023 , .170] 
p = .010  
.054  [-.024,  .132] 
 p = .172  
.054  [-.018,  .126] 
p = .140  
.016  [-.054,  .085] 




1932 cohort N = 203  N = 197 
Model 1 
.009  [-.043,  .061] 
p = .734 
-.018  [-.076,  .040] 
p = .549  
.029  [-.042,  .101]  
p = .421 
-.080  [-.146, -.015] 
p = .017 
 -.126  [-.232, -.020] 
p = .020  
-.116  [-.234,  .003] 
p = .056 
-.062  [-.025,  .081] 
p = .393 
.033  [-.102,  .167] 
p = .631 
Model 2 
-.026  [-.082,  .030] 
p = .362  
-.047  [-.108,  .014] 
p = .131  
-.013  [-.089,  .062] 
p = .724  
-.093  [-.157, -.028] 
p = .005  
 -.142  [-.256, -.029] 
p = .015  
-.105  [-.231,  .020] 
p = .100 
-.083  [-.234,  .068] 
p = .279 
.017  [ .118, -.152] 
p = .806 
Model 3 
-.029  [-.085,  .028] 
p = .316  
-.051  [-.112,  .011] 
p = .104  
-.017  [-.093,  .059] 
p = .653  
-.095  [-.160, -.030] 
p = .004  
  -.154  [-.269, -.040] 
p = .009  
-.119  [-.246,  .007] 
p = .065  
-.098  [-.251,  .054] 
p = .204 
.010  [-.126,  .145] 
p = .889 
Model 4 -.032  [-.090,  .025] 
p = .264 
-.052  [-.113,  .010] 
p = .101  
-.020  [-.096,  .056] 
p = .601  
-.096  [-.162, -.030] 
p = .004  
 -.152  [-.264, -.039] 
p = .009  
-.108  [-.219,  .060] 
 p = .090 
-.090  [-.239,  .058] 
p = .233 
-.012  [-.146,  .123] 
p = .864  
 
 
Note. Statistically significant coefficients are in bold (p < .05).  Higher reaction times are slower (m) and less consistent (sd). Model 1 is the basic model adjusting for age at w1, and weighted for attrition; Model 2: 
Basic model + baseline CVD covariates (smoking and occupational status, plus heart rate in 1952 cohort, and WHR in 1932 cohort); Model 3: Model 2 + education; Model 4: Model 3 + wave5 covariates.  
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Table 6.4  Regression coefficients (and 95% CI) for associations between baseline reaction times and inflammation after 20 years: Women 
 
 
CRP  Fibrinogen 
 SimpleRT m SimpleRT sd ChoiceRT m ChoiceRT sd  SimpleRT m SimpleRT sd ChoiceRT m ChoiceRT sd 
1972 cohort N = 383-4  N = 378-9 
Model 1 
-.004  [-.056,  .047]  
p = .871  
.095  [ .042,  .148] 
p < .001  
.037  [-.015,  .089] 
p = .165  
-.008  [-.057,  .040] 
p = .739  
 -.013  [-.084,  .059] 
p = .720  
-.017  [-.088,  .056] 
p = .644  
.041  [-.027,  .109] 
p = .448 
.032  [-.036,  .099] 
p = .357  
Model 2 
-.014  [-.066,  .037] 
p = .584  
.083  [ .030,  .136] 
p = .002  
.022  [-.031,  .076] 
p = .407  
-.016  [-.064,  .033] 
p = .527 
 -.028  [-.100,  .044] 
p = .452  
-.033  [-.105,  .039] 
p = .370  
.022  [-.048,  .091] 
p = .544  
.021  [-.047,  .090] 
p = .542  
Model 3 
-.025  [-.077,  .026] 
p = .331  
.077  [ .023,  .131] 
p = .008  
.000  [-.054,  .054] 
p = .995  
-.038  [-.087,  .011] 
p = .130  
 -.039  [-.111,  .033] 
p = .286  
-.047  [-.119,  .025] 
p = .200  
.000  [-.071,  .070] 
p = .997  
.001  [-.068,  .070] 
p = .969  
Model 4 
-.022  [-.075,  .030] 
p = .402  
.082  [ .027,  .137] 
p = .005  
.006  [-.049,  .061] 
p = .830   
-.035  [-.085,  .015] 
p = .166  
 -.034  [-.107,  .039] 
p = .359  
-.039  [-.113,  .035] 
p = .296  
.001  [-.070,  .074] 
p = .969  
.006  [-.064,  .076] 
p = .867  
1952 cohort N = 425-30  N = 415-20 
Model 1 
.020  [-.026,  .067] 
p = .386  
.023  [-.022,  .068] 
p = 309 
.024  [-.026,  .073]  
p = .344 
-.004  [-.051,  .044] 
p = .882  
 -.031  [-.099,  .037] 
p = .366 
.003  [-.063,  .070] 
p = .920  
.024  [-.049,  .096]  
p = .518 
.012  [-.059,  .083] 
p = .741 
Model 2 
-.003  [-.049,  .043] 
p = .900  
.004  [-.041,  .048] 
 p = .873 
-.017  [-.069,  .034] 
 p = .504  
-.025  [-.073,  .023] 
p = .311  
 -.044  [-.114,  .025] 
p = .212  
-.004  [-.072,  .063] 
p = .897  
-.005  [-.083,  .072] 
p = .602  
-.005  [-.079,  .070] 
p = .897  
Model 3 
-.007  [-.053,  .039] 
p = .774  
.004  [-.040,  .049] 
p = .843 
-.021  [-.072,  .030] 
p = .427  
-.026  [-.074,  .022] 
p = .293  
 -.045  [-.115,  .023] 
 p = .208  
-.004  [-.072,  .063] 
p = .899  
-.006  [-.084,  .072] 
p = .880  
-.005  [-.080,  .070] 
 p = .892  
Model 4 
-.006  [-.051,  .038] 
p = .776  
.008  [-.034,  .051] 
 p = .703 
-.031  [-.080,  .019] 
 p = .224  
-.037  [-.083,  .009] 
p = .118  
 -.046  [-.115,  .022] 
p = .187  
 .003  [-.063,  .069] 
p = .929  
-.024  [-.269,  .180] 
p = .537  
-.020  [-.093,  .054] 




1932 cohort N = 275-7  N = 265-7 
Model 1 
.005  [-.035,  .044] 
p = .816 
.020  [-.027,  .066] 
p = .409  
-.004  [-.049,  .041] 
p = .853  
-.010  [-.053,  .033] 
p = .650 
 -.005  [-.079,  .068]  
p = .885 
.061  [-.028,  .149] 
p = .178 
-.041  [-.125,  .042] 
p = .330 
-.020  [-.101,  .061] 
p = .623 
Model 2 
.002  [-.040,  .043] 
p = .937  
.020  [-.027,  .066] 
p = .404  
-.008  [-.056,  .041] 
p = .761  
-.011  [-.055,  .033] 
p = .610  
 -.020  [-.097,  .057] 
p = .612  
.059  [-.029,  .147] 
p = .191 
-.054  [-.144,  .036] 
p = .241 
-.023  [-.106,  .059] 
p = .577 
Model 3 
-.002  [-.044,  .040] 
p = .920  
.018  [-.028,  .065] 
p = .437  
-.017  [-.067,  .032] 
p = .494  
-.019  [-.064,  .025] 
p = .394  
 -.022  [-.099,  .056] 
 p = .584  
.059  [-.030,  .147] 
p = .192  
-.060  [-.152,  .032] 
p = .199 
-.028  [-.112,  .057] 
p = .520 
Model 4 
-.016  [-.058,  .027] 
p = .469 
.011  [-.035,  .057] 
p = .633  
-.024  [-.074,  .025] 
p = .337  
-.013  [-.057,  .031] 
P 
p = .570  
 -.009  [-.089,  .071] 
p = .831  
.070  [-.019,  .159] 
p = .122 
-.055  [-.149,  .039] 
p = .249 
-.034  [-.119,  .050] 
p = .425  
 
Note. Statistically significant coefficients are in bold (p < .05).  Higher reaction times are slower (m) and less consistent (sd). Model 1 is the basic model adjusting for age at wave1, and relevant dummy variable at 
wave5 (oral contraceptive use among 1972 cohort; HRT use among 1952 cohort), and weighted for attrition; Model 2: Model 1 + baseline CVD covariates (smoking and occupational status, plus heart rate in 1952 
cohort, and WHR in 1932 cohort); Model 3: Model 2 + education; Model 4: Model 3 + wave5 covariates.  
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Table 6.5 Odds ratios (and 95% CI) for high CRP, predicted by baseline reaction times: Men. 
 
 
 1972 cohort  
N = 331 
 1952 cohort  
N = 351 
 1932 cohort 

























p = .009 
1.08  
(0.90, 1.28) 
p = .407 
0.71 
(0.60, 0.86) 
p < .001 
0.78  
(0.66, 0.93) 
p = .004 
 0.84  
(0.69, 1.03) 
p = .090 
0.95 
(0.76, 1.20) 
p = .674 
0.94  
(0.78, 1.14) 
p = .544 
1.03  
(0.86, 1.25) 
p = .733 
 0.88  
(0.72, 1.06) 
p = .172 
1.09 
(0.88, 1.35) 
p = .422 
0.84  
(0.65, 1.10) 
p = .200 
2.01 
(1.47, 2.74) 




p = .478 
1.18  
(0.99, 1.40) 
p = .072 
0.85  
(0.70, 1.03) 
p = .102 
0.93  
(0.77, 1.11) 
p = .396 
 0.90  
(0.73, 1.11) 
p = .304 
1.01 
(0.80, 1.27) 
p = .854 
1.05 
(0.85, 1.29) 
p = .652 
1.13  
(0.92, 1.39) 
p = .234 
 1.04 
(0.84, 1.29) 
p = .726 
1.35  
(1.04, 1.75) 
p = .024 
1.05 
(0.79, 1.40) 
p = .746 
2.08  
(1.52, 2.85) 




p = .532 
1.18  
(0.99, 1.41) 
p = .066 
0.86  
(0.71, 1.05) 
p = .128 
0.94  
(0.78, 1.12) 
p = .481 
 0.91 
(0.74, 1.13) 
p = .387 
.01  
(0.80, 1.28) 
p = .950 
1.07  
(0.87, 1.32) 
p = .523 
1.14  
(0.93, 1.40) 
p = .201 
 1.08 
(0.86, 1.34) 
p = .521 
1.42 
(1.10, 1.85) 
p = .008 
1.09 
(0.82, 1.47) 
p = .550 
2.14  
(1.56, 2.93) 




p = .696 
1.18  
(0.87, 1.49) 
p = .067 
0.85  
(0.64, 1.13) 
p = .139 
0.88  
(0.67, 1.16) 
p = .423 
 0.93 
(0.75, 1.15) 
p = .494 
1.06  
(0.83, 1.35) 
p = .664 
1.10  
(0.89, 1.36) 
p = .383 
1.22  
(0.99, 1.52) 
p = .066 
 1.10 
(0.88, 1.38) 
p = .398 
1.43  
(1.10, 1.87) 
 p = .008 
1.11 
(0.83, 1.49) 
p = .491 
2.09 
(1.52, 2.87) 
p < .001 
 
 
Note. All models include an inverse probability weighting to account for attrition bias. Reaction time variable scores were reversed, so that lower values 
indicate slower and more variable performance. OR in bold is significant, p < .05. Model 1 is the basic model and adjusts for age at wave1; Model 2: Model 1 + 
baseline CVD covariates (smoking and occupational status, plus heart rate in the 1952 cohort and WHR in the 1932 cohort); Model 3: Model 2 + education; 
Model 4: Model 3 + wave5 covariates. m = mean reaction time speed; sd = reaction time standard deviation (consistency); CVD risk = current smoking and 
occupational status, plus heart rate in 1952 cohort, and WHR in 1932 cohort 
There were no issues of multicollinearity. 
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Table 6.6 Odds ratios (and 95% CI) for high CRP, predicted by baseline reaction times: Women 
 
 
 1972 cohort 
N = 335 
 1952 cohort 
N = 429 
 1932 cohort  




























p = .631 
0.69  
(0.58, 0.83) 
p < .001 
0.93 
(0.79, 1.09) 
p = .378 
1.05 
(0.90, 1.23) 
p = .553 
 0.85  
(0.72, 0.99) 
p = .036 
0.87  
(0.74, 1.02) 
p = .088 
0.82  
(0.70, 0.97) 
p = .022 
0.94  
(0.80, 1.10) 
p = .408 
 1.11  
(0.94, 1.31) 
p = .209 
1.02 
(0.84, 1.22) 
p = .862 
1.07 
(0.89, 1.27) 
p = .493 
1.05  
(0.88, 1.24) 




p = .806 
0.70  
(0.58, 0.84) 
p < .001 
0.96  
(0.81, 1.13) 
p = .588 
1.07 
(0.91, 1.26) 
p = .424 
 0.91  
(0.77, 1.08) 
p = .281 
0.93  
(0.79, 1.10) 
p = .417 
0.95 
(0.80, 1.14) 
p = .583 
1.01  
(0.86, 1.20) 
p = .871 
 1.17 
(0.98, 1.39) 
p = .084 
1.01 
(0.84, 1.22) 
p = .913 
1.11  
(0.91, 1.36) 
p = .286 
1.06  
(0.89, 1.27) 




p = .814 
0.73 
(0.61, 0.87) 
p < .001 
1.03  
(0.87, 1.23) 
p = .710 
1.16 
(0.98, 1.37) 
p = .092 
 0.92  
(0.78, 1.09) 
p = .319 
0.93  
(0.79, 1.10) 
p = .409 
0.96  
(0.80, 1.15) 
p = .633 
1.01 
(0.86, 1.20) 
p = .871 
 1.20 
(1.01, 1.44) 
p = .044 
1.02 
(0.84, 1.24) 
p = .855 
1.19  
(0.97, 1.46) 
p = .096 
1.12  
(0.93, 1.35) 




p = .992 
0.71 
(0.56, 0.96) 
p < .001 
0.98 
(0.77, 1.25) 
p = .872 
1.12  
(0.89, 1.43) 
p = .124 
 0.92  
(0.78, 1.09) 
p = .328 
0.91  
(0.77, 1.09) 
p = .307 
0.99  
(0.83, 1.19) 
p = .924 
1.05 
(0.88, 1.24) 
p = .590 
 1.34  
(1.10, 1.62) 
p = .003 
1.06 
(0.87, 1.29) 
p = .579 
1.25  
(1.01, 1.54) 
p = .040 
1.10  
(0.91, 1.32) 
p = .333 
 
 
Note. All models include an inverse probability weighting to account for attrition bias. Reaction time variable scores were reversed, so that lower values 
indicate slower and more variable performance. ORs in bold are statistically significant at p < .05. Model 1 is the basic model and adjusts for age at wave1 and 
wave5 dummy variables (oral contraceptive use in 1972 cohort; HRT use in 1952 cohort); Model 2: Model 1 + baseline CVD covariates (smoking and 
occupational status, plus heart rate in 1952 cohort, and WHR in 1932 cohort); Model 3: Model 2 + education; Model 4: Model 3 + wave5 covariates. m = mean 
reaction time speed; sd = reaction time standard deviation (consistency); CVD risk = current smoking and occupational status, plus heart rate in 1952 cohort, 
and WHR in 1932 cohort 
There were no issues of multicollinearity. 
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Table 6.7 Stability of cognitive measures between wave1 and wave5. 
 
 
 1972 cohort  1952 cohort  1932 cohort  
 Men 
N = 337-339 
Women 
N = 388-389 
 Men 
N = 358-361 
Women 
N = 438-440 
 Men 
N = 192-211 
Women 
N = 241-280 
SimpleRT m 
.33 
p < .001  
.33 
p < .001 
 
.44 
p < .001 
.35 
p < .001 
 
.25 
p < .001 
.29 
p < .001 
SimpleRT sd 
.09 
p = .095 
.12 
p = .020 
 
.21 
p < .001 
.27 
p < .001 
 
.11 
p = .120 
.17 
p = .005 
ChoiceRT m 
.52 
p < .001 
.55 
p < .001 
 
.62 
p < .001 
.59 
p < .001 
 
.43 
p < .001 
.37 
p < .001 
ChoiceRT sd 
.33 
p < .001 
.32 
p < .001 
 
.40 
p < .001 
.37 
p < .001 
 
.16 
p = .028 
.28 
p < .001 




p < .001 
.82 
p < .001 
 
Note. Values are Pearson’s r coefficients. 
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CRP  Fibrinogen 
 SimpleRT m SimpleRT sd ChoiceRT m ChoiceRT sd  SimpleRT m SimpleRT sd ChoiceRT m ChoiceRT sd 
1972 cohort N = 713-5  N = 703-5 
Model 1 
-.004  [-.016,  .008] 
p = .453  
.021  [-.014,  .055] 
p = .238  
.006  [-.002,  .014] 
p = .152 
.013  [-.004,  .030] 
p = .127 
 -.003  [-.012,  .006] 
p = .542 
-.002  [-.028,  .024] 
p = .859 
-.001  [-.007,  .005] 
p = .678 
.006  [-.007,  .019] 
 p = .330 
Model 2 
-.006  [-.017,  .005] 
p = .254  
.017  [-.017,  .051] 
p = .336 
.001  [-.006,  .008] 
p = .859 
.008  [-.008,  .024] 
p = .330 
 -.003  [-.011,  .005] 
p = .449 
-.004  [-.030,  .022] 
p = .786 
-.003  [-.008,  .002] 
p = .291 
.005  [-.007,  .017] 
p = .430 
1952 cohort N = 788  N = 778 
Model 1 
 .020  [ .007,  .033] 
p = .002  
.033  [-.007,  .072] 
p = .109 
 .017  [ .008,  .026] 
p < .001 
.042 [ .023,  .061] 
p < .001 
 .011  [ .002,  .019] 
p = .020 
.017  [-.011,  .044] 
p = .232 
 .006  [ .000,  .012] 
p = .045 
 .018  [ .005,  .031] 
p = .006 
Model 2 
 .017  [ .005,  .029]  
p = .005 
.031  [-.008,  .070] 
p = .115 
.013  [ .006,  .020] 
p < .001 
.041 [ .024,  .059] 
p < .001 
  .009  [ .001,  .017] 
p = .029 
.014  [-.012,  .041] 
p = .284 
.004  [-.001,  .009] 
p = .148 
 .016  [ .004,  .028] 
p = .010 
1932 cohort N = 486  N = 469 
Model 1 
.017  [-.013,  .048] 
p = .267 
.021  [-.057,  .100] 
p = .595 
.017  [-.003,  .036] 
p = .098 
 .050  [ .004,  .096] 
p = .031 
 -.012  [-.029,  .004] 
p = .135 
-.030  [-.071,  .012] 
p = .159 
-.010  [-.021,  .001] 
p = .068 
-.014  [-.040,  .011] 
p = .271 
Model 2 
.015  [-.015,  .045] 
p = .314 
.023  [-.055,  .100] 
p = .564 
.014  [-.004,  .032] 
p = .137 
 .062  [ .017,  .106] 
p = .006 
 -.009  [-.025,  .007] 
p = .272 
-.028  [-.069,  .013] 
p = .182 
-.008  [-.018,  .002] 
p = .127 
-.012  [-.036,  .013] 
p = .352 
 
Note. All models are weighted for attrition. Model 1 and 2 match on sample sizes for each association. The regression coefficient is the effect of a one unit 
change in biomarker value in relation to a log-transformed unit change in the reaction time variable.
 
Model 1 is the basic model adjusting for sex, age at 
wave5, and dummy variables at wave5 (oral contraceptive among 1972 cohort; HRT among 1952 cohort); Model 2 is model 1 + adjustment for the 
corresponding reaction time-variable measured 20 years earlier. Coefficients marked bold are significant (p < .05). 
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Excl:                  540 died 
22 died FW no contact 
109 refused 
174 dnc throughout 
23 incapacitated 
16 invalid addresses 
2 no resp (contact) 





Excl:      23 unsuccessfui 
69 no consent 





Excl:         22 old bloods 
1 old blood & corts 
5 surgeries 
1 surgery & corts 
2 accidents 




Excl:                  29 died 
1 died FW no contact 
122 refused 
108 dnc throughout 
2 incapacitated 
211 invalid addresses 
66 no resp (contact) 





Excl:      21 unsuccessfui 
9 preg./ clotting disorder 
99 no consent 
19 postal-only w5 
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Excl:         22 old bloods 
2 recent surgeries 






Excl:                  80 died 
8 died FW no contact 
115 refused 
108 dnc throughout 
5 incapacitated 
71 invalid addresses 
34 no resp (contact) 






Excl:      15 unsuccessfui 
90 no consent 
5 postal-only w5 




Excl:         29 old bloods 
5 surgeries 
3 accidents 

















Figure 6.2 Reaction time box used in the Twenty-07 study. 
 
 






Reaction time and the metabolic syndrome after 20 years:  
West of Scotland Twenty-07 Study 
 
Chapters 5 and 6 investigated cognition in relation to systemic inflammation, 
which belongs to a series of pathogenic mechanisms that potentially pose biological 
risk throughout human ageing (Seeman et al., 2010). A closely related cluster of 
parameters showing associations with psychometric intelligence, and the focus of 
this chapter, are the metabolic syndrome (MetS) biomarkers. The collective burden 
of these risk factors for cardiovascular disease has been acknowledged since the 
1920s (Eckel, Grundy, & Zimmet, 2005). The condition constitutes physical and 
biological risk parameters that include abdominal obesity, hyperglycaemia, 
hypertension, and dyslipidaemia (including high triglycerides and low HDL 
cholesterol). Metabolic syndrome is a precursor to life-threatening disease onset 
including type 2-diabetes (Ford, Li, & Sattar, 2008) and cardiovascular disease 
(Khunti & Davies, 2005), and is significantly related to premature mortality (Mottillo 
et al., 2010). That it has substantial prevalence in population-based cohorts, that it is 
evident at a preclinical stage of disease, and that it is detectable in younger and more 
representative adult populations, makes MetS an obvious endpoint in itself to study 
in relation to premorbid cognition, and lends itself to better understanding the 
pathways from intelligence to CVD-related outcomes.  
Two previous studies have reported significant associations between 
psychometric intelligence in youth and later risk of metabolic syndrome, in cohorts 
from the UK and US. The present chapter reports for the first time on the 
longitudinal associations between low-level cognitive processing speed (as seen in 
the previous chapter) and metabolic risk 20 years later, using the west of Scotland 
Twenty-07 cohorts.  
 




Longitudinal cohort data have demonstrated significant associations between 
lower scores on psychometric intelligence in youth, and individual metabolic risk 
factors, including high blood pressure, low HDL cholesterol, high waist 
circumference, high glycated haemoglobin, and high triglycerides (Chandola et al., 
2006; Hart et al., 2004; Power, Jeffries, & Manor, 2010; Richards et al., 2009; Starr 
et al., 2004). These studies report mediation by education, socioeconomic status, 
and/or lifestyle behaviours, as largely explaining the association, although sometimes 
the effect remains robust of full statistical adjustment, for example in the case of 
blood pressure (Starr et al., 2004). Others however, report null effects in unadjusted 
models, for example in the association between intelligence differences, and total 
cholesterol or blood glucose (Hart et al., 2004). Given that such metabolic risk 
factors often cluster together statistically (Batty, Gale, et al., 2008; Pladevall et al., 
2006), particularly with increasing age (Ervin, 2009; Kraja et al, 2006), it has been of 
interest to consider the effect of intelligence differences in predicting later risk for 
MetS.  
 
Premorbid intelligence and the metabolic syndrome 
 
To date two published studies have reported on the association between 
general cognitive ability in youth and the clustering of metabolic risk factors in 
adulthood. The first, the Vietnam Experience Study of over 4,000 male army 
veterans, used intelligence test scores (Army General Technical or AGT Test) at 
army entry, at a mean age of 20 years, and data from clinical examination 18 years 
later (in 1986), which included measurement of risk factors for MetS (Batty, Gale, et 
al., 2008). The cohort was a randomly selected subgroup from >18,000 army 
personnel, representing 23% of the original sample. The AGT test scores showed 
significant inverse associations with four out of five MetS risk factors that included 
hypertension, high body mass index (BMI), high triglycerides and high blood 
glucose. There was no association with HDL-cholesterol. Batty, Gale, et al. (2008) 
reported that a one SD advantage in intelligence test scores was significantly 
associated with a 14% reduced odds of MetS. However, unlike the literature on 
individual metabolic risk factors, this effect was not accounted for by prior 
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educational experience or achievement, nor was it explained by socioeconomic 
factors including income, social prestige, and army rank. 
The second report, of the 1946 British Birth Cohort study, had greater 
longitudinal follow-up, relating intelligence test scores collected at age eight to 
metabolic risk factors when participants were age 53 years (Richards et al., 2009). 
This study’s large-scale psychometric intelligence testing in youth provided greater 
confidence that cognitive performance was a ‘premorbid’ measure, less likely to be 
affected by lifestyle behaviours or educational inequalities that also contribute to 
metabolic syndrome risk (Langenberg, Kuh, Wadsworth, Brunner, & Hardy, 2006; 
Wilsgaard & Jacobsen, 2007). Therefore any observed association would be at lower 
risk of confounding by these factors, relative to studies where collection of baseline 
cognitive measures begins in adulthood. Compared to the US Vietnam veterans the 
participants of the 1946 British Birth Cohort study were also more nationally 
representative; they included both men and women and had broader socioeconomic 
spread. Despite these important differences in study design, Richards et al. (2009) 
replicated the result of the U.S. study, reporting an equivalent effect size among 
nearly 1,800 cohort members; a significant 14% reduced odds of MetS risk given a 
one SD advantage in intelligence test scores.  
An inconsistency between these two studies however was the mediating 
effect of education. In the British cohort educational attainment by age 26 entirely 
accounted for the association between intelligence and MetS. That is, after adjusting 
for the highest educational qualification achieved by individuals the association was 
fully attenuated, implying a mediation effect. Whereas Batty, Gale, et al. (2008) who 
controlled for total years spent in education among the individuals in their cohort, 
observed no such dent in the effect size.  
 
Understanding pathways from IQ to MetS risk 
 
It therefore remains unclear as to the mechanistic pathway(s) linking 
cognitive ability in youth to metabolic risk in adulthood. There may be, for example, 
a sex differential in explaining the effect, given evidence that education is more 
predictive of MetS in women versus men (Wilsgaard & Jacobsen, 2007); in the 
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British cohort that included women, education was an important covariate (Richards 
et al., 2009), relative to the men-only cohort (Batty, Gale, et al., 2008). Furthermore, 
the previous two studies tested mediation via educational and socioeconomic 
inequalities, yet perhaps independent of these, lifestyle behaviours may explain 
additional variance.  
A problematic issue (and theme throughout this thesis) of including 
socioeconomic variables in models where intelligence (as an independent variable) 
correlates strongly with such factors, is one of statistical overadjustment. In this case 
attenuation effects that result from the addition of SES to a model, interpreted as 
mediation or confounding, may be overinflated. To overcome this particular issue, 
the present study makes use of the west of Scotland Twenty-07 study, which as 
explained in the previous chapter, has cognitive processing speed measures rather 
than the more frequently available psychometric intelligence scores. These reaction 
times are more independent of socioeconomic indices than the latter, enabling a 
reduction in risk of overadjustment in models that control for education and SES. 
This therefore allows for mediation effects to be tested more reliably with a range of 
covariates, on a pathway towards metabolic risk.  
 
A potential pathway from processing speed to MetS 
 
Alternative explanations of the pathway from intelligence differences to 
CVD-morbidities may obviously include confounding, and reverse causation, and 
statistical-adjustment for covariates to take account of these potential effects are 
essential. However, as discussed in previous chapters, the possibility of underlying 
system integrity as an alternative theory for the association remains a possibility. 
While it may only ultimately be tested by genetics research, epidemiological 
investigations can at the very least infer its likelihood. Given that processing speed is 
a more direct measure of neurological integrity than intelligence test performance 
(Penke et al., 2010), the present study can test (the plausibility at least of) a system 
integrity hypothesis in cognition—to—MetS associations. That is, if significant 
associations exist between cognitive processing speed and MetS, then an underlying 
cause of association between premorbid cognitive ability and metabolic function, 
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which predate lifestyle and social influence, remains a possibility. If however, a 
relation is not observed, associations between psychometric intelligence and 
metabolic risk reported in the literature can be more confidently interpreted as 
mediation by lifestyle behaviour and influence.  
 
Processing speed and metabolic risk 
 
Although this the first study to examine the association between individual 
differences in baseline reaction time and later MetS, previous studies have looked at 
the relationship contemporaneously or in the reverse direction; that is, the effect of 
MetS on subsequent cognitive function.  
Cross-sectional evidence from case-control studies of adult patients with 
MetS versus healthy control groups suggest that psychometric and experimental 
processing speeds are significantly slower in cases compared to controls (Berg et al., 
2008; Segura et al., 2009). Among the few population-based cohort studies 
investigating associations between metabolic risk factors and processing speed, 
diabetes and hyperglycaemia show contemporaneous associations with slower 
experimental reaction times and poorer performance on an alphabet-coding task 
(measuring information processing speed) respectively (Anstey et al., 2005; Dik et 
al., 2007). Such evidence implicates glucose control as a component of MetS that 
bears relation to cognitive speed. However, in a separate study of older non-diabetic 
men the glucose biomarker HbA1c was found to be unrelated to processing speed 
(MacLullich et al., 2004). 
Another component of MetS is high blood pressure, and there has been less 
evidence for its relation to reaction time performance, including a cross-sectional 
study that reported a null association between hypertension and contemporaneous 
simple and choice reaction times (Anstey et al., 2005). Furthermore, a 12-year 
longitudinal investigation of older adults reported no effect of baseline MetS on later 
processing speed (Komulainen et al., 2007)—although the syndrome was associated 
with poorer memory performance. 
Whereas the evidence is inconsistent and not yet substantive, there remains 
biological plausibility that MetS is a preclinical risk factor for vascular-related 
 
 172 
cognitive decline (Segura et al., 2009). For example, adults with vascular risk 
profiles, including hypertension, relative to healthy controls, show longitudinal 
decline in cortical volume and an increase in white matter hypertensities, associated 
with cognitive decline (Raz, Rodrigue, Kennedy, & Acker, 2007). Therefore, the 
cluster of risk factors that constitutes MetS is most likely detrimental to cognitive 
function and neural health. However, if such an association is observed in older adult 
cohorts, a consideration of premorbid cognitive ability is also important; that is, an 
entirely causal effect of metabolic function on cognition should not be assumed. 
Looking at the association between metabolic risk and cognitive performance in 
reverse is therefore informative to cognitive ageing and cognitive epidemiology 
research.  
 
The present study 
 
The main aim of the present study is to test whether low-level cognitive 
performance measures at baseline—namely simple and choice reaction time speed 
and variability—relate to aspects of the metabolic syndrome 20 years later. This is 
investigated in three distinct age cohorts, and where the risk of confounding or 
reverse causation is lowest in the youngest, born in 1972, when processing speeds 
were recorded at age 16. The associations are investigated with attempts to account 
for reverse causation and to adjust for potentially confounding factors, and are 
further explored for mediation pathways that include adjustment for health behaviour 
indicators, education, and socioeconomic status.  
Given the availability of processing speeds at wave5 in the Twenty-07 
cohort—measured at the same time as metabolic risk factors—there is the additional 
opportunity to measure the contemporaneous relation between metabolic risk and 
processing speeds in three distinct age cohorts, and to test for potential reverse 
causation by adjusting for baseline reaction times. The results of this secondary 
analysis may be informative to cognitive ageing studies that consider cognitive 
decline as a consequence of vascular-related disease states, and to lifecourse 
epidemiology that must account for bidirectional associations among behavioural and 
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biological indices. It also provides opportunity to consider alternative explanations 






The study cohorts from the west of Scotland Twenty-07 Study were described 
in detail in the methods section of chapter 6.  In brief, these included three birth 
cohorts from 1972, 1952 and 1932, interviewed for the first time at approximately 
16, 36 or 56 years of age (wave1). The present study (as in the previous chapter) uses 
20-year follow-up data at wave5 to assess metabolic risk outcomes. Measures at 
baseline included cognitive testing, social status, and self-reported physical health 
measures. The cohorts in this chapter consist of participants who consented to give 
blood at wave5 and who had no missing data on the variables that assessed metabolic 
risk. Sample selection presented in chapter 6’s flow diagram (Figure 6.1) is just as 
relevant to the cohorts used in the present chapter. Among an original baseline 
sample of 4,510 participants, 1,942 (43.1%) had complete data with which to assess 




Simple and four-choice reaction time. The methods to assess mental 
processing speed were described in the previous chapter. The same four performance 
measures were used to predict metabolic syndrome in the present study, at baseline 
and at wave5. They are: (i) SimpleRT m, (ii) simpleRT sd, (iii) choiceRT m, (iv) 
choiceRT sd.     
Psychometric intelligence. Alice Heim 4 test scores (AH4) were available at 
both waves for the 1932 birth cohort only (Heim, 1970). In models where cognition 
was a predictor variable I used the standardised score (M = 0, SD = 1) to enable 
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comparisons with effect sizes for intelligence and metabolic syndrome associations 






I assigned metabolic syndrome (MetS) status as a new variable, according to 
the presence of at least three out of five risk factors available in the Twenty-07 
dataset. These match the risk factors that Richards et al (2009) used in their 
investigation of intelligence and MetS, and are based upon the US’s National 
Cholesterol Education Program recommendations (Expert Panel on Detection, 
Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001), but modified 
due to the availability of glycated haemoglobin (HbA1c) instead of plasma glucose 
(Langenberg et al., 2006). The five risk factors are:  
 
 Waist circumference >102 cm in men and >88 cm in women 
 Systolic blood pressure ≥130 mmHg or ≥140 mmHg in the 1932 cohort 
 Triglycerides ≥1.7 mmol/L 
 High density lipoprotein (HDL) cholesterol <1.036 mmol/L in men and 
<1.295 mmol/L in women 
 Glycated haemoglobin (HbA1c) in the top gender-specific quartile of 
each cohort’s distribution 
 
Triglycerides, HDL cholesterol and HbA1c were measured from nonfasted 
intravenous blood samples taken using an arm tourniquet. The lipids were analysed 
from a sample collected in 6mL plain tube (yellow), and HbA1c was analysed from a 
separate sample collected in 4mL EDTA tube (purple). As described in the previous 
chapter, blood analysis was conducted at the Department of Clinical Biochemistry at 
the Glasgow Royal Infirmary, Glasgow, Scotland, within four days of the samples 
being taken. The participants’ systolic blood pressure (systolic BP) was measured 
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three times and I retained the third reading (based on the highest recorded arm) for 
analysis.  
Before participants were rated for risk on the five metabolic factors, 
medication use necessitated adjustment of measures, including systolic BP, HDL 
cholesterol and HbA1c values. Table 7.1 lists the value constants applied to these 
biomarkers according to each specific medication. Whereas oral contraceptives are 
shown to alter levels of serum triglycerides and HDL cholesterol (Cauci et al., 2008), 
there is insufficient evidence to make systematic adjustments for its use. Instead, in 
the 1972 cohort where 91 participants reported taking oral contraceptives at wave5, I 
included a dummy variable as a covariate (1 = oral contraceptive use, 0 = no oral 
contraceptives). There were no reports of oral contraceptive use in the 1932 and 
1952 cohorts at wave5.  
 
Metabolic risk component 
 
The five variables that constituted the above criteria for metabolic syndrome 
were entered in to principal components analysis, with the intention of extracting a 
single continuous factor score that could best account for the variance in metabolic 
syndrome risk. Data reduction within each of the three cohorts consistently showed 
the same result. That is, triglycerides, HDL cholesterol, waist circumference, and 
HbA1c all loaded highly on a single component, whereas systolic BP loaded on to a 
second component. Given that the literature on metabolic risk often makes the 
distinction between this former cluster of metabolic parameters and the 
cardiovascular system—that includes blood pressure (Juster, McEwan, & Lupien, 
2010; McEwan, 1998)—I decided to remove the blood pressure variables from this 
part of the analyses. Instead, I derived a proxy measure of low-density lipoprotein 
(LDL) cholesterol (total cholesterol minus HDL cholesterol) and added this to the 
models to optimise the validity of a metabolic component. Before estimating LDL 
cholesterol, total cholesterol levels were adjusted where participants used statins 






The wave1 and wave5 covariates listed in Chapter 6 were also tested for their 
associations with MetS or the metabolic component. (Appendix C reports on the 
associations between these outcome measures and the covariates within the three 
aged cohorts). The significant covariates at wave1 and wave5, in one or more 
cohorts
6
, were current smoking status (‘yes’ = 1, ‘no’ = 0), occupational status as the 
SES variable (1 to 6 categories where 1 = unskilled and 6 = professional), and heart 
rate. Waist-to-hip ratio (WHR) was an additional covariate at wave1. At wave5 




Exclusion and outlier criteria  
 
The same exclusion criteria as in Chapter 6 were applied to the data in the 
present study. First, I excluded choiceRT data from analyses where there was record 
of a 25% or greater error rate. Additional factors potentially affecting the validity of 
one or more risk factors associated with metabolic syndrome were: Accident or 
surgery within 31 days of blood sampling; blood samples analysed after four days’ 
delay; use of oral corticosteroids; use of HRT. In such cases data were excluded, 
with the exception of the 1952 cohort participants on HRT; these women were 





Data distributions and transformations for the independent variables were 
described in the previous chapter’s methods section. The metabolic component 
derived from PCA was normally distributed and already standardised. Analyses were 
based on the samples of participants with complete data for, one or more cognitive 
                                                 
6
 If a covariate was significant in one cohort only, it was still included in models of all cohorts, to 
enable a comparison between models’ effects sizes of the different age groups.  
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measures at wave1; metabolic syndrome risk according to the five risk factors
7
, or a 
metabolic component score; covariates at both waves as described in the previous 
section.  Models were run for the separate age groups using PASW Statistics 17. 
After exploratory correlation analysis the hypotheses were tested in the following 
ways: 
(1) Logistic regression modelled the associations between cognitive measures 
and risk for MetS. For this set of analyses I inverted reaction times so that faster and 
more consistent reaction times were reflected in higher values. My reasoning behind 
this was to enable comparisons with effect sizes from previous studies. Odds ratios 
with 95% CI were estimated in a basic model and subsequent covariate-adjusted 
models that tested the effects of potential confounders and mediators.  
In a basic model (Model 1) age and sex were adjusted (as well as wave5 
dummy variables for contraceptive and HRT use, explained in previous sections of 
these Methods).  
A second model (Model 2) attempted to account for existing metabolic risk 
by adjusting for baseline WHR and heart rate (as a proxy for physical fitness), given 
that nothing else relevant to metabolic risk factors was collected at wave1. This 
model also adjusted for wave1 SES and smoking, which may have confounded the 
association.  
Model 3 adjusted for education, as I was interested to see the extent of its 
attenuation effect on the model alone, given its strong mediation effects in the 
background literature.  
Model 4, the final model, tested potential mediation effects by including 
wave5 covariates including SES, smoking, and heart rate. Changes in variance 
explained by odds ratios in adjusted models are calculated as a proportion of the odds 
ratio from the basic model.  
(2) Principal components analysis was used to derive a single metabolic 
component within each cohort. Values from the first unrotated principal component 
were saved, and two sets of multiple regression analyses were run:  
1. A one SD change in wave1 reaction times was modelled to predict the 
metabolic component value at wave5. A basic model and three 
                                                 
7
 If participant data were missing for one or two risk factors, a diagnosis of metabolic syndrome could 
still be made in the presence of three remaining risk factors. 
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subsequent adjusted models were run, using the same covariates and 
rationale as for the logistic regression models above.  
2. The metabolic component was modelled to predict contemporaneous 
reaction times at wave5, before and after adjustment for wave1 reaction 
times—thereby testing for reverse causation.  
For both sets of results, unstandardised regression coefficients and their 95% 
CI are tabulated. Unlike the logistic regression models to predict metabolic 
syndrome, where I inverted the RT data so as to make comparisons with previous 
studies’ effect sizes, in linear regression models the RT data retained their raw form, 
that is, higher values reflected slower and less consistent performances. As in the 
previous chapter, partial correlations are reported to give an indication of effect size 
of the significant associations, as are estimates of change in the proportion of 




basic model - partial r
2




In all models I included the inverse probability weight detailed in Appendix 




Prevalence of metabolic syndrome 
 
Prevalence rates for MetS are shown in Table 7.2, and are similar to 
population data (Khunti & Davies, 2005), albeit they are somewhat lower in the 1932 
cohort compared to rates for over 60s in general populations (Ervin, 2009). The 
condition was higher among 56 and 76 year-olds (37.3 and 32.4%, respectively) 
compared to the 36 year-old-cohort (20.5%), consistent with longitudinal age trends 
showing a substantial shift from adults below 50 years to above (Ervin, 2009; Kraja 
et al, 2006).   
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Table 7.2 also includes group characteristics of those with and without MetS, 
within the three cohorts. A greater proportion of men than women were at risk of 
MetS in the 1972 cohort, 2(1) = 9.37, p = .002, as well as in the 1952 cohort 
although the difference was non-significant. In the 1932 cohort the condition was 
more prevalent among women than men, although again this was only a trend effect. 
There were no group differences in proportions of smokers, either at baseline or 
wave5. In the 1972 and 1952 cohorts the syndrome was associated with lower 
occupational status at wave1, and in the 1952 cohort at wave5. Those with metabolic 
syndrome risk also showed higher WHR (1972 and 1952 cohorts only). Baseline 
heart rate was higher in those with MetS in the 1952 cohort, and was higher at wave5 
among 1972 and 1952 cohort members with the condition. By follow-up those with 
MetS had been in education for less time than those without the condition, both in 
the 1972 and 1952 cohorts. In the 1932 cohort average educational years were 
greater in those with, versus those without, MetS. This effect was not significant, 
although it might indicate survivor bias in this oldest cohort.  
Mean simple and choiceRT performances at wave1 were faster and less 
variable among those without MetS compared to those with the condition in the 1972 
and 1952 cohorts, reaching statistical significance in the youngest cohort only. No 
significant group differences were observed on reaction time performance or the 
AH4 cognitive test score in the 1932 cohort.  
 
Cognition and risk of MetS 
 
Logistic regression models to predict MetS were conducted on the total 
cohorts rather than by sex group, given a lack of interaction effects between sex and 
RT. Table 7.3 displays the odds ratios for MetS according to baseline cognition, as 
measured by simple and choiceRT m and sd. As stated previously, the RT values 







In age- and sex-adjusted models of the 1972 cohort three out of four wave1 
RT variables were predictive of MetS 20 years later. A one SD faster choiceRT and 
one SD more consistent simple- and choiceRT, were significantly associated with the 
reduced odds of the syndrome (OR 0.79, 0.82 and 0.89 respectively). In a second 
model that controlled for baseline CVD risk factors, the effect of choiceRT sd 
attenuated to non-significance (OR 0.92, 95% CI 0.82 to 1.04)—largely due to the 
effect of occupational status—and further adjustment for education attenuated the 
effect of mean choiceRT to non-significance (OR 0.90, 95% CI 0.79 to 1.03). 
However, the effect of simpleRT sd on MetS attenuated by ~25% only in a fully-





Inverse associations were found between the four simple and choiceRT 
variables at age 36 and risk of MetS at age 56, in the 1952 cohort (OR 0.90 to 0.94), 




In the 1932 cohort, simpleRT measures were unrelated to the risk of MetS 
and odds ratios were close to unity. However, in this older age cohort both choiceRT 
variables were positively associated with MetS. That is, faster and more consistent 
choiceRT at age 56 were associated with the increased risk of the condition by age 
76 (choiceRT m, OR 1.49, 95% CI 1.19 to 1.87; choiceRT sd, OR 1.52, 95% CI 1.24 
to 1.86). These effects were stable after full adjustment for covariates (choiceRT m, 
OR 1.44, 95% CI 1.13 to 1.84; choiceRT sd, OR 1.43, 95% CI 1.17 to 1.76). 
Consistent with these findings, a one SD advantage in AH4 scores at 56 years were 
associated with the increased risk of MetS at 76, in an age- and sex-adjusted model 
that included 321 participants with no missing values (OR 1.02, 95% CI 1.01 to 1.04, 
p = .003). Baseline covariates did not explain this effect; adjusting for the potential 
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mediating effects of SES and other CVD-risk factors did however attenuate the effect 
to non-significance (OR 1.01, 95% CI 0.99 to 1.04, p = .33). 
 
A metabolic syndrome component 
 
The results of principal components analysis of the five metabolic risk 
variables are presented in Table 7.4. It is clear from the scree plots that the first 
components derived for each of the three aged cohorts explained substantial variance 
compared to the four subsequent components, illustrated by an elbow at the second. 
The first component loading from the unrotated factor solution explained 50.1% of 
the variance in the 1972 cohort; it explained 44.4% of the variance in the 1952 
cohort, and 37.5% of the variance in the 1932 cohort. Out of the five metabolic 
measures, triglycerides had the highest loading on the PCA component in all cohorts 
(.76 to .85), while HbA1c generally showed the lowest loadings across cohorts (.42 
to .46). The component loading for LDL cholesterol was relatively high in the 
youngest cohort (.77), and showed an incremental decrease with older age cohorts 
(.61 and .46). This may be responsible for the incremental decline in total variance 
explained by the components of the youngest to oldest cohort, and could be due to 
LDL (or non-HDL) cholesterol being differentially affected by age. For example, 
high LDL cholesterol which is a risk factor for premature all-cause mortality in most 
of adulthood can show the reverse effect in adults above 65 years (Akerblom et al., 
2008); at least in relation to vascular-related deaths LDL cholesterol carries a much 
weaker association compared to that in younger adults (Prospective Studies 
Collaboration, 2007).  
 
Baseline cognition and the metabolic component 
 
Table 7.5 shows the unstandardised regression coefficients and their 95% 
confidence intervals for predicting scores on the metabolic syndrome component 
according to baseline reaction times. The models were run for men and women 
combined, given the lack of any interaction effects between sex and RT in predicting 
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variance in the metabolic component.
8
 The non-inverted RT values were modelled, 




In the 1972 cohort, performances on the four RT measures were positively 
related to the metabolic component at wave5. That is, in a basic model that adjusted 
for age and sex, faster and more consistent reaction times at age 16 were significantly 
associated with lower metabolic component scores at age 36. The effect sizes as 
partial correlations (partial r) ranged from .14 to .40. The variances in the metabolic 
syndrome attributable to simpleRT m and sd were attenuated by 56% and 13% 
respectively, after simultaneous adjustment for baseline smoking, SES, heart rate and 
WHR, and which remained statistically significant. The effects of choiceRT m and sd 
in explaining variance in the metabolic component were largely attenuated after 
accounting for baseline covariates (82% and 76% respectively), yet these 
associations also remained statistically significant. In models that adjusted for each 
of the baseline covariates individually (data not reported), it was clear that the 
attenuation effect was largely due to SES; no effects of WHR and heart rate—to 
potentially account for reverse causation—were observed. Further adjustment for 
education made relatively modest changes to the effects. ChoiceRT variables were 
no longer associated with the metabolic component in fully adjusted models 
(ChoiceRT m, partial r = .04; ChoiceRT sd, partial r = .05), and mediation by SES 
was largely responsible for this additional attenuation. However, associations 
between simpleRT speed and consistency, and the metabolic component, which were 
further attenuated by 25% and 7% only after controlling for potentially mediating 
variables, retained statistical significance (SimpleRT m, partial r = .10; SimpleRT sd, 




                                                 
8
 One exception was in the 1972 cohort, where there was a significant interaction effect for Sex x 
SimpleRT sd (see Appendix H for chart). However the association was in the same direction for men 
and women and therefore I combined sex groups in all analysis.   
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In adults born around 1952, both simpleRT performance measures, and 
choiceRT m, were significantly associated with the metabolic system component. 
That is, faster and more consistent simpleRT at age 36, and faster choiceRT 
performance, related to lower scores on the metabolic component at age 56 (partial r, 
.09, .09 and .08 respectively). Attenuation effects for these three significant models 
were greatest when controlling for baseline CVD covariates (by 59%, 47%, and 90% 
respectively), after which the effect sizes were non-significant. Reverse causation 
appeared to be an unlikely explanation; that is, in models that adjusted for each of the 
adult risk factor covariates individually (data again not shown), neither WHR or 
heart rate had an attenuating effect; rather, low SES and to a smaller extent smoking, 
explained attenuation of the significant effects. Adjustment for mediating variables, 
including education and wave5 CVD covariates made negligible changes to the 




In the 1932 cohort there were no significant associations between reaction 
time variables and the metabolic component. The AH4 score at baseline positively 
related to the metabolic component at wave5, but again this was not statistically 
significant (coefficient = 0.03, 95% CI -0.06 to 0.11, p = .51).    
 
Contemporaneous cognition and the metabolic component 
 
 Table 7.6 shows the beta coefficients and their 95% confidence intervals for 
contemporaneous associations between metabolic component scores and RT 
measures taken at wave5, before and after adjustment for wave1 RT. Again, non-
inverted reaction times were used.  
 In the 1972 cohort at age 36, the metabolic component was positively 
associated with choiceRT but not simpleRT performances; that is, faster and more 
consistent choiceRT was significantly associated with lower metabolic component 
scores (partial r = .13 and .12 respectively). After control for equivalent baseline RT 
performance scores the associations were attenuated by 65% and 48% respectively 
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for speed and consistency, although remained statistically significant (partial r = .08 
and .09).  
In the 1952 cohort, at an average of 56 years, metabolic component scores 
were significantly and positively associated with three out of four RT variables 
(partial r = .08 to .12). The one exception was simpleRT sd (partial r = .05). After 
adjustment for baseline processing speed the relation to simpleRT m attenuated by 
44% and was no longer significant. Associations between the metabolic component 
and choiceRT m and sd however, remained statistically significant after adjustment 
for their equivalent performance scores at wave1 (partial r = .10 and .11).  
In the 1932 cohort, at an average age of 76, the metabolic component was 
unrelated to reaction time performance (partial r = -.04 to .01); neither did it relate to 




 This is the first investigation of longitudinal associations between reaction 
times and metabolic syndrome occurrence, in which the processing speed measure 
takes temporal precedence. The logistic regression models to predict MetS may be 
compared to previous investigations where an intelligence test score was the 
independent variable of interest. The magnitude of effects for one SD faster and more 
consistent reaction time performances at age 16 in relation to the reduced risk of 
MetS 20 years’ later (OR in the range 0.77 to 0.90), are consistent with the two 
previous studies that each reported higher intelligence scores in youth relating to 
reduced metabolic risk in adulthood after 20 and 45 years respectively, at odds ratios 
of 0.86 in unadjusted models (Batty, Gale, et al., 2008; Richards et al., 2009). The 
weaker effect sizes among the present study’s 1952 cohort, and the two unexpected 
positive associations in the older 1932 cohort, may be the result of confounding 
and/or an artefact of attrition; issues which are discussed in more detail further 
below. Given that reaction times in the youngest 1972 cohort would have been 
closest to optimal, relative to the two older cohorts where RT were measured at an 
age when processing speeds are already slowing (Der & Deary, 2006), it is these 
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results that arguably carry greater validity in testing the association between 
premorbid cognition and metabolic risk. In the 1972 cohort, reaction times were also 
significantly related to a metabolic component, albeit these were small effect sizes so 
that in the fully adjusted models cognitive speed explained <1% to 4% of the 
variance in this derived standardised score. Furthermore, reaction time performance 
at wave1 explained a substantial proportion of the significant contemporaneous 
associations between equivalent processing speed measures and the metabolic 
component at wave5, in the 1972 and 1952 cohorts. This finding demonstrates the 
likelihood of partial reverse causation in ageing studies that assess cognitive 




Age differential effects 
 
The difference in study effects across the age groups are apparent between 
the older age group who were 76 years’ old when assessed for MetS, versus the 
groups who were 36 years and 56 years when they were assessed on the same criteria 
for risk. Contrary to the present study’s hypothesis, faster and less variable choice 
reaction times and higher intelligence test scores were associated with increased 
metabolic risk in the oldest cohort. However, that the prevalence of MetS in the 
oldest cohort was somewhat lower (particularly among men) compared to national 
prevalence rates for adults over 60 years (Ervin, 2009) is indicative of attrition or 
survivor bias. Evidence for the latter is the significantly lower mean waist 
circumference among survivors (M = 85.9 cm, SD = 11.3, n = 950) vs. non-survivors 
(M = 89.1 cm, SD = 12.9, n = 513) at baseline—when the 1932 cohort were 56 years’ 
old (data not reported in Results). 
Reasons for the association between superior reaction time performance and 
higher inflammatory status among the oldest cohort were reported in the previous 
chapter, including issues of sampling and measurement bias, ruling out the likelihood 
of a biological explanation for this reverse effect. Occupational status was also 
positively related to MetS in the 1932 cohort, which is again unexpected. However, 
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higher SES status that is normally related to the reduced risk of MetS in middle-aged 
groups has shown a null association with MetS in older adults (Loucks et al., 2007). 
Again, this might be attributed to attrition and survival bias in studies of older adults.  
A specific cause of attrition bias in ageing research may be cognitive reserve 
(Stern, 2009), a theory asserting that in some individuals—particularly among groups 
with higher IQ and socioeconomic status—more adaptive processes allow for 
apparently stable or intact cognitive performance, despite evidence of 
neuropathology. Therefore, cohort members with the highest ability scores at 
baseline but who went on to develop metabolic system risk in older adulthood, may 
have had greater cognitive capacity with which to manage their condition, and, 
continue participation in the study, relative to those with lower baseline abilities. 
That such positive associations between reaction times and metabolic 
syndrome in the 1932 cohort, were not observed for the metabolic component, is also 
revealing. The metabolic component excluded blood pressure data, and among 
participants that met criteria for MetS in this cohort, the frequency of hypertension 
was high relative to other risk factors. Therefore, this positive effect may be driven 
by, higher cognitive performers surviving (Deary & Der, 2005), and, continuing in 
the study despite high blood pressure.  
 
Potential for sex differential effects 
 
Given the lack of interaction effects of Sex x Reaction time in predicting 
metabolic risk, the present study combined men and women to optimise statistical 
power. Whereas in the previous chapter smoking was implicated as an apparent 
contributor to sex differentials in the effects of RT on systemic inflammation in the 
younger cohorts, it did not explain significant variance in the present study. Instead, 
baseline and wave5 SES made partial contributions to models. Given that metabolic 
risk differentially affects men and women however, particularly in respect to age, 
and that there are sex differentials on processing speed tasks (Der & Deary, 2006; 
Roivainen, 2011), it would be worth considering these two groups separately in 




Prospective pathways from cognitive speed to metabolic risk 
 
Where three reaction time measures significantly predicted MetS in the 1972 
cohort, two of these associations remained robust after adjustment for potential 
confounders, and one (simpleRT sd) was robust against the further effects of 
education and wave5 covariates. This latter effect replicates results from the Vietnam 
Experience Study in which intelligence test scores retained relations to MetS risk in 
socioeconomic-adjusted models (Batty, Gale, et al., 2008), which was of a similar 




Additional to socioeconomic indicators however, the present study 
considered lifestyle indicators to explain additional variance of the effect. Smoking 
did not contribute to the association between reaction times and MetS. Heart rate and 
WHR were controlled for, to try to account for metabolic risk at baseline, thus 
addressing reverse causation. However, they did not contribute to baseline-adjusted 
models. There are other lifestyle behaviours however that the present study could not 
account for. For example, dietary intake (including alcohol) may be a significant 
mediator, given that childhood intelligence has shown associations with adult dietary 
choices (Batty, Deary, Schoon, & Gale, 2007e; Gale et al., 2007), and that particular 
nutrient intake and excess fat consumption increase metabolic risk (Kimokoti & 
Brown, 2011). The Twenty-07 cohort does not have detailed data on participants’ 
diets with which to evaluate this properly, but it is a lifestyle factor that deserves 
more thorough investigation.  
 
A weaker role for education  
 
Education explained far less of the variance in models predicting metabolic 
risk. However, given that education and SES are strongly correlated in the present 
study (r = .38 to .57), baseline occupational status that I adjusted for prior to 
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education, may have already removed any independent effects of education on the 
models.  
In contrast, the previous British cohort study reported full mediation by 
education of the association between intelligence test scores at age eight and 
metabolic risk nearly 50 years later (Richards et al., 2009).  The authors of this 
article suggested that the closer cognition and health outcomes are measured 
proximally to one another, the stronger an association is likely, due to common 
lifecourse influences. This implied that the non-attenuated effect reported from the 
Vietnam veterans’ study of 20 year-olds, with 18-year follow-up, was less likely a 
direct association between cognition and metabolic risk, but rather a product of 
confounding. However, an alternative explanation is possible for the effects reported 
by Richards et al.; that is, given that the study’s education and intelligence test scores 
correlated highly (r = .57) the importance of education in the model may have been 
an artefact of statistical overadjustment (Christenfeld, Sloan, Carroll, & Greenland, 
2004). In the present study, using cognitive processing measures that held weaker 
associations with education in all three aged cohorts (r in the range -.28 to -.06) 
reduces the likelihood of overadjustment, making education an unlikely proxy for 
premorbid cognition. However, due to the closer proximity between the 1972 
cohort’s reaction time recordings and the end of their compulsory school term, there 
may be a greater chance that the small attenuation by education in the present study 
was due to confounding rather than mediation. That is, educational experience prior 
to age 16 may have contributed to both age 16 reaction times and age-36 metabolic 
risk, thus causing their indirect association.  
To date however there remains little evidence as to whether educational 
experience may impact on processing speed at a population level, whereas there is 
rather more evidence that schooling can impact on psychometric intelligence 
performance (Deary & Johnson, 2010; Richards & Sacker, 2011). Reaction time-type 
tasks are not part of educational training, unlike pencil-and-paper testing—exposure 
to which could be part of improving IQ-test scores. However, whereas differential 
exposure to computer-assisted learning, or computer games, may theoretically affect 
individual differences in processing speed in present day, when the youngest 
participants from the Twenty-07 study were being educated in the late eighties, there 
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would have been limited exposure to information technology within or out with the 
classroom, for training effects to be of concern.  
Another difference between the 1946 British Birth Cohort study and the 
present Twenty-07 study is in the prevalence rates of MetS. In the former metabolic 
syndrome was estimated at 21% among 53 year-olds. In comparison, and under the 
same criteria, I observed a rate of 37% among 56 year-old Glaswegians in the present 
study. This may have contributed to the different attenuation effect of education 
between the two studies. Of course another difference is that highest educational 
qualification was adjusted for in the Richards et al. study, whereas in the present 
study I adjusted for the total number of years in education.  
 
Cognition to metabolic risk: Unexplained variance 
 
I found little evidence for reverse causation (according to the variables 
available) in the forward association between baseline processing speeds and 
metabolic risk after two decades. Beyond partial attenuation by socioeconomic status 
at baseline and follow-up, direct effects between RT measures and metabolic risk 
were still observable in some models within the younger cohort. If all possible 
covariates were accounted for in the present study’s models, then alternative 
explanations, including system integrity theory, remain a plausible explanation.  
By extracting a single component from the constellation of metabolic system 
variables, thus optimising the variance in the data (rather than restricting it to a 
dichotomous variable comprised of arbitrary cut-offs – see Kahn, Buse, Ferrannini, 
& Stern, 2005), the number of significant effects in adjusted models were increased, 
including among the 1952 cohort. This methodological approach was used in the 
only study so far to consider MetS as a mediator in the association between 
psychometric intelligence and CVD-related mortality. The authors reported that a 
metabolic component explained 32% of the association, relative to a model where 
MetS was adjusted for and accounted for only 12% (Batty, Gale, et al., 2008). 
Clearly therefore, allowing for continuous variation in biological risk is informative 
to a field such as cognitive epidemiology, whether it ultimately reflects underlying 
system integrity or lifestyle factors. This approach is also consistent with the 
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construct of allostatic load, a single statistical continuous component that may 
explain dysregulation (or physiological instability) of multiple biological systems in 
response to psychosocial stressors, which include the metabolic syndrome and 
immune biomarkers. Allostatic load has been shown to have optimal predictive 
validity for morbidity and mortality risk, particularly cardiovascular-related risk, 
relative to separate system components (Juster et al., 2010; McEwan, 1998).  
An underlying biological explanation for the association between processing 
speed and the metabolic component might be informed by differential effect sizes 
from the four reaction time tasks. For example, if choiceRT is more reflective of 
neuronal integrity than simpleRT performance (Penke et al., 2010) one might have 
expected relatively stronger effects of choiceRT with metabolic risk. Although 
choiceRT variables were associated with metabolic risk in basic models of the 1972 
cohort, only the effects of simpleRT measures were robust against all covariates, 
particularly simple RT sd. In contrast, in contemporaneous associations at wave5 
both choiceRT measures were associated with the metabolic component at 36 and 56 
years of age, after adjustment for respective reaction time performances 20 years’ 
earlier. This latter observation might either indicate lifecourse influences impacting 
neuronal and metabolic cellular processes in parallel, without necessarily direct 
linkage through antecedent system integrity, or, that alterations in the metabolic 
system are causal of processing speed slowing.  
Collectively the aforementioned results could indicate that choiceRT is a 
closer indicator of alterations in neuronal integrity with ageing, relative to simpleRT 
performance that may be a more reliable indicator of premorbid cognition and 
neuronal integrity. Despite the low stability of simple RT sd, this processing speed 
measure was found to account for the majority of the association between age 11 
intelligence test scores and an indicator of brain white matter integrity at age 83—
centrum semiovale FA—leading the authors of this study to suggest that “efficiency 
of simple information processing might act as an intermediate phenotype” (Deary, 
Bastin, et al., 2006, p. 509), between psychometric intelligence and neuronal 
structure. The differentiation between simple and choice RT performances, in 




Recent evidence suggests that differentiating between mean and variance 
measures of processing speed performance might also be informative to 
understanding associations with metabolic health. Mean reaction time compared to 
intraindividual variability, shows greater impairment in patients with type 2-diabetes 
relative to controls (Whitehead, Dixon, Hultsch, & MacDonald, 2011)—perhaps 
evidence for a bidirectional association between cognition and metabolism, mediated 
by glucose control (Stranahan & Mattson, 2011). However, in the present study’s 
1972 cohort, simpleRT speed and variability performed similarly in their significant 
associations with the metabolic component (while in fully-adjusted models both 
choiceRT variables performed similarly to each other in their lack of relatedness to 
metabolic risk). Furthermore, HbA1c showed the lowest component loading of all 
risk factors in principal components analysis, albeit it was still substantial. However, 
this suggests that average performance speeds and consistencies do not appear to 
differentially relate to the metabolic system perhaps quite as much as simple versus 
choiceRT tasks might.  
Given that the variables loading most highly on the metabolic component, 
including triglycerides, cholesterol and waist circumference, may reflect excess 
dietary fat intake and level of sedentary lifestyles, it is perhaps surprising that effect 
sizes between simpleRT and metabolic risk, particularly in the youngest cohort, were 
attenuated by about a quarter only, in fully adjusted models that attempted to control 
for physical fitness and socioeconomic indicators (that co-vary with lifestyle 
behavioural factors). That significant effects remained, albeit they were small 
(explaining between 1% and 4% of total variance), leaves open the possibility of 
alternative explanations to account for these effects.  
   
Strengths 
 
There are several strengths of the present study, most of which echo those of 
the previous chapter.  
First, this study design is novel in testing for the first time the forward 
association between processing speed and metabolic system risk.  
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Second, use of less culturally biased reaction time tasks that may be closer in 
reflecting neuronal integrity relative to IQ performance scores, is a more effective 
way of testing system integrity theory to explain the cognition-to-metabolic link. 
Whereas education is often proffered as the confounder in intelligence-health 
associations, that significant effect sizes were observed for associations between 
reaction times and cardiometabolic risk suggests that this is an inadequate 
explanation by itself; education mediated some of the association, but a direct 
association remained in fully adjusted models.  
Third, the follow-up of 20 years between cognitive performance and 
metabolic system outcome is a considerable time interval and, particularly in the 
youngest cohort that was 16 years’ old at baseline, the likelihood of reverse causation 
is reduced.  
A fourth strength is that the data allowed an investigation of the association 
within three distinct age cohorts, exposed to different educational and social 
influences, but which can be compared to one another. Observing different—and in 
some cases opposing—effect sizes for the association between cognitive 
performance and metabolic risk is enlightening, not only about the way their 
transactional relationship may shift with age, but also about the importance of 
considering sampling bias in the interpretation of findings. Comparing the rates of 
attrition of the youngest compared to the oldest cohorts (the latter representing one 
third of the original cohort), of participants recruited at the same time under the same 
testing conditions, for example, is revealing about how these groups differ in their 
representativeness. By including a weighting in the model to account for attrition 
among survivors at wave5, it was possible to reduce this element of bias, which 
otherwise may have inflated the effect sizes; whereas the previous two studies 
investigating psychometric intelligence and metabolic syndrome did not account for 
attrition effects (Batty, Gale, et al., 2008; Richards et al., 2009). However, this 
weighting did not account for non-survivors, which would have differentially 






 Interpretation of the present findings must be balanced with the weaknesses 
of this study design.  
First, two out of three of our cohorts were adults at baseline, and therefore 
significant confounding may have impacted on the effects observed in these two 
older age groups. However, there is some evidence at least to suggest a lack of 
differential ageing effects on processing speed throughout the lifecourse; that is, in 
the Lothian Birth Cohort study, interindividual variances in simple and choice 
reaction times at age 70 were largely accounted for by individual differences in 
psychometric intelligence test performance at age 11 (Deary, Johnson, et al., 2010). 
This may not be the case however for metabolic risk parameters, which may be more 
differentially affected by lifestyle risk factors and prescription drug treatments, 
within populations. That the two cohorts were older however revealed differential 
effects of age on attrition, as has been discussed.  
Second, in the absence of data on metabolic risk variables at baseline, 
interpreting direction of causation between cognition and the metabolic system is 
more limited. Nevertheless attempts were made to control for confounding and 
reverse causation at least, by adjusting for baseline covariates. I could not account for 
diet or alcohol in the present study and how these might explain cognition-to-
metabolic risk associations seems an important area for further investigation.  
Third, it was necessary to exclude a disproportionate number of women to 
men from the analysis, particularly in the younger cohorts, due to factors known to 
influence blood results, such as pregnancy. Therefore results may be weakened by 
this lack of representation of women.  
Finally, multiple testing may have incurred type 1 error in some of the effect 
sizes observed, as discussed in the previous chapter, and therefore associations where 
more than one reaction time variable was significantly associated with the metabolic 
outcome, should be given greater precedence.  








The association between premorbid cognition and later risk of MetS in 
adulthood is not limited to higher-level reasoning abilities; that is, similar effect sizes 
are observed for simpleRT tasks and metabolic risk. Socioeconomic factors and 
covarying lifestyle behaviours may explain a moderate proportion of the effect; 
although there is variance left to explain, allowing perhaps for plausibility of 
underlying system integrity. These findings from the Twenty-07 study highlight the 
importance of considering cognition-metabolic associations in earlier life, without 
which, effects reported from cognitive ageing studies may be over inflated and/or 
wrongly interpreted.   
 
 195 
Table 7.1 Adjustments to physiological risk factors according to medication use. 
 
  
Risk factor Medication Adjustment Reference 
Blood pressure anti-hypertensive ↑ 10mmHg Tobin, Sheehan, Scurrah, & Burton (2005) 
 
HDL-cholesterol  beta blockers ↑ 10% Weir & Moser (2000) 
 
HbA1c diabetic medication  
 
↑ 1% Kinshuck, Lamb, & Griffiths (2011) 
 
 
Note. Diabetic medication includes insulin or oral anti-diabetics.
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Table 7.2 Descriptive statistics for reaction time variables and covariates, by MetS group.  
 
 1972 cohort  1952 cohort  1932 cohort  
 No MetS MetS p No MetS MetS p No MetS MetS p 
N (%) 565 (79.5%) 146 (20.5%)  475 (62.7%) 283 (37.3%)  217 (67.6%) 104 (32.4%)  































Wave1 cognition          
SimpleRT m 290 (54) 295 (65) .399 306 (68) 315 (84) .199 336 (105) 329 (82) .782 
SimpleRT sd 69 (41) 79 (63) .099 64 (35) 67 (48) .507 80 (50) 80 (67) .491 
ChoiceRT m 565 (67) 579 (75) .037 610 (74) 618 (87) .565 709 (88) 694 (83) .158 
ChoiceRT sd 110 (30) 116 (34) .031 111 (28) 112 (30) .231 127 (36) 123 (29) .434 
AH4       29.6 (11.7) 31.3 (10.9) .298 
Wave1 covariates          




















































WHR 0.85 (0.07) 0.87 (0.07) .008 0.87 (0.08) 0.89 (0.09) < .001 0.86 (0.08) 0.87 (0.08) .558 
Heart rate 72.8 (10.0) 73.1 (10.0) .744 70.2 (9.5) 71.8 (9.9) .022 70.7 (8.8) 71.6 (9.9) .408 
Education, yrs 14.2 (3.2) 13.3 (3.0) .002 13.0 (3.3) 12.2 (3.0) < .001 10.5 (2.6) 10.8 (3.1) .262 

















































Current smoker 147 (26.0%) 44 (30.1%) .317 120 (25.3%) 77 (27.2%) .555 36 (16.6%) 11 (10.6%) .154 
Heart rate 64.9 (10.1) 70.7 (10.1) < .001 64.8 (10.6) 68.5 (10.8) < .001 64.3 (10.6) 66.7 (11.6) .063 
Contraceptive-use 40 (12.5%) 7 (11.3%) .322       
HRT-use    28 (10.3%) 13 (9.0%) .444    
 
 
Note. Values are M (and SD) for continuous variables; N (and %) for ordinal variables. HRT = hormone replacement therapy; SES = socioeconomic status; WHR = waist-to-hip ratio.  
a 
Independent samples t-tests compared ‘no MetS’ versus ‘MetS’ groups on continuous variables. Pearson’s chi-square compared these groups on categorical variables, including sex, current 
smoker, contraceptive-use, and HRT-use. ANOVA compared SES groups.  
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Table 7.3 Odds ratios for (and 95% CI) for MetS risk, predicted by baseline reaction times. 
 
 1972 cohort   
 
N = 716 to 719 
 1952 cohort   
 
N = 748 to 752 
 1932 cohort   
 









































p = .050 
 0.90  
(0.80, 1.02) 
 












p = .337 
 1.07  
(0.91, 1.25) 
 




p = .414 
1.49  
(1.19, 1.87)  
 





















p = .169 
 0.93  
(0.82, 1.06) 
 












p = .670 
 1.05  
(0.88, 1.24) 
 




p = .512 
1.47 
 (1.16, 1.87) 
 





















p = .494 
 0.94  
(0.83, 1.07) 
 













































p = .328 
 0.95  
(0.83, 1.08) 
 




























p = .001 
 
Note. Values are odds ratios (and their 95% confidence intervals); those in bold are statistically significant (p < .05). All models include an inverse probability weighting to account for attrition bias. Reaction time 
variable scores were reversed, so that lower values indicate slower and more variable performance. Model 1 is adjusts for sex, age at wave1, and wave5 dummy variables (oral contraceptive use in 1972 cohort; 
HRT use in 1952 cohort); Model 2: Model 1 + baseline CVD covariates; Model 3: Model 2 + education; Model 4: Model 3 + wave5 CVD covariates (excl. WHR). CVD covariates are current smoking, occupational 
status, heart rate, waist-to-hip ratio; m = mean RT speed; sd = RT standard deviation. There were no issues of multicollinearity. 
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Table 7.4 Principal components analysis of 5 metabolic risk variables. 
 
 
Birth cohort Component Loading Scree 
    
1972 
 
KMO = .73 








Triglycerides   
LDL cholesterol   
Waist circum  
HDL cholesterol  















KMO = .60 








Triglycerides   
HDL cholesterol  
Waist circum  
LDL cholesterol   












KMO = .60 








Triglycerides   
HDL cholesterol  
Waist circum  
HbA1c   















Table 7.5 Regression coefficients (and 95% CI) for associations between baseline reaction times and the metabolic component after 20 years. 
 
 
 1972 cohort   
N = 700 to 703 
 1952 cohort   
N = 750 to 754 
 1932 cohort  
N = 325 to 326 

















p < .001 
 .087  
(.015, .158) 
 












p = .882 
 -.019  
(-.008, .070) 
 














































































p = .034 
 .052  
(-.019, .123) 
 













































































p = .207 
 
 
Note. Values are unstandardised regression coefficients (and 95% CI). Those in bold font are significant (p < .05). Higher RT values are slower (m) and more variable (sd). All models are weighted for attrition. CVD covariates 
= smoking, occupational status, heart rate, waist-to-hip ratio. 
Model 1 adjusts for sex, age at wave1, and wave5 dummy variables (oral contraceptive use in 1972 cohort; HRT use in 1952 cohort) 
Model 2: Model 1 + baseline CVD covariates 
Model 3: Model 2 + education 
Model 4: Model 3 + wave5 CVD covariates (excl. WHR) 
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Table 7.6 Regression coefficients (and 95% CI) for contemporaneous 




 SimpleRT m SimpleRT sd ChoiceRT m ChoiceRT sd 
1972 cohort N = 703    
Model1 
.001  [-.005, .007] 
 
p = .726 
.013  [-.005, .031] 
 
p = .145 
 .007  [.003, .011] 
 
p < .001 
.015  [.006, .023] 
  
p = .001 
Model2 
-.003  [-.008, .003] 
 
p = .352 
.010  [-.008, .028] 
 
p = .267 
.004  [.000, .007] 
 
p = .039 
.010  [.002, .018] 
 
p = .019 
1952 cohort N = 746    
Model1 
 .007  [.001, .014] 
 
p = .018 
.014  [-.005, .033] 
 
p = .139 
.007  [.003, .012] 
 
p < .001 
.014  [.004, .023] 
 
p = .004 
Model2 
.005  [-.001, .011] 
 
p = .076 
.010  [-.008, .028] 
 
p = .273 
 .005  [.002, .009] 
 
p = .004 
.014  [.005, .022] 
 
p = .002 
1932 cohort N = 479    
Model1 
.002  [-.012, .015] 
 
p = .794 
-.006  [-.041, .029] 
 
p = .726 
-.002  [-.011, .007] 
 
p = .646 
-.009  [-.030, .013] 
 
p = .426 
Model2 
.001  [-.012, .015] 
 
p = .785 
-.002  [-.037, .032] 
 
p = .918 
-.001  [-.009, .007] 
 
p = .857 
-.008  [-.029, .012] 
 
p = .465 
 
 
Note. All models include the inverse probability weight for attrition. Model1 and Model 2 match 
on sample sizes for each association. The regression coefficient is the effect of a one point 
change in the metabolic component (independent) variable in relation to a log-transformed unit 
change in the RT (dependent) variable; those in bold are statistically significant (p < .05). Model 
1 adjusts for age at wave5, sex, and dummy variables at wave5 (oral contraceptive among 1972 






 The thesis investigated the extent to which social and behavioural variables 
explain the variance in mortality or morbidity risk as predicted by premorbid 
cognitive ability. Meta-analysis that aggregated effect sizes of 16 longitudinal studies 
of baseline psychometric intelligence and total mortality-risk assessed confounding 
by parental socioeconomic status and mediation by education and adult social class. 
The study also considered potential sex differences. The close phenotypic association 
between education and intelligence variables was tested for heritability in two 
national cohorts of schoolchildren, raising the issue of overadjusted models in 
cognitive epidemiology. Further large and well-characterised longitudinal cohort 
studies were used to assess social and behavioural mediation in pathways from 
cognitive performance to cardiovascular disease (CVD) risk factors. In two of these, 
reaction times were used as alternatives to psychometric test scores, thereby reducing 
cultural bias in measuring premorbid cognition.   
 
Summary of findings 
 
IQ and all-cause mortality 
 
The first meta-analysis of individual differences in premorbid intelligence 
and adult mortality risk was completed (Chapter 2), which investigated the 
following: 1) The aggregate effect size of the unadjusted association between 
intelligence in youth and all-cause mortality risk; 2) Cohort-specific effects, 
including by age and sex; 3) Confounding by early life factors, including 
socioeconomic background; 4) Mediation explained by either adult occupation or 
educational attainment. The results reported a significant inverse association between 
psychometric intelligence in youth and mortality risk by follow-up validating the 
report of a previous systematic review on a smaller number of studies (Batty, Deary, 
Gottfredson, 2007); that is, a one SD advantage in intelligence test performance 
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related to the 24% reduced hazard of death by follow-up. The aggregate effect sizes 
relating an advantage in intelligence test performance to lower risk of premature 
mortality were equivalent for men and women, despite three individual studies 
reporting sex differences. Although it was recognised that sex differentials are 
important factors for consideration in cognitive epidemiology, particularly given 
distinct patterns of disease risk prevalence between men and women, these few 
studies also reported: 1) Cohort-specific effects, for example, a disproportionate loss 
of men with above average intelligence to war, or, 2) Low cases of mortality among 
women. In studies that adjusted for background socioeconomic status (predominantly 
using parental occupational as the control variable), there was negligible change to 
the IQ-mortality effect size. This was also true of the few studies that further 
controlled for birth weight and gestational age. The interpretation of this finding was 
that the relation of cognitive ability to mortality risk is independent of early life 
social inequality and/or birth effects, and therefore confounding is an unlikely 
explanation. 
Findings from studies that controlled for either occupational status in 
adulthood, or educational attainments however, demonstrated that the IQ-mortality 
link was significantly and partially attenuated. This was understood to support the 
idea of a forward association from cognitive reasoning ability to mortality risk that is 
mediated via these socioeconomic achievements and influences. However, the 
interpretation of a stronger attenuation effect by education, relative to occupation, 
held the caveat that overadjustment may have arisen by using a control variable that 
shares strong phenotypic covariance with intelligence performance. I observed a low 
degree of heterogeneity across the included studies’ effect sizes. However, cohorts 
followed up for longer—which also tended to be the youngest tested for 
intelligence—showed smaller effect sizes than those where mortality records were 
traced after shorter follow up. There is no single clear interpretation of this, although 
I proposed that ‘time to mortality’ would be determined by ‘cause of mortality’ that 
is likely differentially related to baseline intelligence.      
 




The behaviour genetics studies, using a novel whole-population indirect twin 
design applied to two European cohorts of elementary schoolchildren (Chapter 3 and 
Chapter 4), replicated high genetic covariance estimates of the association between 
psychometric intelligence scores and academic attainments. These were generally at 
the high end of estimates reported from the background literature, in which twin 
studies that depend on self-selection may incur bias. The findings highlight the 
difficulty of adjusting for education variables in models that include intelligence test 
scores; that is, if performance on academic achievement tasks and IQ-type tests are 
strongly associated, and that association is due to shared underlying genetic 
influence, then controlling for education in cognitive epidemiological models may 
result in some overadjustment. The finding in the UK cohort, that verbal as well as 
nonverbal reasoning tasks showed equivalent genetic covariance estimates with 
academic attainment (Chapter 3), was considered to support a theory that a general 
and heritable cognitive trait drives associations with academic skills, rather than 
educational experience causing variance in IQ-test performance, through the 
development of language skills for example. I did not replicate the previously 
reported increase in genetic covariance with age in the Dutch cohort comparing 
estimates of 8 and 12 year-old schoolchildren (Chapter 4); the unexplained drop in 
the heritability of the 10 year-old group may suggest specific age- and/or time-effects 
of shared environmental influences; unless this was due solely to large standard 
error.   
 
Cognition and preclinical CVD 
 
Release of biomedical survey data from the 1958 National Child 
Development Study, allowed for the first investigation in the literature on 
associations between childhood psychometric intelligence scores and midlife 
systemic inflammation and haemostasis (Chapter 5), measured 34 years apart. In this 
large population-representative cohort, an advantage in premorbid cognition was 
significantly associated with lower levels of inflammatory biomarkers including CRP 
and fibrinogen, thus replicating results from a study of older adults. Furthermore, 
although effect sizes were relatively smaller, higher premorbid ability also 
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significantly related to lower levels of the haemostatic biomarkers, D-dimer, t-PA 
antigen, and VWF antigen. These latter findings are a novel aspect of the study and, I 
suggest, they highlight the potential for multiple mechanisms linking behavioural 
cognition to biological disease risk. Confounding by birth status and socioeconomic 
background explained only a minor proportion of these effects; the associations were 
better explained by a forward association, mediated via multiple lifestyle indicators, 
including smoking, abdominal obesity and occupational status. Nevertheless, 
cognitive reasoning ability in youth and systemic inflammation were still related 
even after accounting for all study covariates. Inferred from this was the possibility 
of underlying system integrity explaining indirect associations among behavioural 
and biological variables; that is, on the condition that reverse causation was ruled 
out. A weakness of this study was the absence of biomedical data at baseline that 
would have tested reverse causation. The study design did however allow for its 
testing in the forward association from midlife inflammation, to cognition five years 
later. The finding that baseline intelligence explained most of these effects in middle 
age highlights the need to consider the possibility of (1) Underlying system integrity 
explaining lifetime cognition-inflammation associations; (2) Bidirectional 
associations between behavioural cognition and inflammatory status influenced by 
environmental effects in early stages of adulthood.  
The final chapters make contributions to the cognitive epidemiological 
literature by reporting on cognitive processing speed in relation to CVD risk 
factors—whereas results from the background literature depend largely upon 
psychometric IQ-type test performance in relation to CVD risk. The novelty of the 
west of Scotland Twenty-07 study cohort also allowed for the possibility of assessing 
longitudinal effects in three age groups. The first study replicated the forward 
association between higher premorbid cognition (at age 16) and lower systemic 
inflammation as reported in Chapter 5, and this time measured after 20 year follow 
up (Chapter 6). The effects which were significant in men for two out of four 
reaction time variables (choice speed and consistency), were largely attenuated after 
control for baseline and follow up covariates, and I observed smoking to be a 
significant factor. However, in women lifestyle influences did not explain the 
significant effect of more consistent simple reaction time in relation to CRP, which 
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persisted as a direct effect. Faster and more consistent processing speeds among 36 
year-old men— an age when confounding was an increased possibility—related to 
lower fibrinogen 20 years later. Whereas two of these three effects were no longer 
significant after accounting for baseline smoking and occupational status, simple 
reaction time speed was not explained by either confounding or mediating factors. 
This latter finding leaves open the possibility that system integrity may explain an 
indirect association between low-level cognitive performance and blood status that 
relates to CVD risk. Unexpected reverse findings from the older cohort, 76 years’ old 
by follow up, were attributed to attrition and survival bias. In the follow up wave of 
testing, significant contemporaneous associations between systemic inflammation 
and reaction time speed and variability in the 1952 cohort, were not accounted for by 
equivalently-measured processing speeds at baseline. Therefore I suggested that, 
either cognitive processing speed is differentially affected by inflammatory status in 
middle-age, or lifestyle behaviours in the second and third decades of adulthood 
underlie indirect associations between these parameters measured in midlife.  
In the final empirical chapter processing speed in youth was associated with 
metabolic syndrome biomarkers 20 years later, replicating effect sizes of two 
previous studies that reported on psychometric intelligence in relation to this 
premorbid CVD condition (Chapter 7). The effects were more robust when I 
modelled metabolic syndrome risk as a continuous rather than dichotomous measure; 
that is, simple reaction time speed and variability at age 16 held direct associations 
with a metabolic-risk component score in fully-adjusted models that accounted for 
education, socioeconomic status, smoking, and an indicator of physical fitness. I 
suggested that the possibility of underlying system integrity explaining this 
cognition-metabolic association remains open. Although faster and more consistent 
reaction times at age 36 predicted a metabolic syndrome component score 20 years 
later, this did not survive adjustment for potential confounding effects. That 
simpleRT but not choiceRT performance in youth held associations with later 
metabolic risk, while choiceRT but not simpleRT performance at ages 36 and 56 
held contemporaneous associations with metabolic risk, implied that simple RT tasks 





Contributions to the literature 
 
The role of education in cognitive epidemiology 
 
A major theme of this thesis was to consider the role of education in 
pathways from premorbid intelligence to CVD risk factors or all-cause mortality in 
adulthood. The meta-analysis of Chapter 2 found that adjusting for education in the 
association between intelligence and total mortality reduced the effect by about half 
while it retained statistical significance. This study therefore contributes to the 
literature (Calvin, Deary, et al., 2011) in showing independent effects of intelligence 
differences on mortality risk after considering education, whereas cognitive 
influences in epidemiology and health psychology have sometimes been overlooked, 
considered mere proxies for social inequalities related to health (Lubinski, 2009; 
Lubinski & Humphreys, 1997).  
Nevertheless the partial attenuation effect by education is also an important 
finding, and is the most consistent and substantial reported in cognitive 
epidemiology, and relevant to studies that predict a diverse range of health outcomes 
(as outlined in Chapter 1). Given that inclusion criteria for the meta-analysis required 
that cognitive ability be measured in youth as an indicator of premorbid intelligence, 
and, with the knowledge that individual differences in childhood intelligence remain 
highly stable throughout adult life (Deary et al., 2000), mediation was the likely role 
of education in this pathway. That is, higher cognitive performance leads to greater 
success in academic tests (Deary et al., 2007), spending longer in learning 
establishments, and, finally achieving higher educational qualifications; and through 
these experiences a healthier and longer lifespan is ensured. A proposed mechanism 
is that education reinforces health literacy and engagement with public health 
messages, thereby affecting personal health risk assessment, behaviour and 
management (Torssander & Erikson, 2009).  
However, there is the possibility that education is also a partial confounder in 
IQ-mortality pathways, particularly given that half the studies in the meta-analysis 
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tested cognitive ability beyond the age of compulsory school education. Therefore, 
educational fulfilment took temporal precedence to the intelligence performance 
measure, thus increasing the chance of reverse causation between these two measures 
(Bhopal, 2008) and confounding of the intelligence-mortality effect.  
 
A cautionary tale 
 
The potential for bidirectional associations between academic and 
intelligence test performance is accepted in cognitive epidemiology (Deary & 
Johnson, 2010; Richards & Sacker, 2011), particularly with recent evidence that time 
spent in education can affect intelligence test performance in later youth (Brinch & 
Galloway, 2012), just as studies previously accumulated that IQ tests predicted 
educational outcomes. This thesis therefore raises the importance of interpreting 
findings in relation to mediation or confounding with sensitivity to cohort age at 
different waves of follow-up, and the temporal positioning of education and 
cognitive variables.  
Although mainly cross-sectional associations between academic achievement 
and intelligence tests were the subject of Chapters 3 and 4, the need for age- and 
time-sensitivity in interpreting their association was highlighted by the age-
differential effects in the Dutch cohort, a transient period at age 10 where seemingly 
persistent high genetic covariance between traits in childhood was replaced by strong 
shared environment effects (albeit with large standard errors).  
Within this age range at elementary school there was also an indication 
among British schoolchildren that an underlying trait for intelligence drove the high 
genetic covariance with academic achievement, given that different domains of 
cognitive ability were similar in the magnitude of their genetic association with the 
educational component. If on the other hand attained knowledge had caused 
individual differences in intelligence test scores at this age, one might have expected 
stronger shared environmental associations between academic performance and 
verbal reasoning skills, relative to nonverbal reasoning skills, for example. This was 
not evident.  
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The observations from the behaviour genetics analysis of this thesis should be 
heeded in cognitive epidemiology. That is, when cognitive and educational measures 
are assessed, in childhood at least, their strong association will more often than not, 
be largely driven by genetic effects, and therefore including both variables as 
predictors in pathway models may lead to statistical overadjustment. One 
interpretation of the high genetic overlap between these two tests is that, at this age at 
least, academic and intelligence tests are more proxy measures of each other than 
assessments of independent abilities. However, recent factor analysis of individually-
administered academic and intelligence test scores throughout childhood show that 
these extensive data consistently result in two distinct and separate constructs, of 
acquired knowledge and general reasoning ability respectively (Kaufman, Reynolds, 
Liu, Kaufman, & McGrew, 2012).  
 
On reducing risk of overadjusted models 
 
The independent effect of cognitive ability on health outcomes, on accounting 
for educational influence, was reinforced in Chapters 6 and 7 where faster and more 
consistent reaction time performance in youth were associated with reduced 
inflammation and metabolic syndrome risk in adulthood, after controlling for 
education, which has also been related to these outcomes (Gimeno, Ferrie, et al., 
2008; Langenberg et al., 2006). The risk of overadjustment by education would have 
been minimised due to lower correlations between processing speeds and education, 
relative to those for psychometric intelligence and education, as well as performance 
on these tests carrying low cultural bias.  
The effects of processing speed on later inflammatory and metabolic risk 
make novel additions to the literature, which has largely focused on the reverse 
temporal ordering of these variables. Furthermore, given reports from large and well-
characterised cohort studies that education entirely mediates the association between 
psychometric intelligence and metabolic syndrome (Richards et al., 2009), obesity 
(Chandola et al., 2006), and coronary heart disease (Lawlor et al., 2008), the study 
reported in Chapter 7 challenges how generalisable these findings might be. 
Although the behavioural risk factors for metabolic syndrome are likely mediated via 
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educational and social experiences, there exists the possibility that direct effects 
persist between intelligence and later health risk, which may find root in system 
integrity and/or early life influence. Such influences are addressed in sections below.  
 
Beyond socioeconomic influence 
 
The potential for socioeconomic status to confound or mediate intelligence-
health risk pathways was investigated in four chapters of this thesis, by controlling 
for parental occupation and study member’s occupation respectively.  
 
Differential effects of confounding 
 
In Chapter 2, early life socioeconomic status—which as well as indicating 
financial resources, may be a partial proxy indicator for heritable intelligence and 
parental health status—contributed negligible variance in mortality risk explained by 
intelligence differences across nine studies. In the association between childhood 
intelligence and midlife inflammation reported in Chapter 5, SES at birth explained 
from a quarter to almost a half. Along with smoking status at baseline, SES 
attenuated effects of faster and more consistent choice reaction times and lower 
inflammation by about two thirds (Chapter 6), and its unique contribution was about 
a third. Similar attenuation effects by parental occupation were also observed in 
Chapter 7, particularly for associations between premorbid choice reaction times and 
metabolic syndrome risk; significant associations between simple reaction time 
measures and metabolic risk were attenuated by baseline social status, but to a lesser 
degree.  
It is therefore difficult to generalise from these findings as to the extent to 
which background socioeconomic influences confound associations in cognitive 
epidemiology. It could be argued that cognitive and social variables that are 
measured more proximally to one another (e.g. Chapters 6 and 7) will carry stronger 
associations, relative to those that are temporally distant (Chapter 5), thus 
contributing to different degrees of attenuation. An alternative explanation is that 
SES may be a greater confounder in effects of reaction time on health outcomes, 
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relative to psychometric intelligence, given that early life social inequalities relate to 
individual differences in neural development (Hackman, Farah, & Meaney, 2010), 
which processing speeds may better reflect. Nevertheless, that I did not find baseline 
or antecedent parental socioeconomic status to fully account for the effects of 
cognition on health outcomes again highlights the important role of human trait 
individual differences in epidemiology beyond social inequalities, which Lubinski 
and Humphreys (1997) have advocated.    
 
Mediation by social attainment 
 
Socioeconomic status was also found to be a partial mediator of cognition-to-
health risk associations in this thesis. Occupational status of study members in 
adulthood explained a third of the IQ-mortality aggregate effect (Chapter 2); it 
explained over half of associations between childhood intelligence and midlife 
inflammatory and haemostatic biomarkers (Chapter 5); and in associations between 
choice reaction times in youth and a metabolic syndrome component 20 years later 
(Chapter 7), SES and covariates mediated the effects to non-significance. However, 
work occupations in adulthood explained to a far lesser extent the association 
between simple reaction times in youth and later metabolic risk, in this final 
empirical chapter, and made little dent to the effect sizes from Chapter 6, which 
related simple reaction times to later systemic inflammation, although many of these 
effects had already been fully accounted for by baseline-adjusted models.  
It is possible therefore, that choice reaction times, which are more strongly 
related to intelligence test performance compared to simpleRT (Deary, Der, & Ford, 
2001), may be mediated by social inequalities to a larger extent in their relation to 
health outcomes, than their more basic counterparts. These are among the first 
studies to test these associations among socioeconomic status, processing speeds and 
CVD biomarkers however; therefore interpretations remain tenuous until findings 
may be replicated. 
 




The kinds of health behaviours tested for mediation (and confounding) in 
cognitive epidemiology will be determined by their role as risk factors for specific 
morbidities. It was therefore not possible to assess aggregate effects of behavioural 
mediation in the meta-analysis, given the heterogeneous range of covariates in 
individual studies predicting all-cause mortality. The health behaviours that are risk 
factors for CVD—a specific outcome of interest in this thesis—include smoking, 
physical non-activity (or sedentary lifestyle), diet that includes high saturated fat and 
total cholesterol intake, and excess alcohol consumption. The majority of these were 
considered in pathways from cognition to inflammation, haemostasis, and metabolic 




I observed substantial mediation by smoking in the associations between 
premorbid cognition and adult inflammatory status in the two studies from Chapters 
5 and 6. In the 1958 National Child Development Study, current smoking status, 
tested as a mediating covariate at age 42 years, attenuated by over half the 
association between age 11 psychometric intelligence and age 46 systemic 
inflammation.  In the Twenty-07 study baseline smoking alone attenuated by a third-
to-half the associations between age 16 choice reaction times (speed and variability) 
and age 36 systemic inflammation; although as analyses in Chapter 6 were by sex 
group, this effect of smoking was restricted to men. I suggested that the sex 
differential effect of smoking on inflammatory status (Onat et al., 2008; The 
Fibrinogen Studies Collaboration, 2007) might explain this. Although in this latter 
study smoking was assessed at the same time as baseline cognition, it was supposed 
that the effects of smoking on the cognition-inflammation association was more 
likely due to mediation than confounding; for one, smoking in childhood (in the 
short-term) was unlikely to have caused adverse changes to processing speed. These 
attenuation effects by smoking are strong, relative to studies reporting more modest 
attenuation effects in associations between intelligence differences and later all-cause 
mortality (Batty, Shipley, Mortensen, Boyle, et al. 2008; Jokela, Batty et al., 2009), 
and are therefore revealing about the specific mechanistic pathways that lead from 
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cognition through excess circulatory inflammation to specific CVD morbidities, 
although such pathways still require formal testing. It has already been reported that 
cognitive reasoning ability is predictive of smoking; that is, those with higher 
reasoning abilities are relatively infrequent cigarette smokers (Batty, Deary et al., 
2007b; Batty, Deary et al., 2007c; Taylor et al., 2003). However, this is the first 
report to show that smoking is a significant mediator in cognition-to-inflammation 
pathways; a consistent finding whether premorbid cognition is measured by 
psychometric or experimental testing.  
On the other hand, the pathway from cognition to metabolic syndrome risk 
was not explained by smoking status, in Chapter 7. Smoking, along with other health 
behaviour indicators including heart rate and waist-to-hip ratio, were controlled for at 
baseline to account for confounding and/or reverse causation, but these did not 
explain the significant associations observed. Neither did smoking or heart rate (a 
proxy measure for physical activity) suggest mediating effects from cognition to 
metabolic syndrome risk in the Twenty-07 cohort. Only socioeconomic status 
partially attenuated the effect at baseline and follow-up respectively. The variance in 
the effect of occupational status may conceal other health behaviours—such as 
dietary factors and/or alcohol consumption—that could provide a more accurate 
picture of mediation pathways, and it is suggested that these be included in future 
studies.    
 
Indirect evidence for system integrity 
 
System integrity theory was introduced by Whalley and Deary (2001), as an 
explanation (not necessarily an exclusive one) for observations between cognitive 
traits and health outcomes. Yet the search for an elusive underlying biological trait 
remains a challenging proposition. There may be direct means to test system integrity 
via exploratory molecular genetics research. Perhaps more convenient, by use of 
easily accessible data, are the indirect approaches adopted in this thesis. 
First, if associations between premorbid intelligence and disease-risk or 
mortality could not be fully explained by all potential confounding and mediating 
variables, and that reverse causation was unlikely, then system integrity remains a 
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possible explanation. I found evidence to support this from several empirical 
chapters of this thesis (Chapters 2, 5, 6, and 7). For example, in the 1958 National 
Child Development Study childhood intelligence was significantly inversely 
associated with adult systemic inflammation in fully-adjusted models; in the Twenty-
07 cohort simple reaction time (but not choiceRT) measures retained significant 
associations (in some cases) with later inflammatory biomarkers and a metabolic 
component, again in fully-adjusted models. In light of this observation I proposed in 
Chapter 7 that simple reaction time might be a more reliable indicator of a latent trait 
for system integrity than choice reaction time—the latter being more effective in 
measuring lifetime insult-related neurological changes in human ageing studies.  
Second, several indicators of system integrity have been proposed (Gale, 
Batty, et al., 2009), and one of these, tested here, was cognitive reaction time— 
although before this thesis, its forward association with later health outcomes had 
only been investigated in adult-aged cohorts (Deary & Der, 2005; Shipley et al., 
2006), and may therefore have been subject to attrition bias, ageing-effects, and/or 
morbidity-related effects, as suggested for the older age cohort of the Twenty-07 
study. Chapters 6 and 7 considered the plausibility of this low-level cognitive 
indicator of a latent system integrity trait, measured in youth, to predict disease 
biomarkers at extended follow-up to adulthood. Both studies found equivalent effect 
sizes to those where psychometric intelligence in youth has been the predictor. 
Unfortunately the Twenty-07 study does not have intelligence test scores from youth 
that might have tested system integrity more robustly; that is, to test whether simple 
reaction time performance (the intermediate phenotype) would fully account for 
associations between psychometric intelligence and metabolic syndrome risk. 
Nevertheless, as processing speed is considered to be intermediate of neuronal 
integrity and higher-level cognitive reasoning capabilities (Deary, Bastin, et al., 
2006), to find significant associations between processing speed measures and 
biomarkers is to step closer to a system integrity proposition in cognitive 
epidemiology.    
That direct associations were observed between cognitive processing speed 
and continuous measures of inflammation and metabolic function is compatible with 
the concept of allostasis, a neurobiological process where there are “…bidirectional 
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patterns of communication between the brain and the autonomic, cardiovascular, and 
immune systems via neural and endocrine mechanisms” (McEwan & Gianaros, 
2010, p. 190). That these existed after accounting for social and behavioural stressors 
in adulthood, suggests that some of the observations reported in cognitive 
epidemiology may have a biological underpinning, either explained by system 
integrity (realised at conception) or environmental stressors in earlier life, or perhaps 






A major issue in all epidemiological research is the elusive confounding 
variable or set of variables left unaccounted for in analysis of longitudinal data. I 
addressed this in several of the empirical chapters of this thesis (Chapter 2, 5, 6, and 
7), by statistical control of birth weight and gestation, socioeconomic status in early 
life, smoking, heart rate, and/or waist-to-hip ratio. Many of these were collected at 
baseline, contemporaneous with premorbid cognitive measures, when potential 
confounding effects could be inferred at best. However, there remains a need in this 
field to consider events of childhood or earlier, which could account for indirect 
associations between cognition and health. System integrity may be the most 
antecedent of confounders, implying a genetic basis determined at conception. There 
are however, early life exposures in utero, at birth, and postnatally, that could hold 
the key to understanding these later adult associations (Thompson et al., 2010), 
influencing both neurodevelopment and subsequent cognition, and, the susceptibility 
of later life chronic disease (Gluckman, Hanson, Cooper, & Thornburg, 2008). Such 
exposures include nutritional status, maternal stress, maternal disease or infection, 
and/or impacts of adverse psychosocial experience. Longitudinal studies that begin 
selection in the antenatal period of life would be the ideal study design in which to 
investigate these factors (Thompson et al., 2010 include a list of such cohorts), as 
long as the resources exist to then follow up these individuals throughout their 
lifespan, or at least link them to later adult morbidity records. However, no one study 
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design offers the ideal blueprint to test all confounders, unless personnel and 
financial resources, and participant compliance, are unlimited. Collective evidence 
that addresses the plausibility of confounding between variables is therefore useful—
as in the study of education’s role in cognitive epidemiology—and various 
methodologies may contribute to this evidence; for example, behaviour genetics 




The potential for reverse causation is a related issue to confounding, in the 
empirical studies of this thesis. Although it was possible to test for reverse causation 
of the forward association between disease biomarkers (inflammation and 
haemostasis in Chapters 4 and 6, and metabolic risk in Chapter 7) and cognition, by 
adjusting for earlier cognitive performance, it could not test it in the opposite 
direction. That is, biomarker data were not available at baseline or earlier, to control 
and test whether a forward association between cognition and biological risk (as 
interpreted from the temporal ordering of these variables) remained robust. Ideally 
such biomarkers would be tested at the earliest ages possible, in the kind of study 
design proposed to also test for confounding. However it is noted that variances in 




There is also the possibility that large cohort studies yield greater numbers of 
false positive findings, and which have very little utility for policy or practise 
translation (Thompson et al., 2010). At least replication studies provide the 
confidence that findings are not merely products of chance alone, as I showed in the 
meta-analysis of this thesis. Although the twice observation that higher premorbid 
intelligence predicted lower risk of later metabolic syndrome was replicated using an 
experimental cognitive measure in Chapter 7, it remains to be seen whether future 
studies using processing speeds would find the robust relationships to specific 




Future directions and recommendations 
 
The field of cognitive epidemiology already lays claim to a significant body 
of empirical work, although it began in earnest about a decade ago (Batty & Deary, 
2004; Whalley & Deary, 2001) or more (O’Toole et al., 1988). In testing out the 
various theories as to why higher premorbid intelligence test scores should confer 
protection from premature mortality in adulthood (Deary, 2008), pre-existing 
longitudinal cohorts have largely been used, with progress in testing some theories 
more than others; for example, the role of lifetime social and behavioural factors that 
help explain the association. My thesis predominantly contributes to this latter 
interest. The work in earlier sections validated some key findings in the field, such as 
the lesser role of early socioeconomic status in explaining the IQ to all-cause 
mortality association, but partial mediation via educational opportunity and 
socioeconomic attainment. Furthermore, it reported on novel empirical work 
investigating mechanisms of association between premorbid cognition and later 
preclinical stages of CVD—specifically inflammation and metabolic syndrome—
identifying significant contributions from social inequalities (common to all 
outcomes) and smoking (specific to inflammation). As well as exploring social and 
behavioural influences however, the latter empirical chapters also reported 
unexplained variance. The various theories linking intelligence to health outcomes 
require further consolidation however, and some in particular (e.g. system integrity 
and early life confounding) require greater research investment before they can be 
properly tested.  
 
Further testing of integrity biomarkers 
 
Given evidence of significant associations between processing speed 
performance and brain imaging biomarkers, and that reaction times measured in 
youth predicted adult CVD biomarkers in this thesis, it is recommended that future 
longitudinal cohort studies consider further use of reaction time tasks (within a 
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premorbid age range), among other potential indicators of an underlying system 
integrity trait, for testing in cognitive epidemiology. Alternative measures were 
described in Chapter 1, and include the stress hormone cortisol, and indicators of 
physical fitness. This endeavour may be particularly relevant to models predicting 
CVD morbidities, where there exists biological plausibility for system integrity to 
underlie cognitive and vascular processes. Furthermore, the two putative biomarkers 
of disease related to reaction times in this thesis—inflammation and metabolic 
syndrome component—belong to a wider network of biomarkers that comprise 
allostasis (Juster et al., 2010). To investigate premorbid cognition in relation to an 
allostatic indicator—each measured ideally at various time points over the 
lifecourse—would further enlighten directions of association between cognitive 
performance and adult health status. This would involve collection of more extensive 
biomarker data, including stress hormones and alternative inflammatory measures 
(e.g. interleukin-6), which would potentially capture greater accuracy in disease risk-
burden from both genetic and environmental exposures. Such work would contribute 
not only to theoretical understanding in cognitive epidemiology but to scientific 
understanding of cognitive and biological exchanges in ageing processes, with 
ultimate translation to health policy.  
 
Understanding specific mechanisms of health behaviour 
 
As reported in this thesis however, there are likely to be multiple mechanisms 
by which premorbid intelligence relates to later mortality, varying in their strength 
according to the specificity of disease or cause-related death. To take childhood 
cognition and later CVD-risk as the example from this thesis, there are social, 
behavioural, and likely biological contributions to this pathway, based on the data 
presented, with varying degrees of their influence depending on subtype of CVD.  
If lower intelligence performance in youth is partially predictive of excessive 
inflammatory status in later life because of the increased likelihood of smoking, then 
it is of public interest to understand the differential effects of cognition on taking up 
and persisting in this adverse health behaviour. Government policy in democratic 
societies may only do so much—by restricting the convenience of smoking in public 
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and regulating marketing policy—to reduce its burden on public health care and 
expenditure. As socioeconomic indicators often mediate the association between 
psychometric intelligence and smoking status (Modig & Bergman, 2012), it remains 
to be seen whether this is an effect of confounding and/or mediation.  
Furthermore, the finding in this thesis that smoking mediated the effect of 
reaction times on inflammation in men, but not women, is interesting and novel. 
Although the meta-analysis found no sex difference in IQ-total mortality effect sizes, 
sex effects should continue to be assessed, given the distinct behavioural and 
biological profiles of men and women as well as patterns of disease risk over time. 
Among the other lifestyle factors that the World Health Organisation 
(http://www.who.int) identifies as increasing CVD prevalence among urbanised, 
industrialised and globalised nations, are sedentary living and unhealthy diets. These 
behaviours could be considered more rigorously in future studies, if all 
environmental influences are to be accounted for in associations between cognition 
and CVD risk.  
 
A call to social epidemiology 
 
The successful application of robust epidemiological practices to large well-
characterised cohorts gives considerable validity to findings, and sets a high standard 
for continuing work in cognitive epidemiology. This should bring individual 
differences in intelligence—and with it, other psychological traits including 
personality and mood—to the attention of epidemiologists who share an interest in 
understanding pathways of influence to health inequalities, and who link with policy 
makers to affect change. It may still be common practice to put socioeconomic 
influences before intelligence differences in mapping out causal factors of disease in 
social epidemiology (Gallo et al., 2009; Marmot, 2010; Marmot & Kivimäki, 
2009)—indeed some continue to ignore the role of psychological traits altogether 
(Cullen, Cummins, & Fuchs, 2012)—yet there remains compelling evidence for the 
independent effects of cognition on health outcomes, and there continues to be drive 
towards bringing together epidemiologists and differential psychologists (Deary, 
Weiss, & Batty, 2010). To overlook individual differences in psychological traits, 
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and treat these as proxies to educational and social inequalities, will only reduce the 
utility of disease prediction models. 
 
Bringing cognitive epidemiology to cognitive ageing research 
 
A final recommendation is a methodological one and relates to the field of 
cognitive ageing research, in respect of 1) reverse causation and 2) attrition bias.  
This thesis found associations between cognition and disease biomarkers, 
detectable at preclinical stages of disease, and some contemporaneous associations in 
midlife that were partially or fully explained by cognition in youth. This highlights 
the need for researchers in ageing to consider the lifetime raft of exchanges between 
cognitive and biological factors, influenced by environmental stressors, and to take 
account of potential reverse causation when making inferences about disease impact 
on cognitive function.  
Furthermore, the potential hazards of survival and attrition bias were brought 
to the fore in the latter chapters by unexpected positive associations between reaction 
times and disease biomarkers. It is possible therefore, that among older adult 
research cohorts exist a cluster of high ability individuals apparently resilient to 
disease and ageing processes, or managing to function relatively well in spite of 
them. The impact of this form of selection bias should not be underestimated and 
may be contributing to false positive results, or indeed null associations, in the 




The main focus of this thesis was to investigate social and behavioural 
influences on pathways from intelligence differences to all-cause mortality and 
CVD-risk in the general population. Additional to this was an indirect testing of an 
alternative theory in cognitive epidemiology, that of underlying system integrity. It is 
clear that socioeconomic factors can be both confounders and mediators of the IQ-
mortality link, and can cause statistical overadjustment in models, but this thesis also 
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validates evidence of independent effects of cognition on health outcomes in addition 
to such influences. Psychometric intelligence performance and cognitive reaction 
time can predict later CVD biomarker status in healthy populations. However, routes 
of causation can still only be inferred, and future research would benefit from 
looking at the early life origins of these associations in conjunction with genetic 
influence. After all it is of interest to understand all contributory factors to disease 
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adulthood 
6 Batty, G.D., & Deary, I.J. (2004). Early life intelligence and adult health: Associations, plausible 
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16 Batty, G.D., Deary, I.J., & Gottfredson, L.S. (2007). Premorbid (early life) IQ and later mortality 
risk: Systematic review. Annals of Epidemiology, 17, 278-288.  
No empirical data 
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mortality in men: the Vietnam Experience Study. European Journal of Cardiovascular 
Prevention and Rehabilitation, 15, 359-361.  
21 Batty, G.D., Shipley, M.J., Dundas, R., Macintyre, S., Der, G., Mortensen, L.H., & Deary, I.J. 
(2009). Does IQ explain socio-economic differentials in total and cardiovascular disease 
mortality? Comparison with the explanatory power of traditional cardiovascular disease risk 
factors in the Vietnam Experience Study. European Heart Journal, 30, 1903-1909.  
IQ-mortality association unreported 
22 Bittles, A.H., Petterson, B.A., Sullivan, S.G., Hussain, R., Glasson, E.J., & Montgomery, P.D. 
(2002). The influence of intellectual disability on life expectancy. The Journals of Gerontology: 
Series A: Biological Sciences and Medical Sciences, 57A, M470-M472.  
Clinical or unrepresentative sample 
23 Bosworth, H.B., & Schaie, K.W. (1999). Survival effects in cognitive function, cognitive style, and 
sociodemographic variables in the Seattle Longitudinal Study. Experimental Aging Research, 
25, 121-139.  
General intelligence measured in 
adulthood 
24 Corley, J., Crang, J.A., & Deary, I.J. (2009). Childhood IQ and in-service mortality in Scottish 
army personnel during World War II. Intelligence, 37, 238-242.  
Clinical or unrepresentative sample 
25 Deary, I. (2008). Why do intelligent people live longer? Nature, 456, 175-176. No empirical data 
26 Deary, I.J. (2005). Intelligence, health and death. The Psychologist, 18, 610-613. No empirical data 
27 Deary, I.J., & Batty, G.D. (2006). Commentary: pre-morbid IQ and later health--the rapidly 
evolving field of cognitive epidemiology. International Journal of Epidemiology, 35, 670-672. 
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28 Deary, I.J., & Der, G. (2005). Reaction time explains IQ's association with death. Psychological 
Science, 16, 64-69.  
Cognitive indicator is not a measure of 
general intelligence 
29 Deary, I.J., Gow, A.J., Taylor, M.D., Corley, J., Brett, C., Wilson, V., … Starr, J.M. (2007). The 
Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to 
age 70 and beyond. BMC Geriatrics, 7, 28.  
No empirical data 
30 Deary, I.J., Whalley, L.J., et al. (2009). Childhood IQ and specific causes of death and mortality-
related physical factors. In I.J. Deary, L.J. Whalley, & J.M. Starr (Eds.) A Lifetime of Intelligence: 
Follow-up Studies of the Scottish Mental Surveys of 1932 and 1947 (pp. 69-83). Washington 
DC, U.S.: American Psychological Association. 
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31 Deary, I.J., Whiteman, M.C., Pattie, A., Starr, J.M., Hayward, C., Wright, A.F., … Whalley, L.J. 
(2004). Apolipoprotein e gene variability and cognitive functions at age 79: a follow-up of the 
Scottish mental survey of 1932. Psychology and Aging, 19, 367-371.  
Outcomes are risk factors for mortality  
32 Eide, M.G., Skjaerven, R., Irgens, L.M., Bjerkedal, T., & Overn, N. (2006). Associations of birth 
defects with adult intellectual performance, disability and mortality: Population-based cohort 
study. Pediatric Research, 59, 848-853.  
IQ-mortality association unreported 
33 Eitinger, L., & Str, A. (1981). New investigations on the mortality and morbidity of Norwegian ex-
concentration camp prisoners. Israel Journal of Psychiatry and Related Sciences, 18, 173-195.  
Clinical or unrepresentative sample 
34 Gale, C.R., Batty, G.D., & Deary, I.J. (2008). Locus of control at age 10 years and health 
outcomes and behaviors at age 30 years: the 1970 British Cohort Study. Psychosomatic 
Medicine, 70, 397-403.  
Outcomes are risk factors for mortality  
35 Gale, C.R., Hatch, S.L., Batty, G.D., & Deary, I.J. (2009). Intelligence in childhood and risk of 
psychological distress in adulthood: The 1958 National Child Development Survey and the 1970 
British Cohort Study. Intelligence, 37, 592-599. 
Outcome is morbidity or cause-specific 
mortality 
36 Gottfredson, L.S. (2004). Life, death, and intelligence. Journal of Cognitive Education and 
Psychology, 4, 23-46. 
No empirical data 
37 Gottfredson, L. S., & Deary, I.J. (2004). Intelligence Predicts Health and Longevity, but Why? 
Current Directions in Psychological Science, 13, 1-4. 
No empirical data 
38 Gunnell, D., Magnusson, P.K.E., & Rasmussen, F. (2005). Low intelligence test scores in 18 
year old men and risk of suicide: cohort study. British Medical Journal, 330, 167. 
Outcome is morbidity or cause-specific 
mortality 
39 Hart, C.L., & Deary, I.J., MacKinnon, P.L., Davey Smith, G., Whalley, L.J., Wilson, V., Hole, 
D.J., & Starr, J.M. (2003). The Scottish mental survey 1932 linked to the Midspan studies: a 
prospective investigation of childhood intelligence and future health. Public Health, 117, 187-
195.  
Outcomes are risk factors for mortality  
40 Hart, C.L., Taylor, M.D., Davey Smith, G., Whalley, L.J., Starr, J.M., Hole, D.J., … Deary, I.J. 
(2004). Childhood IQ and cardiovascular disease in adulthood: prospective observational study 
linking the Scottish Mental Survey 1932 and the Midspan studies. Social Science and Medicine, 
59, 2131-2138.  
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41 Hemmingsson, T., Essen, J.V., Melin, B., Allebeck, P., & Lundberg, I. (2007). The association 
between cognitive ability measured at ages 18-20 and coronary heart disease in middle age 
among men: A prospective study using the Swedish 1969 conscription cohort. Social Science 
and Medicine, 65, 1410-1419.  
Outcome is morbidity or cause-specific 
mortality 
42 Isager, T., Mouridsen, S.E., & Rich, B. (1999). Mortality and causes of death in pervasive 
developmental disorders. Autism, 3, 7-16.  
Clinical or unrepresentative sample 
43 Isohanni, I., Järvelin, M.R., Nieminen, P., Jones, P., Rantakallio, P., Jokelainen, J., & Isohanni, 
M. (1998). School performance as a predictor of psychiatric hospitalization in adult life: A 28-
year follow-up in the Northern Finland 1966 birth cohort. Psychological Medicine, 28, 967-974. 
Outcome is morbidity or cause-specific 
mortality 
44 Lawlor, D.A., Batty, G.D., Clark, H., Macintyre, S., & Leon, D.A. (2008). Association of childhood 
intelligence with risk of coronary heart disease and stroke: findings from the Aberdeen Children 
of the 1950s cohort study. European Journal of Epidemiology, 23, 695-706.  
Outcome is morbidity or cause-specific 
mortality 
45 Lawlor, D.A., Clark, H., & Leon, D.A. (2007). Associations between childhood intelligence and 
hospital admissions for unintentional injuries in adulthood: the Aberdeen Children of the 1950s 
cohort study. American Journal of Public Health, 97, 291-297.  
Outcome is morbidity or cause-specific 
mortality 
46 Lester, D. (1993). Intelligence and suicide in France: an ecological study. Psychological 
Reports, 73, 1226. 
Outcome is morbidity or cause-specific 
mortality 
47 Lester, D. (1995). Intelligence and suicide in Ireland and the United Kingdom. Psychological 
Reports, 77, 122. 
Outcome is morbidity or cause-specific 
mortality 
48 Marmot, M., & Kivimaki, M. (2009). Social inequalities in mortality: A problem of cognitive 
function? European Heart Journal, 30, 1819-1820. 
No empirical data 
49 Martin, L.T., Fitzmaurice, G.M., Kindlon, D.J., & Buka, S.L. (2004). Cognitive performance in 
childhood and early adult illness: a prospective cohort study. Journal of Epidemiology & 
Community Health, 58, 674-679.  
Outcome is morbidity or cause-specific 
mortality 
50 McGurn, B., Deary, I.J., &  Starr, J.M. (2008). Childhood cognitive ability and risk of late-onset 
Alzheimer and vascular dementia. Neurology, 71, 1051-1056. 
Outcome is morbidity or cause-specific 
mortality 
51 Osler, M., & Batty, G.D. (2004). Commentary: influence of early life intelligence test 
performance on later health: do lower scoring children become less healthy adults? International 
Journal of Epidemiology, 33, 414-5. 
No empirical data 
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52 Osler, M., Andersen, A.M., Laursen, B., & Lawlor, D.A. (2007). Cognitive function in childhood 
and early adulthood and injuries later in life: the Metropolit 1953 male birth cohort. International 
Journal of Epidemiology, 36, 212-219. 
Outcome is morbidity or cause-specific 
mortality 
53 Osler, M., Gottfredsen, N.S., & Prescott, E. (2008). Childhood social circumstances and health 
behaviour in midlife: The Metropolit 1953 Danish male birth cohort. International Journal of 
Epidemiology, 37, 1367-1374.  
Outcomes are risk factors for mortality  
54 O'Toole, B.I. (1990). Intelligence and behaviour and motor vehicle accident mortality. Accident; 
Analysis and Prevention, 22, 211-221.  
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Appendix C. Associations between biomarkers in the 1958 
NCDS 
 





CRP  0.56 0.27 0.27 0.19 
Fibrinogen 7,632  0.33 0.15 0.23 
D-dimer 7,560 7,528  0.00 0.18 
t-PA antigen 7,630 7,591 7,523  0.17 
vWF antigen 7,659 7,621 7,551 7,623  
 
Note. Values are Pearson’s product moment correlation coefficients; italicised values are 




Appendix D. Univariate and Multivariate Parameter Estimate 
Formulae 
 
(i) The proportions of variance attributed to additive genetic (
2ĥ ), shared environment 
(
2ĉ ) and unique environment ( 2ê ) effects in univariate models were estimated for 
intelligence and academic achievement scores, as: 
 
ptth OSSS ˆ/)ˆˆ(2
ˆ2   
   ptptc SSOS ˆ/ˆˆ1ˆˆ2   
 222 ˆˆ1ˆ hce   
 
where p̂ is the estimated proportion of MZ twins among same sex pairs 
(Benyamin et al. 2005), and t̂ denotes the intra-class correlations from the between 
and within-pair variances for same-sex ( SSt̂ ) and opposite-sex ( OSt̂ ) twins 
respectively. Proportion of variance due to unique variance (
2ê ) is estimated from 
deducting the previously estimated parameters (
22 ˆˆ ch  ) from unity.  
 
(ii) Additive genetic ( Gr̂ ) and shared ( Cr̂ ) environmental correlations were 
estimated using: 
 
   21)(12)(12 ˆˆˆ/ˆˆ2ˆ hhprrr OSSSG    




where r̂ is the correlation coefficient between two traits for SS ( )(12ˆ SSr ) and 
OS ( )(12ˆ OSr ) twin pairs respectively, and where 1ĥ and 2ĥ  represent the square roots 
of the univariate heritability estimates for traits 1 and 2 respectively, and 1ĉ and 
2ĉ represent the square roots of the shared environment parameters for traits 1 and 2. 
 
(iii) In models to estimate bivariate heritability (Biv 
2ĥ )—that is, the proportion of 
phenotypic covariance due to additive genetic factors (i.e. the ratio of additive 
genetic to phenotypic covariance)—and proportions of covariance due to shared 
(Biv 
2ĉ ) and unique environmental influence (Biv 2ê ), the following formulae 
were used: 
 




     pC rrcccBiv ˆ/ˆˆˆˆ 22122   
 222 ˆˆ1ˆ hBivcBiveBiv   
   
where pr̂ is the phenotypic correlation between two traits, 1
2ĥ  is the heritability estimate for 
trait 1, 2
2ĥ  is the heritability estimate for trait 2, and so on.
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Appendix E. Correlations among the Twenty-07 study variables 
 
1972 cohort 
 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 
1. Simple m wave1  1 .61 .50 .26 -.11 -.18 -.13 .07 .06 -.02 .33 .15 .30 .21 .07 .07 .05 
2. Simple sd wave1  
   
 1 .27 .21 -.06 -.11 -.08 .02 .02 .04 .16 .10 .15 .11 .06 .04 .08 




 1 .66 -.15 -.21 -.23 .06 .07 -.02 .28 .22 .53 .35 .07 .07 .11 






 1 -.13 -.17 -.22 .06 .05 -.03 .18 .20 .38 .33 .05 .07 .09 
5. SES wave1  
 




 1 .29 .38 -.07 -.13 -.00 -.09 -.08 -.19 -.10 -.15 -.11 -.14 










 1 .42 -.04 -.09 -.04 -.13 -.08 -.19 -.11 -.05 -.07 -.09 












 1 -.03 -.11 -.03 -.13 -.13 -.23 -.15 -.14 -.12 -.13 
8. Heart rate wave1                1 .29 -.13 .02 .07 .08 .05 .00 .06 -.10 








 1 -.04 .03 .06 .08 .06 .18 .16 .18 
10. WHR wave1                
 
   1 .04 -.05 -.01 -.16 -.09 -.10 .28 














       1 .57 .53 .26 .04 .01 .01 














       
 
 1 .32 .24 .08 .01 -.02 






















 1 .59 .06 .06 .10 






















 1 .06 .09 -.01 
15. CRP          
 
   
 




   
 
     1 .57 .32 
16. Fibrinogen      
 
   
 
   
 








 1 .19 


















     
 










 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 
1. Simple m wave1  1 .59 .20 .51 -.23 -.21 -.21 .03 .04 -.05 .39 .18 .33 .20 .04 .04 .02 
2. Simple sd wave1  
 
 1 .21 .31 -.11 -.12 -.07 .06 .04 -.03 .26 .25 .22 .17 .03 .02 .02 




 1 .51 -.17 -.19 -.15 .10 .08 -.12 .17 .17 .37 .40 .02 .04 -.01 






 1 -.32 -.29 -.25 .06 .09 .02 .35 .24 .60 .39 .05 .06 .05 








 1 .63 .57 -.05 -.14 .00 -.20 -.12 -.29 -.21 -.09 -.08 -.10 










 1 .50 -.16 -.18 .01 -.15 -.17 -.29 -.25 -.15 -.11 -.09 












 1 -.07 -.11 -.01 -.18 -.11 -.23 -.21 -.09 -.03 -.13 
8. Heart rate wave1      
 




 1 .30 -.12 .02 .04 -.00 .08 .13 .14 .11 












 1 .01 .12 .08 .15 .14 .17 .21 .19 
10. WHR wave1      
 
         
 
   1 -.00 -.01 .05 -.08 -.05 -.04 .34 














   
 
   1 .66 .52 .27 .08 .05 .07 














   
 
   
 
 1 .33 .24 .03 .02 .02 














   
 




 1 .54 .13 .07 .12 


























 1 .16 .10 .04 










       1 .47 .33 








       
 
 1 .11 
17. Meta component                  1 
 





 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 
1. Simple m wave1  1 .63 .45 .09 -.16 -.14 -.22 .04 .00 .09 .27 .13 .23 .05 .02 -.04 .04 
2. Simple sd wave1  
 
 1 .22 .16 -.10 -.11 -.12 .04 -.01 .01 .19 .14 .15 .09 .00 .04 -.01 




 1 .31 -.24 -.24 -.28 -.00 .02 .08 .21 .15 .38 .15 .02 -.07 .00 






 1 -.09 -.11 -.12 -.02 .01 -.16 .08 .08 .23 .24 -.04 -.04 -.05 








 1 .77 .47 .03 -.09 -.01 -.20 -.16 -.24 -.09 -.08 -.04 .03 










 1 .49 -.02 -.14 -.01 -.15 -.10 -.26 -.12 -.06 .00 .05 












 1 .04 -.09 -.04 -.20 -.14 -.20 -.09 -.08 -.03 -.03 
8. Heart rate wave1                1 .22 .03 .06 .03 .10 .08 .07 .12 -.01 




   
 
 1 -.10 .06 .05 .10 .08 .19 .18 .01 
10. WHR wave1  
 
     
 
         
 
 1 .04 .05 .04 -.04 .03 -.02 .27 












       1 .74 .60 .28 .07 -.01 -.01 












       
 
 1 .39 .20 .03 -.02 -.03 














   
 




 1 .66 .11 -.01 -.01 


















 1 .14 .02 -.03 
15. CRP                  
 




 1 .50 .14 




           
 
 1 .10 
17. Meta component                  1 
 
Note. Sample sizes for correlation coefficients are in the range, n = 353 to 528. Coefficients in bold are statistically significant, p < .05
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 Smoker w1 Smoker w5 




n = 117 
-0.06 (0.86) 
n = 621 
Z = -2.53 
p = .02 
0.12 (1.09) 
n = 198 
-0.06 (0.90) 
n = 538 
Z = -2.39 




n = 117 
-0.04 (0.89) 
n = 619 
Z = -0.74 
p = .46 
0.05 (1.04) 
n = 197 
-0.03 (0.95) 
n = 537 
Z = -1.27 




n = 117 
-0.06 (0.93) 
n = 618 
Z = -1.96 
p = .05 
0.29 (1.08) 
n = 197 
-0.12 (0.94) 
n = 536 
Z = -4.80 




n = 117 
-0.04 (0.98) 
n = 619 
Z = -2.80 
p = .005 
0.24 (1.01) 
n = 197 
-0.07 (1.02) 
n = 537 
Z = -4.43 
p < .001 
SES wave1 3.59 (1.39)  
n = 122  
4.06 (1.23)  
n = 628  
t (748) = 3.82 
p < .001 
3.69 (1.26)  
n = 201  
4.09 (1.25)  
n = 547 
t (746) = 3.87 
p < .001 
SES wave5  4.18 (1.12) 
n = 124 
4.62 (1.04) 
n = 634  
t (756) = 4.23 
p < .001 
 4.04 (1.19) 
n = 205 
4.73 (0.96) 
n = 551 
t (754) = 8.18 
p < .001 
Education  12.6 (2.67) 
n = 125 
14.2 (3.17) 
n = 632  
t (755) = 5.31 
p < .001 
 12.9 (2.76) 
n = 205 
14.3 (3.20) 
n = 552 
t (755) = 5.62 




N = 117 
72.4 (9.79) 
N = 623 
t (738) = -3.07 
p = .002 
73.0 (9.62) 
N = 197 
72.9 (10.1) 
N = 541 
t (736) = -.078 




N = 125 
65.4 (10.2) 
N = 630 
t (753) = -2.84 
p = .005 
67.8 (10.2) 
N = 205 
65.1 (10.2 
N = 549 
t (752) = -3.26 
p < .001 
WHR wave1 .850 (.067) 
N = 117 
.855 (.071) 
N = 624 
t (739) = .62 
p = .53 
.863 (.076) 
N = 199 
.850 (.068) 
N = 540 
t (737) = -2.19 
p = .03 
CRP  0.30 (0.51) 
n = 122 
0.20 (0.48)  
n = 629  
t (749) = -2.23 
p = .03 
 0.26 (0.48) 
n = 203 
0.19 (0.48)  
n = 546 
t (751) = -2.27 
p = .02 
Fibrinogen  3.42 (0.75) 
n = 122 
3.28 (0.65) 
n = 620  
t (740) = -2.00 
p = .05 
 3.45 (0.71) 
n = 201 
3.25 (0.65) 
n = 539 
t (738) = -3.69 




n = 119 
-.03 (0.98) 
n = 614 
t (731) = -2.00 
p = .05 
.25 (1.02) 
n = 199 
-.09 (0.98) 
n = 533 
t (730) = -4.20 
p < .001 
MetS Yes: 18.2% 
No: 15.9%  
Yes: 81.8% 
No: 84.1% 
2 (1) = .48 
p = .49 
Yes: 29.2% 
No: 26.6%  
Yes: 70.8% 
No: 73.4% 
2 (1) = .41 

















n = 345 
-0.01 (0.95) 
n = 470 
Z = -.103 
p = .92 
0.09 (1.02) 
n = 212 
-0.03 (0.99) 
n = 606 
Z = -1.79 




n = 345 
-0.04 (0.89) 
n = 470 
Z = -.498 
p = .62 
0.10 (1.06) 
n = 212 
-0.04 (0.98) 
n = 606 
Z = -1.54 




n = 340  
-0.08 (0.95) 
n = 468 
Z = -2.64 
p = .008 
0.18 (1.06) 
n = 209 
-0.06 (0.97) 
n = 602 
Z = -3.32 




n = 340 
-0.07 (0.92) 
n = 467  
Z = -1.77 
p = .08 
0.11 (1.01) 
n = 209 
-0.04 (0.99) 
n = 601 
Z = -2.36 
p < .02 
SES wave1 3.80 (1.30)  
n = 352  
4.40 (1.22)  
n = 484  
t (834) = 6.77 
p < .001 
3.55 (1.29)  
N = 212  
4.35 (1.22)  
n = 624 
t (834) = 8.13 
p < .001 
SES wave5  3.99 (1.37) 
n = 354 
4.52 (1.16) 
n = 485  
t (837) = 6.13 
p < .001 
 3.70 (1.40) 
n = 15 
4.49 (1.17) 
n = 627 
t (840) = 8.11 
p < .001 
Education  12.1 (2.92) 
n = 350 
13.1 (3.25) 
n = 483  
t (831) = 4.86 
p < .001 
 11.6 (2.51) 
n = 212 
13.1 (3.29) 
n = 625 
t (835) = 5.90 




n = 338 
70.1 (9.75) 
n = 469  
t (805) = -2.57 
p = .010 
 73.2 (9.47) 
n = 208 
70.0 (9.73) 
n = 602 
t (808) = -4.13 
p < .001 
Heart rate 
wave5 
 67.2 (11.5) 
n = 344 
65.8 (10.3) 
n = 478  
t (820) = -1.79 
p = .07 
 69.3 (11.3) 
n = 209 
65.4 (10.5) 
n = 617 
t (824) = -4.59 
p < .001 
WHR wave1 .881 (.087) 
n = 335 
.875 (.090) 
n = 465  
t (798) = -0.91 
p = .37 
 .873 (.089) 
n = 205 
.880 (.088) 
n = 598 
t (801) = 1.04 
p = .30 
CRP  0.44 (0.45) 
n = 349 
0.26 (0.46)  
n = 481  
t (828) = -5.73 
p < .001 
 0.46 (0.43) 
n = 213 
0.30 (0.47)  
n = 620 
t (829) = -0.82 
p < .001 
Fibrinogen  3.68 (0.70) 
n = 345 
3.47 (0.68) 
n = 470  
t (813) = -4.33 
p < .001 
 3.77 (0.75) 
n = 213 
3.48 (0.66) 
n = 605 
t (816) = -5.35 




n = 347 
-.13 (0.96) 
n = 469 
t (814) = -4.12 
p < .001 
.14 (1.08) 
n = 212 
-.05 (0.97) 
n = 608 
t (818) = -2.29 
p = .02 
MetS Yes: 45.2% 
No: 40.8%  
Yes: 54.8% 
No: 59.2% 
2 (1) = 1.55 
p = .21 
Yes: 26.9% 
No: 25.3%  
Yes: 73.1% 
No: 74.7% 
2 (1) = .27 

















n = 178 
-0.03 (0.98) 
n = 341 
Z = 1.30 
p = .20 
0.10 (1.02) 
n = 83 
-0.03 (0.99) 
n = 434 
Z = -1.06 




n = 178 
0.02 (1.06) 
n = 341 
Z = -0.24 
p = .81 
0.03 (0.89) 
n = 83 
-0.01 (1.02) 
n = 434 
Z = -.810 




n = 176 
-0.13 (1.00) 
n = 341 
Z = -3.85 
p < .001 
0.24 (1.01) 
n = 82 
-0.06 (0.98) 
n = 433 
Z = -2.29 




n = 176 
-0.07 (0.91) 
n = 341 
Z = -1.76 
p = .08 
0.28 (1.25) 
n = 82 
-0.06 (0.93) 
n = 433 
Z = -2.36 
p = .02 
SES wave1 3.66 (1.39)  
n = 180 
4.05 (1.27)  
n = 348  
t (526) = 3.27 
p = .001 
3.45 (1.43)  
n = 84  
4.00 (1.29)  
n = 442 
t (524) = 3.53 
p < .001 
SES wave5  3.39 (1.41) 
n = 180 
3.93 (1.34) 
n = 348  
t (526) = 4.30 
p < .001 
 3.23 (1.48) 
n = 84 
3.84 (1.35) 
n = 442 
t (524) = 3.77 
p < .001 
Education  9.99 (2.20) 
n = 171 
10.9 (3.06) 
n = 335  
t (504) = 3.61 
p < .001 
 9.95 (2.35) 
n = 79 
10.8 (2.89) 
n = 426 
t (503) = 2.33 




n = 120 
70.0 (9.13) 
n = 235 
t (353) = -3.65 
p < .001 
74.1 (8.32) 
n = 56 
70.7 (9.15) 
n = 298 
t (352) = -2.63 




n = 173 
64.6 (10.8) 
n = 335 
t (506) = -2.72 
p = .007 
67.0 (12.1) 
n = 81 
65.3 (10.8) 
n = 425 
t (504) = -1.31 
p = .19 
WHR wave1 .871 (.077) 
n = 179 
.854 (.080) 
n = 343 
t (520) = -2.26 
p < .001 
.873 (.074) 
n = 84 
.857 (.080) 
n = 436 
t (518) = -1.71 
p = .09 
CRP  0.53 (0.43) 
n = 177 
0.43 (0.41)  
n = 346  
t (521) = -2.58 
p = .01 
 0.51 (0.40) 
n = 83 
0.45 (0.42)  
n = 438 
t (519) = -1.13 
p = .26 
Fibrinogen  3.80 (0.79) 
n = 170 
3.71 (0.72) 
n = 335  
t (503) = -1.19 
p = .24 
 3.88 (0.85) 
n = 80 
3.72 (0.72) 
n = 423 
t (501) = -1.77 




n = 172 
-.01 (0.98) 
n = 338 
t (508) = -.321 
p = .75 
.03 (1.02) 
n = 80 
-.01 (1.00) 
n = 429 
t (507) = -.280 
p = .78 
MetS Yes: 33.5% 
No: 34.5%  
Yes: 66.5% 
No: 65.5% 
2 (1) = .05 
p = .82 
Yes: 13.3% 
No: 17.4%  
Yes: 86.7% 
No: 82.6% 
2 (1) = 1.51 





Appendix G. Inverse probability weights for wave5 of Twenty-
07 Study 
 
The following procedures were conducted by Shaun Seaman from the MRC 




In the Twenty-07 study not all subjects attended wave5, causing a problem for any 
analysis involving variables measured at wave5. One way to deal with this problem 
would be to restrict the analysis just to those subjects attending Wave5. However, 
these individuals may be unrepresentative of the full cohort, leading to biased 
estimation. Inverse probability weighting can be used to weight the set of the 
subjects attending Wave5 to make them more representative of the full cohort and 
hence reduce this bias. 
 
This text explains how inverse-probability weights for wave5 of the Twenty-07 study 
were derived. Four sets of weights were derived: one for all subjects attending 
wave5; one for subjects attending all of waves 1–5; one for subjects providing a 
blood sample at wave5; and one for subjects attending all of waves 1–5 and 
providing a blood sample. The first set can be used if the analysis involves only 
variables measured at waves 1 and 5; the second, if it involves also variables 
measured at waves 2, 3 or 4. The third and fourth sets can be used if the analysis 
involves data from the blood samples. 
 
Description of Wave-Missingness Pattern 
 
4,510 subjects attended wave1. Of these, 3,861 (86%) were still alive at wave5. We 
assume that the purpose of any analysis is to make inference about the population 
still alive at the time of wave5. So, we weight the subjects who attended wave5 to 
make them representative of the whole set of 3,861 subjects still alive at wave5. 
2,604 (67%) of the 3,861 subjects alive at the time of wave5 attended wave5; of 
these, 2242 (86%) gave a blood sample at wave5. 
 
Non-monotone wave5 weights 
 
We divided the subjects into eight sets according to the last wave they attend prior to 
wave5 and according to whether or not they are in the youngest cohort. We call this 
last attended wave prior to wave5 the ‘latest wave’. Due to the small number of 
subjects attending wave5 but not attending either wave3 or wave4, we combined the 
sets of subjects whose latest wave was 1 with those whose latest wave was 2. Thus, 
the eight sets were reduced to six. 
 
For each of these six sets, a logistic regression model was specified for the 
probability that a subject in that set would attend wave5 and this model was fitted to 
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the subjects in that set. This model used as covariates the most up-to-date 
information available on a number of factors that may affect this probability. Thus, 
for example, in the set of subjects whose latest wave was 3, the covariates used 
included car ownership, drinking behaviour, etc. at wave3, whereas for those whose 
latest wave was 4, they included car ownership, drinking behaviour, etc. at wave4. 
For the set of subjects whose latest wave was 1 or 2, information at wave1 was used, 
as this was available for all subjects in the set. The regression model for the youngest 
cohort included more covariates than were in the model for the middle and oldest 
cohort, because the youngest cohort was asked additional questions, e.g. about school 
and involvement with the police. The ‘non-monotone wave5 weights’ are the inverse 
of the fitted probabilities from these logistic regression models. 
 
The covariates used were: 
 
 Whether in the Region or the Locality sample 
 For subjects in the Locality sample, whether in South-West or North-West 
 Sex 
 Religion 
 Car ownership 
 Self-assessed health (4-level ordinal variable) 
 Smoking (non, current, or ex) 
 Alcohol Drinker (non, current, or ex) 
 Whether returned self-completion questionnaire 
 Social class (professional, other non-manual, or manual) 
 Housing tenure 
 Longstanding illness 
 Housing (detached, semi-detached or terraced, flat or other) 
 Marital status (never married, married, separated or divorced or widowed) 
 Economic status (full-time education, employed, unemployed or government 
training scheme, caring or retired or disabled/sick) 
 In hospital in previous year 
 Log of total number of times in hospital ever at Wave1 
 Carer 
 Registered disabled 
 Total IQ score from AH4 
 
 
For the youngest cohort, the following variables were used in addition: 
 
 Ever used drugs 
 I cannot wait to leave school (measured at wave1 only) 
 If I get a chance to dodge school I do (measured at wave1 only) 
 Trouble with police or in court during 12 months prior to wave1 







Weights for the wave5 Blood Sample 
 
Corresponding to the non-monotone wave5 weight is the weight for the wave5 blood 
sample. The ‘non-monotone blood weights’ is suitable for an analysis involving only 
variables measured at waves 1 and 5 and in the blood sample. The probability that a 
subject attends wave5 and provides a blood sample is the product of the probability 
that he/she attends wave5 and the conditional probability that he/she provides a 
blood sample given that he/she has attended wave5. The estimation of the first of 
these probabilities was described above. The second probability was estimated using 
a logistic regression model, fitting it to the subjects attending wave5. The same set of 
factors as described above was used as covariates in this model, as usual using the 
latest recorded values of these factors, i.e. the values measured at wave5. The non-
monotone blood weights are then the product of the two fitted probabilities.  
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Appendix G. Sex x RT interaction effects in predicting 
inflammatory status: Twenty-07 study 
 
 





Sex interacted with simple and choiceRT sd at wave1, in linear regression models 
predicting CRP: 
 
The association between baseline simpleRT sd and lower CRP levels 20 years later was 
only evident in females (green line) – see left chart above. In a linear regression model 
adjusting for age, oral contraceptives, sex, and simpleRT sd, the Sex x RT interaction 
effect was statistically significant:  
 
Coefficient = .079 [95% CI .015 to .142], p = .016 
 
The association between more consistent baseline choiceRT and lower CRP levels 20 
years later was only evident in males (blue line) – see right chart above. In a linear 
regression model adjusting for age, oral contraceptives, sex, and choiceRT sd, the 
interaction effect was statistically significant:  
 








Sex x RT interaction effects reached statistical significance in logistic regression models 
predicting high CRP levels at wave5. The 95% CIs show these effects in men (blue) and 
women (green), which were significant for: 
 
Sex x SimpleRT sd OR = 0.69 [95% CI 0.55, 0.87], p < .001 (see left chart) 
Sex x ChoiceRT m OR = 1.28 [95% CI 1.02, 1.61], p = .031 (see right chart) 




Sex x RT in predicting inflammatory biomarkers: 1952 
cohort 
 
Sex interacted with simpleRT m at wave1 in predicting Fibrinogen. The association between 
faster simpleRT and lower fibrinogen 20 years later was only evident in men (blue line) – 
see chart above left. In a linear regression model adjusting for age, sex, and simpleRT mean, 
the Sex x RT interaction effect was statistically significant:  
 
Coefficient = -.002 [95% CI -.003 to -.001], p = .006 
 
At wave5 sex interacted with CRP in predicting ChoiceRT sd. The association between more 
consistent ChoiceRT and lower CRP was more evident in men (blue line) than women 
(green line) – see chart above right. The direction of association however was the same in 
both sex groups: 
 




















Sex interacted with simpleRT sd at wave1 in predicting Fibrinogen. The association 
between more consistent simpleRT and lower fibrinogen 20 years later was only evident 
in women (green line), and the reverse trend was seen for men. In a linear regression 
model adjusting for age, sex, and simpleRT mean, the Sex x RT interaction effect was 
statistically significant: 
 





Sex x RT in predicting high CRP: 1952 cohort 
 
 
Sex x RT interaction effects reached statistical significance in logistic models predicting 
high CRP levels at wave5. These 95% CIs show the effects for men (blue) and women 
(green), which were significant for: 
 
Sex x SimpleRT m OR = 2.31, SE = 1.10, p = .036 
Sex x ChoiceRT m OR = 5.94, SE = 2.35, p = .011 



















Sex x RT interaction effects reached statistical significance in linear regression models 
predicting metabolic component score at wave5. The 95% CIs show these effects in men 
(blue) and women (green), which were significant for: 
 
Sex x SimpleRT sd coefficient = .205 [.076, 0.334], p = .002 
 
